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SUMMARY 
Anoctamins are a family of Ca
2+
 activated Cl
-
 channels (CaCCs) that are ubiquitously 
expressed in almost every cell type in our body. Anoctamins play an essential role in volume 
regulation, epithelial Cl- secretion, neuronal excitability, and also nociception. Mutations in 
anoctamin proteins lead to various diseases including bone and muscle dystrophy, cerebellar 
ataxias, and blood coagulation defect. More importantly, up-regulation of anoctamins is 
highly linked to different types of cancers. This family of proteins were identified 2004 but 
their precise function is still under examination. In the following chapters I investigated how 
these channels are regulated, to get a better understanding of how they function as CaCC. I 
demonstrate that i) anoctamins are a family of CaCCs, ii) they produce volume-regulated 
chloride currents, iii) activation of Ano1 occurs in a calmodulin-dependent way, and iv) 
INO-4995 and other inositolphosphates control Ano1. 
Anoctamins are a family of Ca
2+ 
activated Cl
-
 channels 
Ano1 and 2 are reported to be CaCCs, Ano6 operates as an essential component of the 
outwardly rectifying chloride channel (ORCC), while others were reported as intracellular 
proteins. It is therefore unclear whether anoctamins constitute a family of CaCCs, or reflect 
proteins with heterogeneous functions. Using whole cell patch clamping we demonstrate that 
Ano4-10 are able to produce transient Ca
2+
 activated Cl
-
 currents, when expressed in HEK293 
cells. While some anoctamins (Ano1,2,4,6,7) were found to be well expressed in the plasma 
membrane, others (Ano8,9,10) show rather poor membrane expression and are mostly 
retained in the cytosol. The transient nature of the Cl
-
 currents produced by Ano1 may be due 
to deactivation occurring via a calmodulin-dependent kinase. The present results demonstrate 
that anoctamins are a family of CaCCs, which also induce permeability for cations. They are 
located in the plasma membrane or in intracellular compartments. Our results will support 
understanding of the physiological significance of anoctamins and their role in disease.  
Anoctamin proteins produce volume-regulated chloride currents 
All vertebrate cells can regulate their volume through activating chloride channels during 
regulatory volume decrease. Ano1 and other anoctamins function as CaCC. They play a role 
during cell swelling and are activated by an autocrine mechanism that involves ATP release 
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and binding to purinergic P2Y2 receptors. A Ca
2+
 independent mechanism which engages 
extracellular-regulated protein kinases (ERK1/2) is also an important step during Ano1 
activation induced by cell swelling. Swelling activated Cl
-
 currents are abolished in the 
colonic epithelium and in salivary acinar cells in Ano1 knockout mice. Thus, amoctamin 
proteins constitute a crucial component of epithelial volume-regulated Cl
-
 channels and may 
also have a function during cellular proliferation and apoptotic cell death. 
Calmodulin-dependent activation of Ano1 
Ano1 is activated upon an increase in intracellular Ca
2+
 concentration, but it is unclear 
whether Ca
2+
 binds directly to the channel or whether additional components are required. We 
demonstrate that Ano1 is strictly plasma membrane localized and requires cytoskeletal 
interactions to be fully activated. Despite the need for cytosolic ATP for full activation, 
phosphorylation by protein kinases is not required. In contrast, the Ca
2+
 binding protein 
calmodulin appears indispensable and interacts physically with Ano1. Openers of small- and 
intermediate-conductance Ca
2+
 -activated potassium channels known to interact with 
calmodulin also activated Ano1. These results reinforce the use of these compounds for 
activation of electrolyte secretion in diseases such as cystic fibrosis (CF).  
Control of Ano1 by INO-4995 and other inositolphosphates 
Earlier studies suggested CaCCs are regulated by membrane lipid inositol phosphates, and 
augmented by 1-O-octyl-2-O-butyryl-myo-inositol 3,4,5,6-tetrakisphosphate octakis 
(propionoxymethyl) ester (INO-4995). Here we examined whether Ano1 is a target of 
INO-4995, and if the channel is regulated by inositol phosphates. We found that INO-4995 
directly activates Ano1 in Ano1 over expressing cells. The tetrakisphosphates Ins(3,4,5,6)P4 
or Ins(1,3,4,5)P4 and enzymes controlling levels of InsP4 or PIP2 and PIP3 had no effects on 
the magnitude or kinetics of Ano1 currents. In contrast in Xenopus oocytes, human airways 
and colonic epithelial cells, which endogenously express Ano1, Cl
-
 currents were not acutely 
activated by INO-4995. However incubation with INO-4995 augmented Ano1-dependent 
currents activated by ionomycin or ATP in Xenopus oocytes and human airways epithelial 
cells, while intracellular Ca
2+
 signals were not affected. Our data indicate that Ano1 is the 
target for INO-4995, although the mode of action appears different for over-expressed and 
endogenous channels. INO-4995 may be useful for the treatment of CF lung disease. 
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ZUSAMMENFASSUNG 
Anoctamine sind eine Familie von Ca
2+
 aktivierten Cl
-
 Kanälen (CaCCs), die ubiquitär in den 
meisten Zellen des Körpers exprimiert werden. Anoctamine spielen eine essentielle Rolle für 
die Volumenregulation, epitheliale Sekretion, neuronale Erregbarkeit und auch für die 
Nozizeption. Mutationen der Anoctamin-Proteine führen zu verschiedenen Erkrankungen wie 
Knochen- und Muskeldystrophie, zerebrale Ataxie und zu Defekten der Blutstillung. Darüber 
hinaus ist eine erhöhte Expression von Anoctaminen mit verschiedenen Krebsarten verbunden. 
Die Proteinfamilie wurde 2004 identifiziert, aber bis heute ist die exakte Funktion dieser 
Proteine unbekannt. In den folgenden Kapiteln untersuchten wir wie diese Kanäle reguliert 
werden, um ein besseres Verständnis über deren Funktion als CaCC zu bekommen: 
Anoctamine sind eine Familie von CaCCs, sie produzieren einen volumenregulierten 
Chloridstrom, Aktivierung von Ano1 ist von Calmodulin abhängig und schließlich 
kontrollieren INO-4995 und andere Inositolphosphate Ano1. 
Anoctamine sind eine Familie von Ca
2+
 aktivierten Cl
-
 Kanälen 
Ano1 und 2 sind als CaCCs beschrieben worden. Ano6 ist eine wichtige Komponente des 
auswärtsgleichgerichteten Chloridkanals (ORCC), während die anderen Anocatmine als 
intrazelluläre Proteine vorliegen. Es ist deswegen unklar, ob die Anoctamine eine Familie von 
CaCCs bilden, oder ob sie Proteine mit unterschiedlichen Funktionen darstellen. Mittels der 
Patch- Clamp- Technik in der Ganzzell-Konfiguration konnten wir zeigen, dass Ano4-10 in 
der Lage sind transiente Ca
2+
 aktivierte Cl
-
 Ströme zu produzieren, wenn sie in HEK293 
Zellen exprimiert werden. Während manche Anoctamine (Ano1, 2, 4, 6, 7) in der 
Plasmamembran exprimiert werden, zeigen andere (Ano8, 9, 10) nur eine schwache 
Expression in der Plasmamembran und verbleiben eher zytosolisch. Die transiente Natur des 
Cl
-
 Stroms von Ano1 könnte durch eine Deaktivierung über eine Calmodulin- abhängige 
Kinase zustande kommen. Die vorliegenden Ergebnisse demonstrieren, dass Anoctamine eine 
Familie von Ca
2+
 aktivierten Cl
-
 Kanälen sind, die auch für Kationen permeabel sind. Sie sind 
sowohl in der Plasmamembran als auch im Zytosol lokalisiert. Unsere Ergebnisse werden das 
Verständnis über die physiologische Bedeutung der Anoctamine bei der Entstehung von 
Krankheiten vertiefen. 
Anoctamin Proteine erzeugen einen volumen-regulierten Chlorid Strom 
Alle vertebralen Zellen können ihr Volumen durch die Aktivierung eines Chlorid Kanals 
während der regulatorischen Volumenabnahme regulieren. Ano1 und andere Anoctamine sind 
funktionell CaCCs. Sie spielen eine Rolle während des Zellschwellens und werden über einen 
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autokrinen Mechanismus, über ATP Freisetzung und Aktivierung von purinergen P2Y2 
Rezeptoren aktiviert. Ein Ca
2+
 unabhängiger Mechanismus, an dem extrazellulär-regulierte 
Protein Kinasen (ERK1/2) beteiligt sind, ist ein zusätzlicher wichtiger Schritt für die 
Aktivierung von Ano1 durch Zellschwellung. Durch Schwellung aktivierte Cl
-
 Ströme sind 
reduziert in Epithelzellen des Kolons und Azinuszellen der Speicheldrüse von Ano1 
defizienten Mäusen. Darum sind Anoctamin Proteine eine kritische Komponente von 
epithelialen volumen-regulierten Cl
-
 Kanälen und haben deswegen auch eine Funktion 
während der Zellteilung und der Apoptose. 
Calmodulin- abhängige Aktivierung von Ano1 
Ano1 wird während des Anstiegs der intrazellulären Ca
2+
 Konzentration aktiviert, aber es ist 
unklar ob Ca
2+
 direkt am Kanal wirkt oder ob zusätzliche Komponenten gebraucht werden. 
Wir konnten zeigen, dass Ano1 grundsätzlich in der Plasmamembran lokalisiert ist und 
zytoskeletale Interaktionen für die vollständige Aktivierung benötigt. Zytosolisches ATP ist 
für die vollständige Aktivierung notwendig, eine Phosphorylierung durch Kinasen jedoch 
nicht. Dagegen ist das Ca
2+
-bindende Protein Calmodulin unabdingbar für die Aktivierung 
und interagiert physikalisch mit Ano1. Öffner von Ca
2+
 aktivierten Kalium Kanälen mit 
kleinen und mittleren Leitfähigkeiten, die mit Calmodulin interagieren, aktivieren auch Ano1. 
Diese Ergebnisse bekräftigen die Verwendung von diesen Verbindungen für die Aktivierung 
einer Elektrolytsekretion in Krankheiten wie Mukoviszidose. 
Kontrolle von Ano1 durch INO-4995 und anderen Inositolphosphaten 
Frühere Studien deuteten an, dass CaCCs über das Membranlipid Inositolphosphat reguliert 
wird und die Aktivität über 1-O-octyl-2-O-butyryl-myo-inositol 3,4,5,6-tetrakisphosphate 
octakis (propionoxymethyl) ester (INO-4995) verstärkt werden kann. Wir untersuchten 
deswegen, ob Ano1 ein Angriffsziel für INO-4995 ist und ob Ano1 durch Inositolphosphate 
reguliert wird. Wir fanden, dass INO-4995 in Ano1 überexprimierten Zellen direkt Ano1 
aktiviert. Tetrakisphosphat Ins(3,4,5,6)P4 oder Ins(1,3,4,5)P4 und Enzyme, die den Gehalt von 
InsP4 oder PIP2 und PIP3 regulieren, hatten keinen Effekt auf die Größe oder Kinetik des 
Ano1 Stroms. Dagegen wurde der endogene Cl
-
 Strom in Xenopus Oozyten, humanen 
Luftwegs- und Kolonepithelzellen nicht akut von INO-4995 aktiviert. Allerdings wurde der 
Ano1-abhängige Strom, aktiviert durch Ionomycin oder ATP, nach Inkubation mit INO-4995 
in Xenopus Oozyten und humanen Luftwegsepithelzellen verstärkt, während der intrazelluläre 
Ca
2+
 Signalweg nicht beeinflusst wurde. Unsere Daten zeigen, dass Ano1 ein Angriffsziel für 
INO-4995 ist, obwohl die Art der Aktivierung in über-exprimierten oder endogenen Kanälen 
unterschiedlich ist. Ino-4995 könnte für die Behandlung der Mukoviszidose von Nutzen sein. 
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CHAPTER 1 
Introduction 
Ion channels are pore-forming proteins that help establish and control the voltage gradient 
across the plasma membrane of cells by allowing the flow of ions down their electrochemical 
gradient. Gated ion channels consist of one or more subunits with amphipathic α helical 
membrane-spanning segment. Ion channels have four functional components. 1) Gating of the 
ion channel; these membrane proteins have several conformations that can result in an open or 
closed channel; 2) ion channel sensors: which can detect different signals, for example: (a) 
membrane potential changes; (b) second messenger, which can be sensed at the cytoplasmic 
side of the plasma membrane; (c) ligands, which bind to the extracellular side of these 
membrane proteins; 3) the selectivity filter through which ions with positive or negative 
charge or only one class of ions can go through; 4) the pore, when the channel opens, the 
selectively permeable ions can get through freely down their chemical gradient. As mentioned 
above, the ion channels can be classified by the particular ions that are conducted by the 
channel pore, so subsequently I will refer to them as sodium, potassium, calcium, water, and 
chloride channels. 
Sodium channels are ion channels, which can primarily conduct sodium ions through a cell's 
plasma membrane. Na
+
 is the most abundant cation in extracellular fluid in our body. Since 
extracellular Na
+
 concentration is much higher than the intracellular one, equilibrium 
potential for Na
+
 is always positive, so when sodium channel is open, Na
+
 will move down its 
chemical gradient and get into the cell, inducing membrane voltage depolarization. For 
example, diffusion of Na
+
 through epithelial sodium channels (ENaC) leads to absorption of 
salt and water. ENaC is expressed in many epithelial tissues; among them are endometrial 
epithelial cells. Through ENaC activation and membrane voltage depolarization, voltage 
gated calcium channels are activated to induce prostaglandin E2 (PGE2) production, a key 
step for embryo implantation (139). 
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Potassium channels are the most widely distributed type of ion channels, ubiquitously 
expressed in virtually all living organisms. The equilibrium potential for K
+
 is strongly 
negative and usually plays a role in generating cell resting membrane potential, so K
+
 is either 
at equilibrium or tends to move out of the cell, nevertheless inwardly rectifying K
+ 
channels 
are responsible for K
+ 
influx into the cell. Other kinds of K
+
 channels play a key role in 
excitable cells, where these channels help terminate action potentials. 
Calcium channels are ion channels, which display selective permeability to calcium ions. 
The equilibrium potential for Ca
2+
 is always positive, so Ca
2+
 tends to flow into the cell. 
When Ca
2+
 channels are open, Ca
2+
 rapidly enters the cell down a steep electrochemical 
gradient. This inward movement of Ca
2+
 is a very important signal, because Ca
2+
 is a common 
second messenger with downstream effects on many cellular processes.  
Water channels are membrane proteins that form channels that are just large enough to allow 
water molecules to pass through. The first identified water channel was aquaporin 1 (AQP1), 
a 28-kDa protein. AQP1 belongs to a large family of aquaporins that have representatives in 
organisms as diverse as bacteria, plants and animals (2). In mammals the various aquaporin 
isoforms have different tissue distributions, different mechanisms of regulation, and varying 
abilities to transport small neutral molecules other than water. In the lipid bilayer, AQP1 exists 
as tetramers. Each monomer consists of six membrane-spanning helices as well as two shorter 
helices that dip into the plane of the membrane (147). These structures form a permeation 
pathway for the single-file diffusion of water. Since most of the other channels are permeable 
for different cations, Cl
-
 channel is the most important anion channel for balancing cation 
movement and to move Cl
-
 either into or out of the cell. I will thus focus on Cl
-
 channels. 
Chloride channels 
Cl
-
 channels are ubiquitously expressed and found in all eukaryotic cells, plant cells, protozoa, 
bacteria and yeast. In contrast to cation channels, they generally have a role in nonexcitable 
cells such as epithelial cells, where they participate in electrolyte secretion. Chloride ion 
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channel research has been neglected for many years. It is now appreciated that these channels 
play important functional roles in diverse processes, such as blood pressure regulation, cell 
cycle and apoptosis, muscle tone, volume regulation, synaptic transmission and even cellular 
excitability (121). Cl
-
 channels form pores in the plasma membrane and in intracellular 
membranes and are permeable to various anions, such as iodide, bromide, but also for nitrates, 
phosphates and even negatively charged amino acids. We refer mostly to these anion channels 
as Cl
-
 channels, because Cl
-
 is the most abundant anion in all organisms. From the functional 
point of view, Cl
-
 channels have been classified according to their gating mechanisms, which 
may depend on changes in the cell volume, transmembrane voltage, on a protein 
kinase/nucleotide mediated mechanism, an increase in intracellular Ca
2+
 concentration, or 
binding of a ligand. They also participate in many housekeeping processes, for example 
volume regulation, pH regulation in organelles, electro genesis and control of synaptic activity. 
The Cl
-
 channels are important for transepithelial transport and the control of water flow, and 
because their selectivity is not strict, they often provide permeation pathways for a large 
variety of anions.  
CFTR and others Cl
-
 channels 
The most extensively examined Cl
-
 channel is the cystic fibrosis transmembrane conductance 
regulator (CFTR). Mutations of this channel cause the most common fatal genetic disorder 
among the Caucasian population. Cystic fibrosis (CF) is an autosomal recessive disorder that 
results in an abundance of thick airway mucus, pancreatic insufficiency, obstruction of the 
bile ducts, high sweat chloride, intestinal blockage, nasal polyps and chronic sinusitis (28). 
CFTR is a cAMP dependent Cl
-
 channel that is expressed in the apical membrane of epithelial 
cells (151). In the airways, where CF patients show the most serious defect, CFTR and CaCCs 
have intensive cross talk (Fig. 1) (98). It was reported that purinergic receptors such as P2Y2 
or P2Y6 couple to both second messengers: cAMP and Ca
2+
 (49). Intracellular Ca
2+
 affects the 
activity of enzymes that control intracellular cAMP levels such as adenylate cyclase and 
phosphodiesterase (119). On the other hand, cAMP affects proteins that control intracellular 
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Ca
2+
 levels for example the endoplasmic reticulum (ER) Ca
2+ 
ATPase SERCA or IP3 receptors 
(18). Intracellular Cl
-
 via the Cl
-
 channel Best1 affects Ca
2+ 
transport across the ER- 
membrane and Ca
2+ 
influx via ORAI and TRP channels, because Cl
-
 serves as a counter ion 
for Ca
2+
 (10). Recently we proposed that CFTR translocates a proton receptor to the plasma 
membrane of Xenopus oocytes and allows for extracellular protons to activate CaCCs (89). 
CFTR and Ano1/6 may interact directly or through scaffold proteins such as NHERF1 or 
other PDZ-domain proteins. Finally, other novel messengers like the IP3-receptor binding 
protein IRBIT may link IP3/Ca
2+ 
signaling to CFTR (194). 
 
Fig. 1: Ca
2+
-dependent Cl
−
 secretion may occur at several levels. (i) Purinergic receptors such 
as P2Y2/P2Y6 increase both intracellular cAMP and Ca
2+
. (ii) Intracellular Ca
2+
 affects the 
activity of enzymes that control intracellular cAMP (adenylate cyclase, AC; 
phosphodiesterase, PD). (iii) Intracellular cAMP affects proteins that control intracellular Ca
2+
 
levels (SERCA). (iv) Intracellular Cl
−
 concentration affects Ca
2+
 transport over the 
ER-membrane (via the Cl
−
 channel Best1) and Ca
2+
 influx (via ORAI/TRP). (v) CFTR and 
TMEM16A/F may interact directly or through scaffold proteins (NHERF1 and other 
PDZ-domain proteins). (vi) CFTR translocates Gq-coupled receptors to the plasma membrane 
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that allow for Ca
2+
 increase and activation of TMEM16A. (vii) Novel messengers like IRBIT 
link IP3/Ca
2+
 signaling to CFTR. 
Another very well studied and understood family of Cl
-
 channel is the ClC chloride channels 
family, which is a family of voltage dependent Cl
-
 channels. Mammalian tissues contain nine 
different genes that encode for ClC channels (79). The volume regulated anion channel 
(VRAC) is ubiquitously expressed in animal cells and is involved in cell volume regulation, 
cell division, apoptosis, transport processes, metabolism and the regulation of electrical 
excitability (45; 146). Although biophysical properties had been extensively discussed, its 
molecular identity has not yet been identified. Until recently this was also the case for calcium 
activated Chloride channels (CaCCs). For a long time its molecular identity was unknown. 
From here, I will focus on CaCCs, because these are the Cl
- 
channels I work most intensively 
on during my thesis.  
Calcium activated chloride channels 
Ca
2+
 activated Cl
-
 channels are abundant proteins and are present in many different cell types, 
although with slight differences regarding their biophysical properties and pharmacology (51; 
63). CaCCs play various roles in cell physiology including epithelial secretion (166), sensory 
transduction and adaptation (158), regulation of smooth muscle contraction (103), control of 
neuronal and cardiac excitability (39), and also nociception (105). Prior to 2008, the proteins 
responsible for CaCCs were unknown; indeed, several other proteins were proposed as 
molecular candidates. These proteins included ClC-3 (73), ClCAs (107), and the bestrophins 
(11).  
ClC-3 belongs to voltage-gated chloride channel superfamily and may be responsible for the 
volume-regulated outwardly rectifying Cl
-
 current (40). Although reported as Ca
2+
 activated 
Cl
-
 channels, there is serious doubt that ClCAs are even ion channels at all. It has been 
suggested that they are more likely accessory proteins of ion channels (126). In contrast 
bestrophin-1 is expressed in the retinal pigment epithelium and certain mutations in 
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bestrophin-1 cause degeneration of the retina and blindness (95). Bestrophin-2 is expressed in 
goblet cells of the colon and may play a role in bicarbonate secretion (199). Although 
bestrophins are indeed CaCCs, their expression and functional roles are more restricted.  
Only recently it has been reported simultaneously by three independent groups that 
TMEM16a and b, which are also named anoctamin 1 (Ano1) and anoctamin 2 (Ano2), belong 
to a family of ten members of unidentified proteins with 8 membrane spanning domains. 
These proteins have been reported as the true molecular identities of CaCCs (19; 149; 197). 
One might speculate that the other members of the anoctamin family also function as CaCCs 
and contribute to calcium activated chloride current in different tissues. If they are, this is an 
exciting finding since these proteins have previously attracted significant interest in other 
research fields, particularly cancer and developmental biology.  
There is hardly any tissue in which CaCCs does not have at least a modulatory role, and 
consequently anoctamins are expressed in all of these tissues (97). The character of Cl
- 
currents generated by Ano1 fit very well to endogenous CaCC currents. Obviously, silencing 
of Ano1 in different cells abolishes CaCC currents and mice in which knockdown of Ano1 
produces defects in calcium dependent Cl
-
 secretion in a number of tissues, which support the 
concept of Ano1 forming an essential component of CaCC (124; 137; 169). 
The physiological role of Ano1  
Ano1 is widely expressed in epithelia including salivary gland, pancreas, gut, mammary 
glands and the airways (97). Ano1 also performs important functions in nonepithelial tissues, 
namely its pacemaker activity in the gut and regulation of vascular and airway smooth muscle 
tone (26; 120). Ano1 can also mediate nociceptive signals. It is expressed in small dorsal root 
ganglion neurons and triggered by bradykinin (105), which is a very potent inflammatory and 
pain inducing substance. 
The structure of Ano1 
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Fig. 2: Topological Models of mAno1. The locations of HA tags are indicated with gray 
numbers. Left, Re-entrant loop model. Right, revised model. The topology of the sequence 
depicted in gray remains in question. 
The tertiary structure of Ano1 contains eight predicted transmembrane helices, intracellular 
NH2- and COOH ends and a pore, formed by the 5
th
 and 6
th 
transmembrane helices together 
with a p-loop dipping back into the membrane (Fig. 2 left). However, in 2012 the research 
team led by Criss Hartzell proposed an alternative model for Ano1. Their data contradict the 
popular re-entrant loop model by showing that the putative extracellular loop 4 (amino acids 
650-706) is oriented intracellularly and may contain a Ca
2+
 binding site (Fig. 2 right) (198). In 
this new model, there is no putative pore forming domain and the authors also did not find the 
selectivity filter, so the true structure of Ano1 still needs to be determined. It is also indicated 
that Ano1 does not exist as a single protein, but as obligate homodimer (47; 153). As the 
quaternary structure of Ano1 is not altered by changes in cytosolic Ca
2+
, dimerization appears 
to be permanent.  
Different splicing of Ano1  
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Human Ano1 primary transcript undergoes alternative splicing. Three alternative exons: 6b, 
13, and 15, corresponding to segments b, c, and d, respectively, which are differently spliced 
in human organs. Alternative splicing of Ano1 gene has an impact on ion channel properties 
(52). For example, skipping of exon-6b may increase Ca
2+
 sensitivity, while skipping of exon 
13 abolishes the characteristic time-dependent activation observed for CaCCs. 
Gating of Ano1 
Ano1 is gated by both voltage and Ca
2+
, but unlike voltage-gated channels that have 
amphipathic transmembrane helices with charged amino acids that serve to sense voltage, or 
EF hand to bind to Ca
2+
, Ano1 has no such sequences. Deletion of the alternatively-spliced 
segment (ΔEAVK) alters both voltage-dependent gating and Ca2+ sensitivity (191). One 
candidate for the Ca
2+ 
binding site is a stretch of five glutamic acids located in the first 
intracellular loop because of its resemblance to the “Ca2+ bowl” of the large-conductance K+ 
channel (191). Another candidate for Ca
2+
 sensors are E702 and E705, and mutation of these 
glutamates residues dramatically altered Ca
2+
 sensitivity (198). Except for the Ca
2+
 binding 
site, calmodulin (CAM) is also a good candidate that could serve as an accessory subunit for 
Ca
2+
 dependent Ano1 activation. CAM is a calcium-binding messenger protein that is 
activated by binding of Ca
2+
 and then modifies its interactions with various target proteins. 
We reported that CAM binds to a 22-amino acid region that overlaps with the b segment in 
the N-terminus called CAM-BD1 and is essential for Ano1 activation (169).  
Ano1 and cancer 
Ano1 has also attracted the interest of cancer biologists because the gene is amplified in head, 
and neck squamous cell carcinomas, parathyroid tumors, breast, pancreatic and gastric cancer 
and its expression level may correlate with cell proliferation (84). Gastrointestinal stromal 
tumor (GIST) is the most common kind of mesenchymal tumor found in the gastrointestinal 
tract. Ano1 is highly upregulated in these tumors (46). Although Ano1 may not be the cause of 
the tumor, its function may support tumor progression. 
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Other anoctamins 
Members of the anoctamin family are found throughout the eukaryotes, including mammals, 
flies, worms, plants, protozoa and also yeast. However, the anoctamins seem to be best 
represented in higher vertebrates. Mammals have 10 genes encoding anoctamin family 
members, whereas invertebrates and plants have distinctly fewer. C. elegans, for example, has 
only two Anoctamin genes and Drosophila has six paralogues (64). The phylogenetic tree (Fig. 
3) (197) shows how different members of anoctamins are constructed through evolution. 
Ano2 is the closest relative of Ano1 in the phylogenetic tree (Fig. 3), and it displays similar 
electrophysiological properties when compared to Ano1. In olfactory sensory neurons, 
odorants binding to G-protein coupled olfactory receptors open cyclic nucleotide gated 
channels by elevating cAMP (65). Ca
2+
 influx through the cyclic nucleotide gated channels 
then activates CaCCs that depolarize the receptor potential. Ano2 localized in the cilia and 
dendritic knobs of olfactory sensory neurons is the best candidate for the pore-forming 
subunit of CaCCs in olfactory sensory neurons (158). Ano2 is also highly expressed in 
photoreceptor synaptic terminals and may serve to regulate synaptic output in these cells 
(160). Ano3 was a silent member within the anoctamin family, until this year when it was 
reported through association analyses that the Ano3 locus is associated with eczema in 
families ascertained through asthma (38), and with Alzheimer’s disease (AD) (17). So it is 
interesting to check whether Ano3 is also a CaCC and how is it related to these diseases. Ano4 
until now has no functional correlate, but according to our data, it is also a CaCC, which can 
be activated through both purinergic receptor and directly by increasing intracellular Ca
2+
, it 
will be discussed in chapter 2. 
Ano5, also named GDD1, is highly expressed in cardiac and skeletal muscle as well as bone, 
and is greatly up-regulated during myocyte differentiation (116; 174). Autosomal dominant 
mutations in a conserved cysteine-356 in the first extracellular loop of Ano5 lead to abnormal 
bone mineralization and bone fragility called gnathodiphyseal dysplasia (GDD) (175). The 
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importance of Ano5 in skeletal muscle physiology is further enhanced by the recent finding 
that mutations in Ano5 produce several recessive muscular dystrophies (15; 66; 108). The 
phenotypes resulting from Ano5 mutations are related to dysferlinopathies. In particular a 
deficiency in dysferlin causes defective skeletal muscle membrane repair (9). It has been 
suggested that chloride currents are important in membrane repair (50) and Ano5 may be the 
chloride channel involved in this process. The role of Ano5 in muscle membrane repair is still 
speculative, but we have already determined Ano5 function as a CaCC and it needs 
un-physiological high Ca
2+
 to be activated. It is helpful to elucidate its role in musculoskeletal 
pathologies. 
 
Fig. 3: Phylogenetic tree depicting the anoctamin family in humans. Scale bar, 0.1 nucleotide 
substitutions per site. 
Ano6 is ubiquitously expressed and has been reported to function as a phospholipid 
scramblase. Ano6 mutant patients have defect in phospholipid scrambling activity, which 
leads to a defect in blood coagulation, called Scott syndrome (163). Our group has reported 
that Ano6 is a crucial component of outwardly rectifying chloride channels (ORCC), which 
can be activated during membrane depolarization or apoptosis (110). Since Ano6 belongs to 
the anoctamin family, the Ca
2+
 dependence scramblase activity suggests it could be activated 
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by Ca
2+
 and function as an CaCC. According to our data, Ano6 can also be activated by Ca
2+
 
ionophore ionomycin in over-expressed HEK293 cells, the current showed outward 
rectification and also cation permeability, which fits with a recent finding that Ano6 is a 
non-selective cation channel (195). Taken together, Ano6 is not only a scramblase, but also an 
outwardly rectifying CaCC with cation permeability (110). 
Ano7 (NGEP), which is highly expressed in the prostate, was discovered by analysis of 
expressed sequence tag databases (29). Ano7 is expressed on the apical and lateral membranes 
of normal prostate, and the enhanced expression is closely linked to prostate cancer (13). 
Ano7 has two isoforms generated by a differential splicing event. The short variant is derived 
from 4 exons and encodes a 20-kDa intracellular, possibly a nuclear protein. The long form is 
derived from 18 exons and encodes a 95-kDa protein that is predicted to contain 8 
transmembrane domains (30).  
Ano8 is also broadly expressed although at lower levels (97). We have found there is a Cl
-
 
current attached to it, which can be activated by Ca
2+
 in Ano8 over-expressed HEK 293 cells, 
but compared to classical CaCCs the current activation is delayed, and with relatively small 
amplitude. 
Ano9 is encoded by 23 exons and is also named TP53I5 (tumor protein P53 inducible protein 
5). It is located at human chromosome locus, 11p15.5, and expressed in human colorectal, 
lung and breast cancer (86). Ano9 was also reported by our group to inhibit Ano1 current in a 
co-expression model (148). The function of Ano9 and its relationship with cancer still needs 
to be investigated.  
Ano10 mutations have been linked to autosomal- recessive cerebellar ataxias associated with 
moderate gait ataxia, down-beat nystagmus and dysarthric speech (182). Affected individuals 
display severe cerebellar atrophy. We have detected that Ano10 also functions as a CaCC, 
with some permeability for cations. It is possible that our findings can be helpful to 
investigate the association between Ano10 function and cerebellar ataxias. 
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Intention and outline of the present thesis 
Anoctamins have been identified a few years ago. They provide a new view for the function 
of CaCCs. Although these important proteins are expressed ubiquitously, for most of them the 
functions have not been clarified in detail. In this thesis I aimed in elucidate regulation and 
various functions of Ano1 and also other anoctamins, to introduce new knowledge which will 
help to increase our understanding of this family of chloride channels. 
In Chapter 2 we provide evidence that the entire family of anoctamins form CaCCs. This will 
be very helpful to understand why patients with different anoctamin mutations have their 
pathological symptoms. Volume regulation, which is always accompanied by elevation of 
intracellular Ca
2+
, is a fundamental process for the survival of every living cell and organism. 
CaCCs are involved in this process. We focused on endogenous anoctamins in HEK293 cells 
and found that all of them contribute to cell volume regulation. We have also found that Ano1 
knock-out mice have abolished volume regulated chloride currents. These results will be 
discussed in Chapter 3. Ano 1 functions as CaCC, but does not contain a typical Ca
2+
 binding 
domain. Prior to my work, the Ca
2+
 regulatory site was still elusive. We have found that 
calmodulin is the key accessory protein for this channel activation. In chapter 4 we have 
investigated what role calmodulin plays in activation of Ano1 and why ATP is necessary for 
full channel activation. 
In Chapter 5, we ask whether Ano1 is inhibited by inositol 3,4,5,6-tetrakisphosphate (82; 32; 
20), which is a downstream product of InsP3 and suggested to inhibit CaCCs. But this is not 
the case in the Ano1 overexpressing system. Nevertheless, the membrane permeable 
compound 1-O-octyl-2-O-butyryl-myo-inositol 3,4,5,6-tetrakisphosphate octakis (propion- 
oxymethyl) ester (INO-4995) can activate the channel acutely, and through repeated 
incubation it can enhance membrane expression in HT29 cells.  
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CHAPTER 2 
Anoctamins are a family of Ca
2+
 activated Cl
-
 
channels 
Abstract 
Anoctamin 1 (Ano1; TMEM16A) and anoctamin 2 (Ano2; TMEM16B) are novel Cl
-
 
channels transiently activated by increase in intracellular Ca
2+
. These channels are essential 
for epithelial Cl
-
 secretion, smooth muscle peristalsis and olfactory signal transduction, and 
are central to several inherited diseases and certain types of cancer. Surprisingly, another 
member of this protein-family, Ano6, operates as a Ca
2+
 activated phospholipid scramblase, 
while others were reported as intracellular proteins. It is therefore unclear whether anoctamins 
constitute a family of Ca
2+
 
activated Cl
-
 
channels, or reflect proteins with heterogeneous 
functions. Using whole cell patch clamping we demonstrate that Ano 4 – 10 are all able to 
produce transient Ca
2+
 
activated Cl
-
 
currents, when expressed in HEK293 cells. While some 
anoctamins (Ano1,2,4,6,7) were found to be well expressed in the plasma membrane, others 
(Ano8,9,10) show rather poor membrane expression and were mostly retained in the cytosol. 
The transient nature of the Cl
-
 
currents was demonstrated to be independent of intracellular 
Ca
2+
 
levels. We show that inactivation of Ano1 currents occurs in the continuous presence of 
elevated Ca
2+
 
concentrations, possibly by calmodulin-dependent kinase. The present results 
demonstrate that anoctamins are a family of Ca
2+
 
activated Cl
-
 channels, which also induce 
permeability for cations. They may operate as Cl
-
 channels located in the plasma membrane 
or in intracellular compartments. These results will support our understanding of the 
physiological significance of anoctamins and their role in disease. 
 
Key words: CaCC, TMEM16A, TMEM16D, TMEM16E, TMEM16F, TMEM16G, 
TMEM16H, TMEM16J, TMEM16K, Ca
2+
 
activated Cl
-
 
channels, CaCC, calmodulin, 
anoctamin 
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Introduction 
Ca
2+
 activated Cl
-
 currents (CaCC) are abundant and are present in nearly every cell type, 
where they fulfill very different functions (63). It is now well accepted that TMEM16A 
(anoctamin 1, Ano1) forms the plasma membrane localized Ca
2+
 activated Cl
-
 channel (19; 
149; 197). Voltage-and calcium-dependent gating of Ano1 has been examined in detail, and is 
linked to the first intracellular loop (191). Ano1 is essential for Cl
-
 secretion in a number of 
epithelial tissues (124; 137), for smooth muscle contraction (109; 168), the function of 
nociceptive neurons and smooth muscle pacemaker cells (72; 77; 105). Ano2, the closest 
relative of Ano1, has been shown to form a CaCC in olfactory receptors (14; 142).  
The family of anoctamins consists of 10 different proteins, but only Ano 1, Ano2, and Ano6 
have been examined in more detail (14; 51; 92). For Ano6 a dual role as Fas ligand activated 
Cl
-
 channel and phospholipid scramblase has been described (110; 163). However, whether 
Ano3-10 also produces Ca
2+
 activated Cl
-
 currents similar to Ano1 and Ano2, is currently 
unclear. A recent report claimed that Ano3-7 are intracellular proteins (42), although we 
demonstrated earlier that most anoctamins overexpressed in HEK293 cells can be detected in 
the cell membrane (148).  
Anoctamins do not show any obvious homology to other ion channels. Ano 1 contains 8 
predicted transmembrane helices, intracellular NH2-and COOH ends and a pore, formed by 
the 5th and 6th transmembrane helices, containing a p-loop dipping back into the membrane 
(197). The other anoctamins (2-10) show a high degree of structural similarity, which is 
particularly obvious for the putative pore region (92). Apart from some indirect evidence 
showing enhanced ATP-induced halide permeability in Ano6 and Ano7 expressing cells 
(148), it is not clear whether other anoctamins also produce Ca
2+
 activated Cl
-
 currents. We 
demonstrated earlier that Ano6 produces an outwardly rectifying chloride channel, which is 
activated during stimulation of Fas receptors upon induction of apoptosis (110). Notably, at 
high intracellular Ca
2+
 concentrations as induced by Ca
2+
 
 
ionophores, Ano6 was reported to 
operate as a membrane phospholipid scramblase (163). In contrast to Ano1 and Ano2, Ano6 
Cl
-
 currents were not activated by physiological Ca
2+
 concentrations (110). As demonstrated 
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in the present report, high intracellular Ca
2+
 levels are required to activate Ano6. Although 
plasma membrane-expression of some anoctamins is very poor, the present experiments also 
demonstrate for the first time that essentially all anoctamins are able to produce Cl
-
 currents 
when activated by an increase in [Ca
2+
]i. We speculate that anoctamins may operate as plasma 
membrane or intracellular Cl
-
 channels.  
Materials and Methods  
Cell culture, cDNAs, siRNAs and transfection   
HEK 293 and HT29 cells were grown in DMEM and DMEM-F12 separately (GIBCO, 
Karlsruhe, Germany) supplemented with 10% fetal bovine serum at 37°C in a humidified 
atmosphere with 5% CO2. Cells were placed on fibronectin-and collagen-coated 18 cm 
diameter cover slips and co-transfected with cDNA encoding either hTMEM16A, D, E, F, G, 
H, J, K, or empty pcDNA3.1 vector (mock) along with P2Y2 receptor and CD8. Expression of 
TMEM16A, F, H, J was suppressed each by two independent sets of RNAi. Duplexes of 
25nucleotide of RNAi were designed and synthesized by Invitrogen (Paisley, UK) and 
Ambion (Darmstadt, Germany). RNAi was transfected using Lipofectamin 2000 (1 µg/µl) and 
cells were examined 48 h or 72 h after transfection. Transfections were carried out using 
lipofectamine 2000 (Invitrogen) according to the manufactures protocol. Successful 
knockdown of anoctamins was demonstrated by real time RT-PCR (93).  
Patch Clamping  
2-3 days after transfection of His-tagged anoctamins or siRNA, respectively, overexpressing 
HEK293 or siRNA-transfected HT29 cells were identified by incubating the cells 1-2 min with 
Dynabeads CD8 (Invitrogen). His-tagging of anoctamins did not interfere with its properties 
as a Cl
-
 channel. Cover slips were mounted on the stage of an inverted microscope (IM35, 
Zeiss) and kept at 37 °C. The bath was perfused continuously with ringer solution (mM: NaCl 
145, KH2PO4 0.4, K2HPO4 1.6, d-glucose 5, MgCl2 1, Ca-gluconate 1.3, pH 7.4) or NMDG 
solution (NMDG 145, HCl 130, KH2PO4 0.4, K2HPO4 1.6, d-glucose 5, MgCl2 1, 
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Ca-gluconate 1.3, pH 7.4) at the rate of 5 ml/min. For fast whole cell patch clamping pipettes 
were filled with intracellular like solution containing (mM: KCl 30, potassium gluconate 95, 
NaH2PO4 1.2, Na2HPO4 4.8, EGTA 1, calcium gluconate 0.758, MgCl2 1.034, D-glucose 5, 
ATP 3, pH was 7.2) or CsCl solution containing (mM: CsCl 130, NaH2PO4 1.2, Na2HPO4 4.8, 
EGTA 1, calcium gluconate 0.758, MgCl2 1.034, D-glucose 5, ATP 3, pH was 7.2) and had 
an input resistance of 2 – 4 MΩ. In other experiments K+ in the pipette filling solution was 
replaced by NMDG
+
. For all solutions Ca
2+
 concentrations were adjusted to 10
-7
 (pipette) and 
1.3 mM (bath). Experiments were conducted as described earlier (124). During experiments 
cells were current clamped and membrane voltages were measured. In intervals cells were 
voltage clamped to ± 50 mV in steps of 10 mV for 1 s. The applied clamp voltages were 
corrected for liquid junction potentials. Because current voltage relationships were linear 
(except for Ano6), membrane conductances were usually calculated according to Ohm’s law. 
For some experiments, patch pipettes (P6060S; New England Biolabs, Germany) were loaded 
with pre-activated calmodulin-dependent kinase II (5000 U/ml). In these experiments, 
CAMKII was given sufficient time (40 min) to enter the cell before stimulation with 
ionomycin, and the cell was current clamped during this time.  
Measurement of intracellular Ca
2+
 
concentration   
For single cell fluorescence measurements HEK293 cells were grown on glass covers slips, 
mounted in a cell chamber and perfused with ringer solution at 8 ml/min at 37˚C. Cell 
fluorescence measurements was measured continuously on an inverted microscope Axiovert 
S100 (Zeiss, Germany) with a Flua 20x/0.75 objective (Zeiss, Germany) and a high speed 
polychromator system (VisiChrome, Visitron Systems, Germany). Cells were loaded with 2 
µM Fura-2, AM (Molecular Probes) in ringer solution or Opti-MEM (GIBCO) under 
experimental conditions with 0.2% pluronic (Molecular Probes) for 1h at 37°C. Fura-2 was 
excited at 340/380 nm, and the emission was recorded between 470 and 550 nm using a 
CCD-camera (CoolSnap HQ, Visitron Systems, Germany). Control of experiment, imaging 
acquisition, and data analysis were done with the software package Meta-Fluor (Universal 
imaging, USA) and Origin (OriginLab Corporation, USA). For calibration of intracellular 
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Ca
2+
 
concentration were perfused with ringer solution and Ca
2+
 free ringer with 1 µM 
ionomycin, 10 µM monensin and 5 µM nigericin. 
Iodide Quenching 
Quenching of the intracellular fluorescence generated by the iodide- sensitive enhanced 
yellow fluorescent protein (YFP) was used to measure anion conductance. YFP fluorescence 
was excited at 490 nm using a semi-automatic Novostar plate reader (BMG-Labtech, 
Offenburg, Germany). I
-
 influx was induced by replacing 20 mM extracellular Cl
-
 by I
-
. 
Background fluorescence was subtracted and auto-fluorescence was negligible. Changes in 
fluorescence induced by I
-
 are expressed as initial rates of fluorescence decrease (arbitrary 
units/sec). 
Immunocytochemistry   
Transfected HEK293 cells were grown on glass cover slips and fixed for 10 min with 4% 
(w/v) paraformaldehyde at room temperature. Cells were incubated for 5 minutes with 0.1% 
SDS in PBS. After washing, cells were permeabilized and blocked with 2% (w/v PBS) BSA 
and 0.04% (v/v PBS) Triton X-100 for 1 h and incubated overnight with primary anti His AB 
(1:500, Qiagen, Hilden, Germany) and anti ß-catenin (1:500, Sigma, Taufkirchen, Germany) 
at 37°C. Binding of the primary antibody was visualised by incubation with a secondary 
donkey anti mouse antibodies conjugated with AlexaFluor
(R)
546 (1:400, Molecular Probes, 
Invitrogen). Nuclei were stained with Hoe33342 (0.1 µg/ml PBS, Aplichem, Darmstadt, 
Germany). ß-catenin was visualized using an Alexa 488-labeled secondary antibody. Cells 
were mounted on glass slides with fluorescent mounting medium (DAKO Cytomation, 
Hamburg, Germany) and examined with an ApoTome Axiovert 200M fluorescence 
microscope (Zeiss, Göttingen, Germany).  
Results and Discussion  
Activation of Ano1,4,5,6,7,8,9 and 10 by ATP-induced increase in intracellular Ca
2+ 
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Fig. 1: Activation of anoctamins by ATP. (A) Continuous recordings of whole cell currents 
measured in HEK293 cells expressing different human anoctamins and activation by 10 µM 
ATP. In intervals cells were voltage clamped from -50 to + 50 mV in steps of 10 mV. (B) 
Summary of the calculated peak conductances and membrane voltages of transiently activated 
anoctamins. Mean ± SEM (number of cells). # different to mock; p < 0.05; ANOVA. * 
Anoctamins are a family of Ca2+ activated Cl- channels                                                    19 
significant activation; p < 0.05; paired t-test.  
Previous studies have demonstrated that Ano1 can be activated by stimulation of G-protein 
coupled receptors, such as purinergic P2Y2 receptors, which increase [Ca
2+
]i (197). Because 
Ano2 has also been demonstrated to operate as a Ca
2+
 activated Cl
-
 channel (14; 142), we 
asked whether other anoctamins are also able to produce Ca
2+
 activated Cl
-
 currents. To that 
end we coexpressed different anoctamins together with P2Y2 receptors in HEK293 cells, 
which were stimulated by 10 µM ATP, in the presence of a cytosol-like pipette filling solution 
and extracellular Ringer solution (c.f. Methods). We observed that overexpressed Ano1 and 
Ano6 produce significant whole cell Cl
-
 currents, even in the absence of ATP-stimulation (97). 
In cells expressing Ano1, 4, 7, 8, 9, and 10, whole cell currents of variable magnitudes were 
activated by ATP (Fig. 1). Current activation by ATP was fast (below 1 s) for Ano1, but was 
delayed for the other anoctamins. It is currently unclear whether this is due to a reduced 
sensitivity towards intracellular Ca
2+
, since intracellular Ca
2+
 levels are increased equally fast 
in all cells by either ATP or ionomycin, when assessed by Fura-2 (Fig. 2). Increase of [Ca
2+
]i 
may not only activate the Cl
-
 channel, but may also trigger inhibition of anoctamins via 
CAMKII, which may actually counteract further activation. 
 
Fig. 2: Ca
2+
 
dependence of anoctamins. (A, B) Time course for (A) ATP-induced (10 µM; 
summary of 30 experiments) and (B) ionomycin-induced (1 µM; summary of 16 experiments) 
increase in [Ca
2+
]i in HEK293 cells, as detected by ratiometric Fura-2 fluorescence. (C) 
Summary of baseline (control) and activated whole cell conductances obtained in Ano1 
expressing HEK293 cells under control conditions and after pre-incubation with 25 µM 
BAPTA-AM. (D) Summary of ionomycin activated whole cell conductance in the presence or 
absence of 10 µM clotrimazole, an inhibitor of Ca
2+
 activated K+ channels (number of 
experiments). # different control; p < 0.05; ANOVA. * significant activation; p < 0.05; paired 
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t-test.  
CAMKII inhibition was suggested in a recent study (169) and is also demonstrated in the 
present paper for both, Ano1 and Ano6. For all anoctamins except of Ano4, membrane 
voltages were depolarized through stimulation of purinergic receptors and increase of [Ca
2+
]i, 
which is expected upon increase of a Cl
-
 conductance along with cation influx through store 
operated Ca
2+
 channels (Fig. 1B). Surprisingly, expression of Ano6 hyperpolarized the 
membrane voltage of non-stimulated cells, which is probably due to its partial permeability 
for K
+
 ions as further described below. We wondered whether largely enhanced baseline Cl
-
 
currents in Ano1-expressing cells are due to activation of by the baseline Ca
2+
 concentration 
of 100 nM (Fig. 2A). In fact, 30 min pre-incubation with the Ca
2+
 chelator BAPTA-AM (25 
µM) abolished this baseline Cl
-
 conductance (Fig. 2C). We hypothesize that an inhibitory 
factor or additional protein is missing that keeps overexpressed channels closed under control 
conditions. As described below, this unknown protein could be another anoctamin, like Ano9, 
which may be able to heterooligomerize with Ano1 (Fig. 6G). Moreover, since expression of 
anoctamins also induced a cation permeability (c.f. below), we exclude a possible 
contribution of endogenous Ca
2+
 activated SK4 K
+
 channels: Activation of whole cell currents 
in Ano1 expressing HEK293 cells by ionomycin was identical in the absence or presence of 
10 µM of the SK4 inhibitor clotrimazole (Fig. 2D). No message (RT-PCR) was detected for 
either SK4 or the large conductance Ca
2+
 activated (BK) K
+
 channel in HEK293 cells (data 
not shown). 
Activation of anoctamins by Ca
2+
 ionophore   
Stimulation by 10 µM ATP raised intracellular Ca
2+
 
 
levels to about 1 µM, which is mainly 
due to release of Ca
2+
 from intracellular ER stores (Fig. 2A) (10). This Ca
2+
-increase may not 
be sufficient to activate every member of the anoctamin family. We therefore stimulated the 
cells with the Ca
2+
 ionophore ionomycin (1 µM), which raised [Ca
2+
]i in a more sustained 
manner to levels well above 1 µM (Fig. 2B). In fact whole cell currents could be activated in 
cells expressing Ano5 or Ano6, when stimulated by ionomycin, suggesting that these 
channels require higher and maybe more sustained Ca
2+
 levels to be activated (Fig. 3A). Close 
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to the plasma membrane ionomycin raises [Ca
2+
]i probably to much higher levels than 
suggested by Fura-2 measurements. We examined the Ca
2+
 dependence of Ano6 by varying 
cytosolic (patch pipette) Ca
2+
 concentrations and detected substantial activation of Cl
-
 currents 
only at concentrations as high as 10 µM or larger (Fig. 3D). Moreover Ano6, shows little 
inactivation during continuous stimulation with 1 µM ionomycin (Fig. 3B). Anion selectivity 
was similar for Ano1, 4, 6, and 10, and was I
-
  Br
-
  Cl
-
  HCO3
-
, suggesting a low field 
strength anion selectivity. HCO3
-
 was conducted surprisingly well by Ano6 (Fig. 3C). It is 
therefore entirely possible that Ano6 serves as a channel for bicarbonate secretion in airways 
and other epithelial tissues.  
Notably, at very high [Ca
2+
]i of 0.1 and 1 mM, whole cell Cl
-
 currents were also activated in 
mock transfected cells, which express Ano6 endogenously (Fig. 3D, E). Replacement of 
extracellular Cl
-
 by gluconate strongly inhibited whole cell currents and depolarized 
membrane voltages, indicating activation of whole cell Cl
-
 currents at high [Ca
2+
]i in both 
mock transfected and Ano6 overexpressing cells (Fig. 3D-F). We speculate that endogenous 
anoctamins may be activated only at very high [Ca
2+
]i (3). Indeed when endogenous Ano6 
(together with Ano1, 8 and 9) were knocked-down simultaneously by siRNA, we found 
reduced baseline currents: Current activated by 1 mM [Ca
2+
] in the patch pipette filling 
solution were largely attenuated (Fig. 3G). Because of the lack of suitable antibodies we 
assessed knockdown of anoctamins by real time RT-PCR. Expression levels (relative to 
ß-actin) were very different for the endogenous anoctamins, with anoctamin 6 being the most 
abundant anoctamin (n = 3 for all): Ano1 1.4 x 10
-6
 (downregulation by 52 %); Ano6 3.1 x 
10
-4 
(downregulation by 82 %); Ano8 1.3 x 10
-4
 (downregulation by 42 %); Ano9 2.0 x 10
-8
 
(downregulation by 76 %). Thus Ano6 and maybe Ano8 have probably the largest impact on 
endogenous Ca
2+
 activated Cl
-
 conductance. It remains currently unclear why endogenous 
anoctamins require such high [Ca
2+
]i to be activated. 
In more than 20 cell lines and in oocytes we examined endogenous expression of anoctamins. 
Ano6 and Ano8 were always expressed most abundantly (92). Thus, there is no “empty” 
system without background expression of endogenous anoctamins. However, given the low  
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Fig. 3: Activation of anoctamins by ionomycin. (A) Summary of the calculated ionomycin (1 
µM) activated peak conductances and measured (currents clamp) membrane voltages of 
HEK293 cells expressing anoctamins. (B) Whole cell currents activated by ionomycin in 
Ano6-expressing cells. (C) Mean current/voltage relationships for Ano6 whole cell currents, 
with different anions (Cl
-
, I
-
, Br
-
, bicarbonate) present in the bath solution. (D) Concentrations 
response curve for the Ca
2+
 activation of whole cell conductance in Ano6 overexpressing and 
mock transfected HEK293 cells. (E) Continuous original recordings of the whole cell 
conductance (left: mock; black; right: Ano6; red) activated by 1 mM Ca
2+
 in the patch pipette 
solution, and effects of removal of extracellular Cl
-
 (5Cl
-
). In intervals cells were voltage 
clamped from -50 to + 50 mV in steps of 10 mV. (F) Summaries of the calculated whole cell 
conductances and measured membrane voltages in the presence of 0.1 and 1 mM Ca
2+
, before 
and after removal of extracellular Cl
-
 (5Cl
-
). (G) Original current recording and summary of 
the effects of 1 mM Ca
2+
 on HEK293 cells treated with siRNA for Ano1,6,8, and 9. Mean ± 
SEM (number of cells). # different to mock; p < 0.05; ANOVA. * significant activation or 
effect of 5 Cl; p < 0.05; paired t-test. 
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levels for endogenous anoctamins compared to overexpressed proteins (about 1000 times 
higher according to real time RT-PCR analysis), possible heterooligomerization of 
endogenous and overexpressed proteins does not appear to be a major problem in the present 
study.  
Contribution of nonselective currents and gating by cations 
 
Fig. 4: Cation dependence of anoctamin currents. Summary I/V curves of whole cell currents 
activated by ionomycin (1 µM) in anoctamin-expressing HEK293 cells. Currents were 
measured in the presence of a cytosolic like solution in the patch pipette and a bath  (gray 
circles), or with Cs
+
/Cl
-
 in the patch pipette and NMDG
+
/Cl
-
 in the bath (black squares).  
Cl
-
 currents activated by ionomycin or high intracellular (pipette) Ca
2+
 concentrations 
demonstrated rather linear current/voltage relationships (Fig. 4). We compared currents 
activated by ionomycin in the presence of extra-and intracellular cations (cytosol-like pipette 
filling solution and bath Ringer solution), with currents detected in the absence of extra-and 
intracellular cations (patch pipette 132 mM CsCl, bath 132 mM NMDGCl) (c.f. Methods). In 
general, replacing intracellular K
+
 by Cs
+
 and extracellular Na
+
 by impermeable 
NMDG
+
markedly reduced whole cell currents produced by some anoctamins (Fig.4). We 
further examined possible cation permeability of anoctamins by replacing intracellular K
+
 and 
extracellular Na
+
 by NMDG
+
 separately (Fig. 5). Indeed we found that removal of 
intracellular K
+
 depolarized Vm and reduced outward currents, while removal of bath Na
+
 
hyperpolarized Vm and reduced inward (and outward) currents (Fig. 5). Particularly in Ano6 
expressing cells permeability for K
+
 ions was detected. Indirect evidence for cation 
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conductance of anoctamins has already been provided earlier (97; 96). Moreover, anoctamins 
are also permeable for Ca
2+
, as reported for Ano6 (195). Taken together these results suggest 
that anoctamins are either poorly selective for anions or lead to parallel activation of a cation 
conductance. 
 
Fig. 5: Ano1, Ano6, and Ano10 induce permeability for cations. Summary I/V curves of 
whole cell currents obtained in Ano1 (B), Ano6 (C), and Ano10 (D) overexpressing HEK293 
cells or mock transfected (A) cells. Effects of replacement of intracellular K+ by NMDG 
(black squares) and replacement of extracellular Na+ by NMDG+ (blue diamonds). 
Inactivation of anoctamins   
Increase in intracellular Ca
2+
 activates anoctamins only transiently. On the other hand, 
overexpression of Ano1 in HEK293 and other cell types leads to channels that are partially 
active even under baseline Ca
2+
 concentrations of 100 nM (Fig. 1,2) (97). We observed that 
during transient activation/deactivation of Ano1 whole cell Cl
-
 currents declined even below 
the initial high current levels, This was observed during continuous stimulation by ATP (10 
µM) or ionomycin (1 µM), or when 1 µM Ca
2+
 was provided through the patch pipette filling 
solution (1 µM) (Fig. 6A). This suggests that increase in [Ca
2+
]i initially activates the channel 
but then triggers inactivation by a Ca
2+
 dependent process. Spontaneous current-inactivation 
was not due to a loss of ATP or calmodulin, since we also observed inactivation when both 
components (3 mM ATP, 2 µM calmodulin) were present in the patch pipette. Because 
Ca
2+
/calmodulin dependent kinase II (CAMKII) inhibits overexpressed Ano1 currents (169), 
we hypothesized that an increase of Ca
2+
 may activate CAMKII, which in turn inhibits Ano1. 
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In fact, in the presence of the CAMKII-blocker KN62 (5 µM), inactivation of the channel was 
significantly attenuated (Fig. 6B). Similar to Ano1, also Ano6 contains 4 putative CAMKII 
phosphorylation sites in the N-terminus (Supplemental Fig S2). Thus inhibition of CAMKII 
by 10 µM KN62 also increased activation of Ano6 by 1 µM ionomycin ( GIono = 29.6 ± 3.6 
(w/o KN62) vs. 43.3 ± 4.5 nS (w/ KN62); n = 5). 
Moreover, when patch pipettes were loaded with pre-activated CAMKII (5000 U/ml), 
activation of whole cell currents in Ano1-overexpressing cells was significantly reduced (Fig. 
6C). Thus CAMKII inhibits overexpressed Ano1, which is reminiscent to inhibition of CaCC 
by CAMKII in smooth muscle cells (60). Along this line, a splice variant of Ano1 (ac-Ano1) 
had been reported to have a higher Ca
2+
 sensitivity than the splice form abc-Ano1 (52), which 
we used in our experiments. As reported by Ferrera et al, we also found that the channel is 
activated at [Ca
2+
]i below 100 nM (Fig. 6D). However, we also found that ac-Ano1 currents 
inactivated at lower Ca
2+
concentrations than the splice form abc-Ano1 (Fig. 6D). We tried to 
further localize the molecular site within Ano1 that is in charge for its only transient 
activation. Since activation of Ano6 produces more sustained currents (110), we generated a 
chimeric protein in which the N-terminus of Ano1 was replaced by that of Ano6 (Ano1N6). 
Notably whole cell currents generated by the chimeric Ano1N6 channel were no longer 
transient, but generated a rather sustained current when activated by 1 µM ionomycin (Fig. 
6E, F). This suggests that the N-terminus controls both activation and inactivation of 
anoctamins. Notably, potential binding sites for calmodulin have been found in the 
N-terminus of Ano1, along with a number of putative phosphorylation sites, including those 
for CAMKII (92).  
Overexpressed anoctamins behaves differently   
The data presented above indicate that Ano6, 8, and 9, when overexpressed in HEK293 cells, 
produce Cl
-
 currents upon increase in intracellular Ca
2+
 by ionomycin. However, although all 
three paralogs are expressed endogenously in HEK293 cells, no currents are activated in 
mock transfected cells (Fig. 3A) (3). However, when increasing [Ca
2+
]i to very high levels (≥ 
10 µM), endogenous anoctamins were activated (Fig. 3B, E). This may be due to a lack of 
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sufficient membrane expression of endogenous anoctamins. Endogenous anoctamins are  
 
Fig. 6: Increase in [Ca
2+
]i activates and subsequently inhibits anoctamins. (A) Activation and 
time dependent decay of Ano1 whole cell currents in HEK293 cells, when activated by ATP 
(10 µM), ionomycin (1 µM), and 1 µM Ca
2+
 in the patch pipette solution. (B) Time dependent 
decay of whole cell currents activated by 1 µM Ca
2+
 (patch pipette) in the absence or after 
pre-incubation with the inhibitor of CAMKII, KN62 (25 µM/2 hrs). (C) Activation of 
Ano1-whole cell currents by ionomycin and effect of active CAMKII (5000 U/ml; 40 min) on 
current activation. (D) Ca
2+
 dependent activation of the splice forms ac-Ano1 and abc-Ano1. 
(E) Sustained whole cell conductances activated by 1 µM ionomycin in HEK293 cells 
expressing the chimeric protein Ano1N6 in which the N-terminus of Ano1 has been replaced 
by that of Ano6. (F) Summary of the effect of ionomycin (1 µM) on whole cell conductance 
and membrane voltage in Ano1N6 expressing HEK293 cells. (G) Summary of whole cell 
conductances measured in HEK293 cells coexpressing different anoctamins. Mean ± SEM 
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(number of cells). # different to con or Ano1, respectively; p < 0.05; ANOVA. * significant 
activation; p < 0.05; paired t-test. 
expressed at much lower levels than overexpressed proteins and may be inhibited by 
endogenous accessory proteins, such as CAMKII. Alternatively, specific Ca
2+
 release and/or 
influx pathways need to be triggered to activate these endogenous anoctamins. The overall 
linear structures appear similar in all anoctamins (Supplemental Fig. S1) and an analysis of 
putative functional domains revealed a number of similar motifs and putative phosphorylation 
sites in all ten anoctamins (Supplemental Fig. S2). Notably, Ano1 exists as a stable dimer (47; 
153), and may even form heterooligomeric proteins with other anoctamins (148). In the 
present study we therefore coexpressed different anoctamins and found that only coexpression 
of Ano9 inhibited Ano1-currents activated by ATP, suggesting a specific interaction of 
different anoctamin paralogs (Fig. 6G). 
The present results suggest that endogenous and overexpressed anoctamins behave differently. 
We found earlier that calmodulin and 1-EBIO, a calmodulin-dependent activator of K
+
 
channels, activate overexpressed Ano1 (169). In the present study we made use of a well 
established technique to assess endogenous Ca
2+
 activated Cl
-
 currents in HT29 cells stably 
expressing I
-
 -sensitive yellow fluorescent protein (YFP). Cellular YFP-fluorescence is 
quenched by iodide influx from the bath solution, (181) (Fig. 7A-C). Stimulation of 
purinergic receptors by ATP, dose dependently activated I
-
 influx and YFP quenching, 
indicating activation of a Ca
2+
 dependent Cl
-
 conductance (Fig. 7A, B). ATP activated Cl
-
 
conductance was blocked by typical Ano1-inhibitors (Fig. 7C). Moreover, siRNA-knockdown 
of Ano1 inhibited ATP-induced whole cell currents in HT29 cells in another study (53). We 
examined the effects of 1-EBIO on Ca
2+
 dependent Cl
-
 conductance in HT29 cells. However, 
even at a concentration of 1 mM 1-EBIO was unable to directly activate a Cl
-
 conductance 
(data not shown). It only slightly and dose dependently augmented ATP (1 µM) -activated Cl
-
 
conductance (Fig. 7D). A number of 1-EBIO-related compounds (DCEBIO, riluzole, CBIQ, 
NS8593, CYPPA, NS309, NS4591) were examined in a dose dependent manner. However, 
for none of them we found activation of a Cl
-
 conductance and receptor-mediated activation 
by ATP was not augmented (data not shown).We further performed experiments in a human 
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airway epithelial cell line expressing the most common mutant form of CFTR, F508del-CFTR 
(CFBE/F508del-CFTR). We found: i) that ATP (10 µM) activated a whole cell Cl
-
 
conductance of 3.5 ± 0.4 nS (n = 5), while direct application of 1-EBIO (100 µM) did not. ii)  
 
Supplemental Fig. S1: Structure prediction of anoctamins 
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Supplemental Fig. S2: Anoctamin Motif Scan. Anoctamins were analyzed using the 
following resources: 
1
Combet C., Blanchet C., Geourjon C. and Deléage G., NPS@: Network 
Protein Sequence Analysis, TIBS 25:147-150, 2000. 
2
H.D. Huang, T.Y. Lee, S.W. Tseng and 
J.T. Horng. KinasePhos: a web tool for identifying protein kinase-specific phosphorylation 
sites, Nucleic Acids Research, 33: W226-229, 2005.
3
Brannetti B, Helmer-Citterich M. iSPOT: 
A web tool to infer the interaction specificity of families of protein modules. Nucleic Acids Res. 
31: 3709-11, 2003.
4
Sigrist CJA, Cerutti L, de Castro E, Langendijk-Genevaux PS, Bulliard V, 
Bairoch A, Hulo N. PROSITE, a protein domain database for functional characterization and 
annotation, Nucleic Acids Res. 38: 161-6 (2010) 
5
CALMODULIN TARGET DATABASE, 
http://calcium.uhnres.utoronto.ca/ctdb/ctdb/home.html. 
 
Fig. 7: Ca
2+
 
activated halide permeability in HT29 cells expressing endogenous Ano1. (A) 
Application of different concentrations of ATP leads to influx of extracellular I
-
 (20 mM) and 
concentration dependent quenching of fluorescence in HT29 cells, stably expressing YFP. (B) 
Concentration response curve for ATP-induced YFP-fluorescence-quenching, indicating 
concentration-dependent activation of a Ca
2+
 activated Cl
-
 conductance by ATP. (C) 
Summary of the inhibition of ATP-induced fluorescence-quenching in HT29 cells by typical 
inhibitors of Ano1 (AO1 20 µM; NFA 10 µM; tannic acid TA 20 µM; DIDS 100 µM). (D) 
Incubation with 1-EBIO enhanced ATP-induced I
-
 uptake and quenching of YFP-fluorescence 
in a dose dependent manner. The Ca
2+
 activated Cl
-
 conductance was inhibited at the end of 
the experiment by AO1 (20 µM). Cells were measured in the presence of clotrimazole (10 
µM) to inhibit a possible contribution by the Ca
2+
 dependent K
+
 channel SK4. (E) Inhibition 
of protein kinase C by pre-incubation with bisindolylmaleimide 1 (BIM; 0.1 µM/2 hrs) did 
not affect activation and time course for inactivation of Ano1 overexpressed in HEK293 cells. 
(F) Inhibition of PKC by BIM augmented endogenous Ano1 currents in HT29 cells. Mean ± 
SEM (number of cells). * difference to control; p < 0.05; paired t-test.  
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activation of the whole cell Cl
-
conductance through ATP-stimulation was slightly augmented 
by 0.7 ± 0.08 nS (n = 5) in the presence of 1-EBIO.  
Taken together these results demonstrate i) that endogenous Ano1 behaves differently than 
overexpressed Ano1, and ii) that 1-EBIO is probably not useful to directly activate Ca
2+
 
activated Cl
-
 secretion in airways of CF patients.  
Finally, we detected differential regulation by protein kinase C of Ano1 overexpressed in 
HEK293 cells and endogenous Ano1 in HT29 cells: While inhibition of protein kinase C by 
preincubation with bisindolylmaleimide 1 (BIM; 0.1 µM/2 hrs) did not affect activation (by 
1µM ionomycin) of overexpressed Ano1 (Fig. 7E) (169), it augmented endogenous 
Ano1-currents in HT29 cells (Fig. 7F). Thus properties and regulation of overexpressed 
anoctamins may not fully reflect those of native channels. 
Most anoctamins are plasma membrane localized   
A recent report did not find membrane expression or Ca
2+
 activated Cl
-
 currents for Ano3-7 
(42). This is in contrast to our earlier results which demonstrate plasma membrane expression 
for Ano1, 2, 5, 6, 7, and 9 when overexpressed in HEK293 and FRT cells (148). Moreover, it 
was shown recently that Ano6 is an essential component of outwardly rectifying Cl
-
 channels 
(ORCC) and, at the same time, operates as a membrane localized phospholipid scramblase 
(110; 163). Moreover, also Ano5 and Ano7 were detected in the plasma membrane in earlier 
studies (29; 116). We re-examined plasma membrane expression of overexpressed anoctamins 
in HEK293 cells and, again, found clear membrane expression for Ano1,4,5,6 and 7 and a 
weak membrane staining for Ano8, 9, and 10 (Fig. 8). We produced additonal YFP- fusion 
proteins for Ano6, Ano8 and Ano9. Life cell imaging of YFP-fluorescence suggested (partial) 
membrane expression for Ano6, 8, and 9 (Supplemental Fig. S3). For Ano10 we managed to 
introduce a FLAG-tag into the 3
rd
 extracellular domain and labeled non-permeabilized cells. 
The results show a spotted membrane expression of Ano10 (Supplemental Fig. S3). Thus the 
present data fully confirm those obtained in earlier studies (148). 
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Nevertheless overexpressed Ano8, 9, and 10 show poor membrane expression. Since 
endogenous anoctamins are expressed at much lower levels, these anoctamins may not even 
accumulate at significant numbers in the plasma membrane of native cells. It is therefore 
entirely possible that Ano8, 9, and 10 have an intracellular rather than plasma membrane 
function. Currently available commercial antibodies are mostly of insufficient quality to stain 
endogenous anoctamins. Noteworthy, in contrast to Duran et al, we expressed only human 
anoctamins and acutely activated anoctamins, by either receptor stimulation or by ionomycin.  
 
Fig. 8: Plasma membrane localization of anoctamins. Immunocytochemistry of human 
anoctamins (red) overexpressed in HEK293 cells, and co-staining of ß-catenin. Nuclei are 
shown in blue (DAPI staining). Bars indicate 20 µm. 
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Supplemental Fig. S3: (A) 
Immunocy- tochemistry of 
hAno8, hAno9, and hAno10 as 
expressed in HEK293 cells. 
Ano8 and Ano9 were visualized 
using YFP fusion proteins (live 
staining). Ano10 contained a 
FLAG-tag in the predicted 3
rd
 
extracellular loop, and was 
labeled using a FLAG-antibody 
(non-per- meabilized cells) Bar 
= 10µm. (B) YFP-Ano6 
expressed in HEK293 cells. 
Live imaging of YFP 
fluorescence. Bar = 20µm. 
Since activation of most anoctamins was found to be transient, it is possible to overlook these 
currents, particularly if they are small, as those found for Ano5, 7, 8 and 9 (Fig. 1, 2). In 
summary, our present results suggest that anoctamins form a family of Ca
2+
 activated Cl
-
 
channels, which may have their function in the plasma membrane or in intracellular 
compartments. In addition to their property as Ca
2+
 activated Cl
-
 channels, anoctamins may 
either have some permeability for cations, or their expression activates independent cation 
channels. These results may help to understand the physiological function of anoctamins and 
their role in disease. 
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CHAPTER 3 
TMEM16 proteins produce volume regulated chloride currents that are reduced in mice 
lacking TMEM16A 
Abstract 
All vertebrate cells regulate their cell volume by activating chloride channels of unknown 
molecular identity, thereby activating regulatory volume decrease (RVD). We show that the 
Ca
2+
 activated Cl
-
 channel TMEM16A together with other TMEM16 proteins are activated by 
cell swelling through an autocrine mechanism that involves ATP release and binding to 
purinergic P2Y2-receptors. TMEM16A channels are activated by ATP through increase in 
intracellular Ca
2+
 and by a Ca
2+
- independent mechanism engaging extracellular regulated 
protein kinases (Erk1/2). The ability of epithelial cells to activate a Cl
-
 conductance upon cell 
swelling, and to decrease their cell volume (RVD) was dependent on TMEM16 proteins. 
Activation of ICl,swell was reduced in the colonic epithelium and in salivary acinar cells from 
mice lacking expression of TMEM16A. Thus TMEM16 proteins appear to be a crucial 
component of epithelial volume-regulated Cl
-
 channels and may also have a function during 
proliferation and apoptotic cell death.  
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Introduction 
Regulation of cell volume is fundamental to all cells, particularly during cell growth and 
division. External hypotonicity leads to cell swelling and subsequent activation of volume 
regulated chloride and potassium channels, to release intracellular ions and to re-shrink the 
cells, a process termed regulatory volume decrease (RVD) (162). Volume regulated chloride 
currents (ICl,swell) have dual functions during cell proliferation as well as apoptotic volume 
decrease (AVD), preceding apoptotic cell death (123). While ICl,swell is activated in swollen 
cells to induce RVD, AVD takes place under normotonic conditions to shrink cells (100; 101). 
Early work suggested intracellular Ca
2+
 as an important mediator for activation of ICl,swell and 
volume-regulated K
+
 channels (70), while subsequent studies found an only permissive role of 
Ca
2+
 for activation of ICl,swell (129; 162). In addition a plethora of factors and signaling 
pathways have been implicated in the activation of ICl,swell, making cell volume regulation an 
extremely complex process (69; 100; 162). These factors include intracellular ATP, the 
cytoskeleton, phospholipase A2-dependent pathways and protein kinases such as extracellular 
regulated kinase Erk1/2 (69; 162). Previous approaches in identifying swelling activated Cl
-
 
channels have been unsuccessful or have produced controversial data. Thus none of the 
previous candidates such as pICln, the multidrug resistance protein, or ClC-3 are generally 
accepted to operate as volume regulated Cl
-
 channels (56; 80). Notably, the cystic fibrosis 
transmembrane conductance regulator (CFTR) had been shown in earlier studies to influence 
ICl,swell and volume regulation (177; 178; 180). The variable properties of ICl,swell suggest that 
several gene products may affect ICl,swell in different cell types. 
The TMEM16 transmembrane protein family consists of 10 different proteins with numerous 
splice variants that contain 8-9 transmembrane domains and have predicted intracellular N- 
and C-terminal tails (85). TMEM16A (also called ANO1) is required for normal development 
of the murine trachea (135) and is associated with different types of tumors, dysplasia and 
nonsyndromic hearing impairment (21; 85). TMEM16A has been identified as a subunit of 
Ca
2+
 activated Cl
-
 channels that are expressed in epithelial and non-epithelial tissues (19; 149; 
197). Interestingly, members of the TMEM16 family have been suggested to play a role in 
osmotolerance in Saccharomyces cerevisiae (165). Here we show that TMEM16 proteins also 
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contribute to ICl,swell and regulatory volume decrease.  
Material and Methods 
Cell culture, cDNAs, and transfection 
Cell lines from human embryonic kidney (HEK293), human colon carcinoma (HT29), and 
human cystic fibrosis pancreatic epithelial (CFPAC) cells were cultured as described 
previously (90). cDNA for mouse TMEM16B was purchased from ImaGenes GmbH (Berlin, 
Germany, Clone name: IRAVp968H1167D). cDNA for human TMEM16A were cloned into 
pcDNA3.1 V5-His (Invitrogen, Karlsruhe, Germany) from total RNA of 16HBE-14o cells 
(bronchial epithelium; kindly provided by Prof. D. Gruenert, CPMRI, San Francisco, USA) 
by RT-PCR using the primer 5´- AAAAGCGGCCGCGGCCACGATGAGGGTC -3´ and 5´- 
AAATCTAGAAACAGGACGCCCCCGTGGTA-3´. All cDNAs were verified by sequencing. 
16HBE-14o cells express a TMEM16A isoform containing the exons a, b and c, according to 
Caputo, A. et. al. (19). Plasmids were transfected into HEK293 cells using standard methods 
(lipofectamine, Invitrogen, Karlsruhe, Germany). All experiments were performed 48 hours 
after the transfection. 
Western blotting 
Protein was isolated from transfected HEK293 cells in a lysis buffer containing 50 mM 
Tris-HCl 150mM NaCl, 50mM Tris, 100mM DTT, 1% NP-40, 0,5 % Deoxycholate sodium, 
and 1% protease inhibitor cocktail (Sigma, Germany) and was separated by 7 % SDS-PAGE. 
For Western blot analysis, proteins separated by SDS-PAGE were transferred to a PVDF 
membrane (GE Healthcare Europe GmbH, Munich, Germany) using semi dry transfer unit 
(BioRad, Munich, Germany). Membranes were incubated with primary antibodies (dilution 
from 1:2000 to 1:5000) overnight at 4°C. Proteins were visualized using a suitable (HRP) 
conjugated secondary antibody (dilution 1:30000) and ECL Detection Kit (GE Healthcare, 
Munich, Germany). Protein bands were detected on a FujiFilm LAS-3000. 
Patch clamp 
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Cells were grown on cover slips which were mounted in a perfused bath on the stage of an 
inverted microscope (IM35, Zeiss) and kept at 37 °C. Cells and acini isolated from mouse 
glands were allowed to settle onto poly-L-lysine coated cover slips. The bath was perfused 
continuously with Ringer solution at about 10 ml/min. For activation of volume dependent Cl
-
 
currents, isotonic Ringer bath solution (mM: NaCl 145, KH2PO4 0.4, K2HPO4 1.6, d-glucose 
6, MgCl2 1, Ca-gluconate 1.3, pH 7.4) was changed to isotonic control solution in which 50 
mmol/l NaCl was replaced by 100 mmol/l mannitol. Subsequently, mannitol (50, 75 and 100 
mmol/l) was removed to produce extracellular hypotonicity of -50, -75, and -100 mosmol/l, 
i.e. 17%, 25% and 33% hypotonicity.  Patch-clamp experiments were performed in the fast 
whole-cell configuration. Patch pipettes had an input resistance of 2–4 M , when filled with 
an intracellular like “physiological” solution containing (mM) KCl 30, K-gluconate 95, 
NaH2PO4 1.2, Na2HPO4 4.8, EGTA 1, Ca-gluconate 0.758, MgCl2 1.034, D-glucose 5, ATP 3, 
pH was 7.2, the Ca
2+
 activity was 0.1 µM. We choose this solution since it enabled normal 
swelling/shrinkage behavior and allowed for direct comparison of results from patch 
clamping and volume measurements. The access conductance was measured continuously and 
was 30 – 140 nS. Currents (voltage clamp) and voltages (current clamp) were recorded using 
a patch-clamp amplifier (EPC 7, List Medical Electronics, Darmstadt, Germany), the 
LIH1600 interface and PULSE software (HEKA, Lambrecht, Germany) as well as Chart 
software (AD-Instruments, Spechbach, Germany). Data were stored continuously on a 
computer hard disc and were analyzed using PULSE software. In regular intervals, membrane 
voltages (Vc) were clamped in steps of 10 mV from -50 to +50 mV relative to resting potential. 
Membrane conductance Gm was calculated from the measured current (I) and Vc values 
according to Ohm law. 
Animals and Ussing chamber experiments 
Generation of a null allele of Tmem16a and TMEM16A knockout animals has been described 
previously (135). Pups (1-4 days) were sacrificed with Isofluran (Baxter, Germany). The 
pancreas and submandibular glands were removed and epithelial cells were dispersed in a 
PBS buffer composed of Collagenase VIII (Sigma, Taufkirchen, Germany). Tracheas were 
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dissected, opened longitudinally on the opposite side of the cartilage free zone and were 
transferred immediately into an ice cold buffer solution. Stripped colon was put into ice cold 
Ringer bath solution (mM: NaCl 145, KH2PO4 0.4, K2HPO4 1.6, d-glucose 6, MgCl2 1, 
Ca-gluconate 1.3, pH 7.4) containing amiloride (10 µM) and indomethacin (10 µM). For 
activation of volume dependent Cl
-
 currents, isotonic Ringer bath solution (mM: NaCl 145, 
KH2PO4 0.4, K2HPO4 1.6, d-glucose 6, MgCl2 1, Ca-gluconate 1.3, pH 7.4) was changed to 
isotonic control solution in which 50 mmol/l NaCl was replaced by 100 mmol/l mannitol. 
Subsequently, mannitol was removed to produce extracellular hypotonicity of - 100 
mosmol/liter, i.e. 33% hypotonicity.  Tissues were mounted into a micro-perfused Ussing 
chamber with a circular aperture of 0.785 mm
2
. Luminal and basolateral sides of the 
epithelium were perfused continuously at a rate of 5 ml/min. Bath solutions were heated to 
37 °C, using a water jacket. Experiments were carried out under open circuit conditions. Data 
were collected continuously using PowerLab (AD-Instruments, Australia). Values for 
transepithelial voltages (Vte) were referred to the serosal side of the epithelium. 
Transepithelial resistance (Rte) was determined by applying short (1s) current pulses ( I = 0.5 
µA). Rte and equivalent short circuit currents (ISC) were calculated according to Ohm’s law 
(Rte = Vte/ I, ISC = Vte/Rte).  
RT-PCR, cDNA, siRNA, RealTime PCR 
TMEM16A was cloned from airway epithelial cells (16HBE14o-), corresponding to isoform 
abc (19). TMEM16A-K610A, TMEM16A-S967A, and TMEM16A-S970A were produced by 
PCR-based side directed mutagenesis. Expression of mRNAs encoding all 10 human 
TMEM16-proteins were examined in HEK293, HT29 and CFPAC cells by standard RT-PCR 
using real time and additional primers: (name, accession number: sense, antisense): 
hTMEM16C, NM_031418.2: 5'-TCAGAGCAGAAGGCTTGATG-3',
 
5'-AAACATGATAT- 
CGGGGCTTG-3', hTMEM16D, NM_178826.2: 5'-TGACTGGGATTTGATAGACTGG-3',
 
5'- GCTTCAAACTGGGGTCGTAT-3', hTMEM16GL, NM_001001891.3: 5'-GCTCTGTGG- 
TGATCGTGGT-3',
 
5'-GGCACGGTACAGGATGATAGA-3', hTMEM16GS, NM_00100 
1666.3: 5'-GGCTCTTACGGGAGCACAG-3',
 
5'-CAAACGAGGACGAAGTCGAT-3' and 
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hTMEM16K, NM_018075.3: 5'-CAGGGTCTTCAAACGTCCAT-3',
 
5'-TCATCGTTTCAA- 
AAGCCAACT-3'. Expression of TMEM16A, TMEM16F, TMEM16H, and TMEM16J were 
suppressed by two independent sets of siRNA. Duplexes of 25-nucleotide of siRNA were 
designed and synthesized by Invitrogen (Paisley, UK) and Santa Cruz (Heidelberg, Germany). 
siRNA was transfected using Lipofectamin (1 µg/µl) and cells were examined 48 h or 72 h 
after transfection. Suppression of expression of TMEM16A, TMEM16F, TMEM16H, and 
TMEM16J was verified by real time PCR. Total RNA was isolated from HEK293 or HT29 
cells using NucleoSpin RNA II
 
columns (Macherey-Nagel, Düren, Germany). Total RNA (2
 
µg) was reverse-transcribed using
 
random primer and RT (M-MLV Reverse Transcriptase, 
Promega,
 
Mannheim, Germany). The
 
oligonucleotide primers were designed for real-time 
PCR as folowing (name, accession number: sense and antisense primer): hTMEM16A, 
NM_018043.4: 5'-CCTCACGGGCTTTGAAGAG-3',
 
5'-CTCCAAGACTCTGGCTTCGT-3', 
hTMEM16B, NM_020373.1: 5'-TGGATGTGCAACAATTGAAGA-3', 5'-GCATTCTGCTG- 
GTCACACAT-3', hTMEM16E, NM_213599.1: 5'-TGGAAACATTAAAGAAGCCATTTA-3', 
5'-GAGTTTGTCCGAGCTTTTCG-5', hTMEM16F, NM_001025356.1: 5'-AGGAATGTTTT- 
GCTACAAATGGA-3', 5'-GTCCAAGGTTTTCCAACACG-3' hTMEM16H, NM_020959.1: 
5'-GGAGGACCAGCCAATCATC-3', 5'-TGCTCGTGGACAGGGAAC-3', hTMEM16J, 
NM_001012302.2: 5'-CAAACCCCAGCTGGAACTC-3', 5'-GGATCCGGAGGCTCTCTT-3', 
ß-actin, NM_001101: 5'-CAACGGCTCCGGCATGTG-3',
 
5'-CTTGCTCTGGGCCTCGTC-3'. 
Real-time PCR was performed in a Light Cycler (Roche), using
 
the Quanti Tect SYBR Green 
PCR Kit (Qiagen, Hilden, Germany).
 
Each reaction contained 2 µl Master Mix (including Taq
 
polymerase, DNTPs, SYBR green buffer), 1 pM of each primer sence and anti-sense, 2.5 mM 
MgCl2, and 2 µl
 
cDNA. After activation of the Taq polymerase for 10 min at 94°
 
cDNA was 
amplified by 15 s at 94°C, 10 s at 55°C, and
 
20 s at 72°C, for 50 cycles. The amplification 
was followed
 
by a melting curve analysis to control of the PCR products. Analysis of the data 
was performed using Light
 
Cycler software 3.5.3. Standard curves for TMEMs mRNA
 
and 
ß-actin mRNA were produced by using cDNA of transfected HEK
 
cells at different dilutions. 
The ratio of the amount of TMEM
 
to ß-actin mRNA was calculated for each sample and 
analysis was performed in triplicates. 
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Analysis of cell volume and FACS 
For cell volume measurements, HEK293 cells were loaded with 2 µg calcein-AM (Molecular 
Probes) and 0.025% Pluronic in standard bath solution (Ringer) for 30–60 min at 37ºC. 
Analysis was done at excitation wavelength of 500 nm and emission wavelength of 520-550 
nm. Cell swelling and RVD were observed for 10-15 min after applying hypotonic bath 
solution. To produce extracellular hypotonicity, isotonic Ringer bath solution (mM: NaCl 145, 
KH2PO4 0.4, K2HPO4 1.6, d-glucose 6, MgCl2 1, Ca-gluconate 1.3, pH 7.4) was changed to 
isotonic control solution in which 50 mmol/l NaCl was replaced by 100 mmol/l mannitol. 
Subsequently, mannitol was removed to reduce extracellular hypotonicity by 100 mosmol/liter 
(33% hypotonicity). Experiments were performed 48h after transfection of HEK293 cells with 
cDNAs encoding P2Y2 and hTMEM16A and 72h after transfection with siRNA targeting 
TMEM16 family members or scrambled. All the compounds were dissolved in the bath 
solutions and their effect on cell swelling was analyzed after 5-10 min incubation. Cell 
volume of HEK293 cells was also assessed by flow cytometry (Prof. Mathias Mack, 
University Hospital Regensburg) before (t = 0) and 30 sec (t = 0.5 min) and 5 min (t = 5 min) 
after swelling which was induced by reduction of the solution osmolarity to 1/3. In flow 
cytometry experiments, HEK293 cells were resuspended in PBS and the average volume of 
30000 cells per condition was determined.  
Materials and statistical analysis 
All compounds (ionomycin, carbachol, ATP, tamoxifen, 4,4'-diisothio-cyanostilbene-2, 
2'-disulfonic acid (DIDS), suramin, 1,2-bis(2-aminophenoxyl)ethane-N,N,N’,N’-tetraacetic 
acid-AM, U0126, staurosporine, CFTRinh-172, apyrase, MTSET, cyclopiazonic acid) were of 
highest available grade of purity and were from Sigma (Taufkirchen, Germany) or Merck 
(Darmstadt, Germany). The anti-hTMEM16A was a generous gift from Prof. van de Rijn 
(Dept. of Pathology, Stanford University, USA).  All cell culture reagents were from 
GIBCO/Invitrogen (Karlsruhe, Germany). For activation of volume dependent Cl
-
 currents, 
isotonic Ringer bath solution (mM: NaCl 145, KH2PO4 0.4, K2HPO4 1.6, d-glucose 6, MgCl2 
1, Ca-gluconate 1.3, pH 7.4) was changed to isotonic control solution in which 50 mmol/l 
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NaCl was replaced by 100 mmol/l mannitol. Subsequently, mannitol (50, 75 and 100 mmol/l) 
was removed to produce extracellular hypotonicity of -50, -75, and -100 mosmol/l, i.e. 17%, 
25% and 33% hypotonicity. Regulatory volume decrease (RVD) due to swelling activation of 
ion channels is an initial event which was assessed by analysis of the initial volume decrease. 
RVD indicates initial rate of regulatory volume decrease or initial RVD rate, RVDi(%) = 
(Vmax-Vmin)/(Vmax-Vo) x 100% (4). Initial rate of RVD in hepatocytes is controlled by 
extracellular ATP (125). Student’s t-test (for paired or unpaired samples as appropriate) and 
analysis of variance (ANOVA) was used for statistical analysis. P<0.05 was accepted as 
significant. 
Results and Discussion 
Suppression of ICl,swell by siRNA-TMEM16A in three different cell lines 
Because TMEM16A has been shown 
to be a major component of the Ca
2+
 
activated Cl
-
 channel, we examined 
the contribution of TMEM16A to 
swelling activated whole cell 
currents (ICl,swell) in a human 
pancreatic cell line (CFPAC) that 
lacks expression of the cystic 
Fig. 1: Activation of ICl,swell in CFPAC cells requires TMEM16A channels. (A) RT-PCR 
analysis indicates expression of TMEM16A, TMEM16F, and TMEM16H
 
in CFPAC cells. M 
= marker, A-K = TMEM16A-K. Gs, Gl; short and long splice variants. (B) Original 
recordings of whole cell currents in CFPAC cells activated by hypotonic bath solution (33%). 
Cells were voltage clamped in intervals from -50 to +50 mV. Treatment with siRNA for 
TMEM16A (si16A) reduced the swelling activated whole cell current, when compared to 
cells treated with scrambled (scrbld) RNA. (C) Summary of swelling activated whole cell 
conductances (GHypo) measured in CFPAC cells treated with scrambled RNA or after 
RNAi-knockdown of TMEM16A, CLC-3, and CLCA-proteins. Mean ± SEM, (n) = number 
of cells measured. # significant inhibition of ICl,swell by RNAi-knockdown of TMEM16A 
when compared to treatment with scrambled (scrbld) RNA (unpaired t-test). 
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fibrosis transmembrane conductance regulator (CFTR) Cl
-
 channel (90). CFPAC cells express 
TMEM16A, F, and H and show pronounced activation of whole cell Cl
-
 currents when 
exposed to hypotonic bath solution (90) (Fig. 1A, B). Activation of whole cell currents was 
suppressed by siRNA for TMEM16A, but not by siRNA knockdown of CLC3, ClCA1, and 
CLCA4, which are also expressed in 
CFPAC cells (Fig. 1C).  This result 
was confirmed in HT29, which also 
expresses TMEM16A, F, H, J. (Fig. 
2A). 
ICl,swell was activated upon exposure to 
increasing extracellular hypotonicity 
(17%, 25%, and 33%; arrows) (Fig. 
2B). Partial removal of Cl
-
 from the 
extracellular bath solution (white bars; 
30 mM Cl
-
) reduced ICl,swell and depolarized Vm by 9.1 ± 0.8 mV (n = 7), indicating activation 
of a Cl
-
 conductance by hypotonic bath solution. Importantly, activation of ICl,swell was 
reduced by siRNA-TMEM16A (Fig. 2B, C). Finally, the role of TMEM16A for ICl,swell was 
examined in HEK293 cells, which also express endogenous TMEM16-proteins (Fig. 3A). 
Equal to HT29 and CFPAC cells, ICl,swell was activated upon exposure to hypotonic bath  
Fig. 2: Activation of ICl,swell in HT29 cells requires TMEM16A channels. (A) RT-PCR analysis 
indicates expression of TMEM16A, TMEM16F, TMEM16H, and TMEM16J
 
in HT29 cells. M 
= marker, A-K = TMEM16A-K. Gs, Gl; short and long splice variants. (B) Original 
recordings of whole cell currents in HT29 cells, activated by a gradual increase of 
extracellular hypotonicity (17%, 25%, and 33%; arrows). Cells were voltage clamped in 
intervals from -50 to +50 mV. Partial replacement of extracellular Cl
-
 by gluconate (open bar; 
30 mM Cl
-
) inhibited whole cell outward currents. Treatment with siRNA for TMEM16A 
(si16A) reduced the swelling activated whole cell current, when compared to cells treated 
with scrambled (scrbld) RNA. (C) Summary of whole cell conductances measured in HT29 
cells under control conditions (open bars; normotonic bath solution) and after exposure to 
33% hypotonicity (black bars). Mean ± SEM, (n) = number of cells measured. *significant 
increase in whole cell conductance (paired t-test). # significant inhibition of ICl,swell by 
RNAi-knockdown of TMEM16A, when compared to treatment with scrambled (scrbld) RNA 
(unpaired t-test). 
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solution (Fig. 3B). Partial removal of Cl
-
 from the ex tracellular bath solution reduced ICl,swell 
and depolarized Vm by 8.2 ± 0.9 mV (n = 7). Most importantly, ICl,swell was inhibited by 
siRNA-TMEM16A (Fig. 3B, C).  
Members of the TMEM16-family participate in ICl,swell 
HEK293 cells which express low but detectable amounts of TMEM16A (Fig. 3A, 4A), were 
incubated with two different batches of siRNA and knockdown of TMEM16A was verified by 
 
Fig. 3: Activation of ICl,swell in HEK293 cells requires TMEM16A channels. (A) RT-PCR 
analysis indicates expression of TMEM16A, TMEM16F, and TMEM16H, in HEK293 cells. 
PCR product of TMEM16A becomes only visible when cDNA input was doubled. M = 
marker, A-K = TMEM16A-K. Gs, Gl; short and long splice variants. (B) Original recordings 
of whole cell currents in HEK293 cells, activated by a gradual increase of extracellular 
hypotonicity (17%, 25%, and 33%; arrows). Cells were voltage clamped in intervals from -50 
to +50 mV. Partial replacement of extracellular Cl- by gluconate (open bar; 30 mM Cl-) 
inhibited whole cell outward currents. Treatment with siRNA for TMEM16A (si16A) reduced 
the swelling activated whole cell current, when compared to cells treated with scrambled 
(scrbld) RNA. (C) Summary of whole cell conductances measured in HEK293 cells under 
control conditions (open bars; normotonic bath solution) and after exposure to 33% 
hypotonicity (black bars). Mean ± SEM, (n) = number of cells measured. *significant increase 
in whole cell conductance (paired t-test). # significant inhibition of ICl,swell by 
RNAi-knockdown of TMEM16A, when compared to treatment with scrambled (scrbld) RNA 
(unpaired t-test). 
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real time RT-PCR (Fig. 4B). Activation of whole cell conductance by hypotonic bath solution 
(GHypo) was potently inhibited by the inhibitor of TMEM16A-currents, DIDS (100 µM) (197), 
the specific inhibitor of Ca
2+
 activated Cl
-
 currents CACCinh-A01 (31) and tamoxifen (100 
µM) (Fig. 4C). 
 
Fig. 4: Activation of ICl,swell in HEK293 cells depends on the presence of TMEM16 channels. 
(A) Western blot analysis indicates expression of endogenous TMEM16A in HEK293 cells 
(B) Realtime PCR analysis of expression of TMEM16A in HEK293 cells treated with 
scrambled siRNA (scrbld) and TMEM16A-siRNA (si16A). (C) Inhibition of swelling 
activated whole cell conductances (GHypo) in HEK293 cells by DIDS (100 µM), 
CaCCinh-A01 (10 µM), and tamoxifen (100 µM). (D) Summary of GHypo in HEK293 cells 
expressing empty plasmid (mock), TMEM16A, or TMEM16B. (E) Summary of swelling 
induced whole cell conductances in cells treated with siRNA for various TMEM16 proteins. 
Mean ± SEM, (n) = number of cells measured. # significant difference when compared to 
control cells (mock, scrbld, absence of inhibitors) (unpaired t-test). 
We further confirmed the role of TMEM16 proteins for swelling activated Cl
-
 currents by 
overexpression of exogenous TMEM16A or TMEM16B, another Ca
2+
 activated Cl
-
 channel 
and member of the TMEM16 family (132). Overexpression of both TMEM16-proteins 
augmented swelling activated Cl
-
 currents in HEK293 cells (Fig. 4D). This suggests that 
several TMEM16-proteins may contribute to swelling activated Cl
-
 currents. We therefore 
knocked down endogenous TMEM16F, H and J individually or simultaneously, each by two 
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different batches of siRNA, which in each case significantly reduced ICl,swell (Fig. 4E). Since 
knockdown of each TMEM16 protein caused a non-additive reduction in ICl,swell, this may 
suggest that TMEM16 proteins heterooligomerize to form swelling activated Cl
-
 channels. In 
preliminary studies we found that endogenous volume activated Cl
-
 channels in HEK293 cells 
were potently suppressed by expression of K610A-TMEM16A, a TMEM16A-mutant that 
produced very little Cl
-
 conductance (unpublished data).  
Role of purinergic signaling for activation of TMEM16A by cell swelling 
Coexpression of G-protein coupled receptors has been shown to increase Ca
2+
 activated Cl
-
 
currents produced by TMEM16A (197). Although P2Y2 receptors are expressed endogenously 
in HEK293 cells, additional expression of exogenous purinergic P2Y2 receptors further 
increased swelling activated whole cell currents in HEK293 cells (Fig. 5A). 
 
Fig. 5: Role of purinergic signaling for activation of TMEM16A in HEK293 cells by cell 
swelling. (A) Activation of whole cell conductance by increased extracellular hypotonicity in 
cells expressing empty plasmid (mock), TMEM16A, or TMEM16A together with 
P2Y2-receptors. (B) Swelling activation of whole cell currents in a HEK293 cell and 
inhibition of the current by suramin (100 µM; grey bar). (C) Inhibition of the swelling 
activated whole cell conductance by suramin (100 µM), apyrase (3 U/ml), and ATP-free 
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pipette solution, the cystein reagent MTSET (2.5 mM) and the inhibitor of extracellular 
regulated kinase (Erk1/2) U0126 (25 µM). (D) Summary of swelling activated (Hypo) and 
ATP induced whole cell conductances in TMEM16A expressing HEK293 cells, under control 
conditions and after removal of Ca
2+
 from both pipette and bath solution. Both ATP and 
swelling induced whole cell conductances were reduced under Ca
2+
 free conditions and when 
two Erk1/2 consensus sides in TMEM16A were mutated. (E) Activation of whole cell 
currents by ATP (open bar; 10 µM), before and after swelling activation whole cell currents 
(Hypo). (F) Summary of whole cell conductances in the absence and presence of ATP 
hypotonic bath solution. Mean ± SEM, (n) = number of cells measured. *significant 
ATP-effect (paired t-test). # significant difference when compared to control (unpaired t-test). 
§
significant difference when compared to the absence of hypotonic bath solution (unpaired 
t-test). 
Intracellular ATP and swelling induced ATP-release from cells has been identified as an 
important factor for RVD (54). Moreover, it has been shown that ATP binds to purinergic 
P2Y2-receptors and activates TMEM16A (197). We found that blockage of P2Y2 receptors 
with 100 µM suramin largely reduced swelling activated whole cell currents (Fig. 5B, C), 
confirming the role of P2Y2-signaling for ICl,swell. Since ATP release is obviously a critical 
factor for activation of ICl,swell, we exposed the cells to hypotonic bath solution in the presence 
of the ATP-hydrolyzing enzyme apyrase, or removed ATP from the pipette filling solution, 
which both significantly reduced ICl,swell (Fig. 5C). Moreover, TMEM16A has been shown to 
be inhibited by the sulfhydryl-reagent MTSET, which reacts with three cysteine residues in 
the putative pore forming loop of TMEM16A (197). MTSET also blocked swelling activated 
whole cell currents in HEK293 cells. Remarkably, the Erk1/2-inhibitor U0126 completely 
inhibited ICl,swell thus clearly implying a role of this kinase for activation of 
TMEM16-channels (Fig. 5C). Notably, also ATP, i.e. Ca
2+
 activated whole cell currents were 
reduced by U0126 (data not shown). 
We further examined the contribution of Ca
2+
 and Erk1/2 for activation of ICl,swell and Ca
2+
 
dependent activation of TMEM16A by ATP, using Ca
2+
 free solution (in patch pipette and 
bath) and by mutating two potential C-terminal Erk1/2 consensus sides (S967, S970) in 
TMEM16A. We found that eliminating Ca
2+
 abolished activation of TMEM16A by ATP and 
inhibited ICl,swell (Fig. 5D). Mutating ser 967 to alanine inhibited ATP-activated currents, while 
mutating ser 970 to alanine inhibited both, ATP-activated Cl
-
 currents (TMEM16A) and 
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ICl,swell (Fig. 5D). Thus both swelling activation and ATP-dependent activation of TMEM16A 
use Ca
2+
 and Erk1/2 as intracellular messengers. While ICl,swell requires Erk1/2 for activation, 
Ca
2+
 has only a permissive function (25; 179). ATP release by swollen cells may activate 
Erk1/2 at very low local extracellular ATP concentrations, and may thereby induce swelling 
activated Cl
-
 conductance, as reported earlier (179). 
To further demonstrate that ATP and cell swelling target the same Cl
-
 channel, we applied ATP 
before and after exposure to hypotonic bath solution (paired experiments). We observed that 
after activation of ICl,swell, ATP induced (Ca
2+
 dependent) whole cell currents were largely 
reduced (Fig. 5E, F). Similar non-additive effects of ATP and cell swelling on whole cell Cl
-
 
conductance were observed in HT29 cells (data not shown).  
TMEM16 proteins are essential for RVD in HEK293 cells 
To further confirm the role of TMEM16-channels for ICl,swell and regulatory volume decrease 
(RVD) we loaded HEK293 cells with the fluorescence dye calcein (1). Hypotonic bath 
solution induced cell swelling and decreased calcein fluorescence which was followed by a 
98 % recovery after 20 min, indicating RVD (Fig. 6A).  
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Fig. 6: TMEM16 proteins are essential for RVD in HEK293 cells. (A) Swelling (Hypo) 
induced changes in calcein fluorescence in control HEK293 cells and cells treated with 
siRNA for TMEM16A or suramin (100 µM) or DIDS (100 µM). Mean curve ± SEM (n = 10). 
(B) Summary of the rate of fluorescence recovery per second, indicating recovery of the cell 
volume from hypotonic swelling. Treatment with siRNA for TMEM16A or exposure to 
various inhibitors of ICl,swell inhibited recovery of the cell volume, i.e. RVD. (C) Hypotonic 
cell swelling and recovery from cell swelling of cells treated with i) scrambled RNA, ii) 
TMEM16A-RNAi or iii) coexpressing P2Y2-receptors/TMEM16A, as determined by FACS 
analysis of 30.000 cells per experiment. Experiments were performed in triplicates. (D) 
Summary of volume, i.e. fluorescence recovery after hypotonic cell swelling of HEK293 cells 
treated with siRNA for the different TMEM16-proteins, as determined by FACS analysis of 
30.000 cells per experiment. (E) Apoptotic cell shrinkage induced by staurosporin (2 µM) 
under normotonic conditions in cells treated with two different batches of siRNA for 
TMEM16A (si16A-a, si16A-b), or when treated with scrambled RNA (FACS analysis of 
30.000 cells). Mean ± SEM, (n) = number of cells measured. *significant recovery from cell 
swelling of cells treated with scrambled siRNA (paired t-test). # significant difference when 
compared to control (unpaired t-test). 
Recovery from swelling was reduced in cells treated with siRNA-TMEM16A (42 % after 20 
min). Similarly inhibition of P2Y2-receptors by suramin, or application of the Cl
-
 channel 
blockers tamoxifen and DIDS, or apyrase, all significantly reduced RVD (Fig. 6A, B).  
These results obtained in single cell measurements were confirmed by FACS-analysis of a 
larger number of cells. HEK293 cells treated with scrambled siRNA increased their cell 
volume, which returned to control values within 5 min of exposure to hypotonic bath solution 
(Fig. 6C). In contrast, cells treated with siRNA for TMEM16A did not return to their initial 
volume, demonstrating reduced RVD. Notably, overexpression of P2Y2-receptors together 
with TMEM16A reduced the cell volume of HEK293 cells under control conditions. 
Overexpression of P2Y2 receptors probably sensitizes HEK293 cells towards extracellular 
ATP, thus P2Y2/TMEM16A expressing cells activate Cl
-
 channels more rapidly and therefore 
tend to reduce their cell volume. Moreover, their large RVD-capacity counteracts any 
tendency to swell and therefore the cells show only a small increase in cell volume when 
exposed to hypotonic bath solution (Fig. 6C). We determined the rate of recovery from cell 
swelling and found that not only TMEM16A but also the other TMEM16 proteins expressed 
in HEK293 cells contribute to RVD, as demonstrated by siRNA-knockdown of the individual 
TMEM16 proteins (Fig. 6D).  
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It has been reported earlier that cell shrinkage due to opening of ion channels not only occurs 
during hypotonic swelling, but also in normotonic solution, when cells go into apoptotic cells 
death (102; 123). Apoptotic volume decrease (AVD) is an initial step during apoptosis, which 
can be induced by compounds such as staurosporin (102). When we exposed HEK293 cells to 
staurosporin we observed a decrease in cell volume, indicating AVD (Fig. 6E). In contrast, 
knockdown of TMEM16A with two independent siRNAs significantly reduced AVD, 
suggesting that TMEM16A is important for both cell volume regulation (RVD) and apoptotic 
cell death (AVD).  
Impaired ICl,swell in epithelial tissues of mice lacking TMEM16 
TMEM16A is expressed at high levels in the submandibular gland and to lower degree in 
hepatocytes (135; 149); (Unigene-database). We examined activation of ICl,swell in freshly 
isolated acinar cells from submandibular glands and in hepatocytes of 1-4 day old wt (+/+)  
mouse pups and compared the results with those obtained in cells from mice lacking 
expression of TMEM16A (-/-). Exposure to hypotonic solution of submandibular acinar cells 
from +/+ animals activated a whole cell current that was essentially absent in cells from -/- 
animals (Fig. 7A, C).  
 
Fig. 7: Impaired ICl,swell in epithelial tissues of mice lacking TMEM16-/-. (A,B) Whole cell 
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currents and corresponding i/v curves obtained in submandibular acinar cells of 
TMEM16A-knockout mice (-/-) and wild type litter mates (+/+) before and after exposure to 
hypotonic (33%) bath solution. (C) Summary of the whole cell conductances induced by 
hypotonic bath solution in wt and knockout animals. (D, E) Whole cell currents and 
corresponding whole cell conductances obtained in hepatocytes of TMEM16A-knockout mice 
(-/-) and wild type litter mates (+/+), before and after exposure to hypotonic bath solution. (F) 
Recording of the change in transepithelial voltage (Vte) induced by hypotonic bath solution 
(25%) in wt (+/+) and knockout (-/-) animals. (G) Summary of the ion transport, i.e. the short 
circuit currents induced by hypotonic bath solution in wt (+/+) animals and knockout (-/-) 
littermates. Mean ± SEM, (n) = number of cells measured. *significant increase in whole cell 
conductance (paired t-test). # significant difference when compared to wt (+/+) (unpaired 
t-test). 
Thus the volume activated whole cell conductance was almost abolished in submandibular 
gland cells from -/- mice (Fig. 7C). In hepatocytes ICl,swell was of similar magnitude in both 
cells from +/+ and -/- animals, however, currents activated in -/- cells showed a different time 
dependence, suggesting some contribution of TMEM16A to ICl,swell also in hepatocytes (99). 
Volume activated Cl
-
 currents have also been identified previously in the basolateral 
membrane of colonic epithelial cells (37). Opening of basolateral Cl
-
 channels due to 
exposure to hypotonic bath solution reduced the lumen negative transepithelial voltage (Vte) 
in the distal colonic epithelium (Fig. 7F). In contrast the distal colon from TMEM16A-/- 
animals showed little changes when exposed to hypotonic solution, and thus swelling induced 
short circuit currents were significantly reduced in the TMEM16A-/- colon (Fig. 7F, G). 
Taken together the data clearly indicate that TMEM16A channels contribute to volume 
regulated Cl
-
 currents in native mouse epithelial cells. The present results suggest that volume 
regulated Cl
-
 channels may be composed of different members of the TMEM16-family, 
probably in a tissue specific manner, thus giving rise to variable properties of ICl,swell in 
different cell types and tissues (56). As these channels also control apoptotic cell shrinkage, 
they may affect cell survival, which could explain the role of these proteins in tumor 
development (85).  
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CHAPTER 4 
Calmodulin-dependent activation of the epithelial calcium-dependent chloride channel 
TMEM16A 
Abstract 
TMEM16A (anoctamin 1, Ano1), a member of a family of 10 homologous proteins has been 
shown to form an essential component of Ca
2+
 activated Cl
-
 channels. TMEM16A null mice 
exhibit severe defects in epithelial transport along with tracheomalacia and death within one 
month after birth. Despite its outstanding physiological significance, the mechanisms for 
activation of TMEM16A remain obscure. TMEM16A is activated upon increase in 
intracellular Ca
2+
, but it is unclear whether Ca
2+
 binds directly to the channel or whether 
additional components are required. We demonstrate that TMEM16A is strictly membrane 
localized and requires cytoskeletal interactions to be fully activated. Despite the need for 
cytosolic ATP for full activation, phosphorylation by protein kinases is not required. In 
contrast, the Ca
2+
 binding protein calmodulin appears indispensable and interacts physically 
with TMEM16A. Openers of small and intermediate conductance Ca
2+
 activated potassium 
channels like 1-EBIO, DCEBIO or riluzole known to interact with calmodulin, also activated 
TMEM16A. These results reinforce the use of these compounds for activation of electrolyte 
secretion in diseases such as cystic fibrosis. 
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Introduction 
Broadly expressed Ca
2+
 activated Cl
-
 channels (CaCC) are of fundamental importance in 
many tissues, as they control electrolyte secretion, neuronal excitability, and smooth muscle 
contraction. CaCC have been identified as TMEM16A (19; 149; 197). TMEM16A (anoctamin 
1, ANO1) belongs to a family of 10 TMEM16-proteins (TMEM16A-K, ANO1-10). 
TMEM16A has eight putative transmembrane domains (TMD) and a p-loop between TMD 5 
and 6. Along with multiple splice variants, several isoforms are coexpressed in a tissue 
specific manner, which provide a Ca
2+
 activated Cl
-
 conductance of distinct biophysical and 
pharmacological features (52; 92). It has been shown that alternative splicing of TMEM16A 
changes voltage dependence and Ca
2+
 sensitivity (52). Moreover, membrane expression, time 
dependence and amplitude of the current, Ca
2+
 dependence as well as sensitivity towards 
inhibitors vary among TMEM16 proteins. Preliminary data suggest that these proteins can 
exist as heterooligomeric complexes (148).  
TMEM16A shows common characteristics of the native CaCCs, present in a large number of 
tissues and cell types (19; 44; 63; 149; 197). We and others demonstrated the fundamental 
importance of TMEM16A for Ca
2+
 dependent Cl
-
 secretion in a number of epithelial tissues 
(124; 137; 138). TMEM16A is essential for Ca
2+
 dependent Cl
-
 currents in airways, large 
intestine, salivary gland, pancreatic gland and hepatocytes (124; 137; 138). Severe transport 
defects were detected in epithelial tissues of TMEM16A knockout mice, leading to reduced 
saliva production and attenuated mucociliary clearance of the airways (104; 124; 137). Thus 
TMEM16A is essential for proper development and hydration of the airways (135). Knockout 
animals die early because of instable airways and because they cannot digest and absorb food. 
The outstanding physiological significance of TMEM16A is further supported by its role in 
pacemaker cells, where it controls smooth muscle contraction, and by its contribution to 
generation of acute nociceptive signals (59; 72; 77; 105; 197). Moreover, TMEM16A does 
also participate in fundamental cellar mechanisms such as regulation of the cell volume, and it 
interferes with E. coli alpha-hemolysin-induced shrinkage of erythrocytes and subsequent 
hemolysis (3; 155). 
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Although it is clear that TMEM16A produces Cl
-
 currents upon increase in , it is not known 
whether  binds directly to the channel. A string of negatively charged glutamic acid residues 
in the first intracellular loop could form a Ca
2+
 binding pocket, but its role for Ca
2+
 binding 
remains currently unclear (57). The available data do not explain the mechanism for 
activation of TMEM16A by Ca
2+
 and whether phosphorylation or membrane trafficking are 
required. Here we elucidate the mechanisms for activation of TMEM16A and found that both 
ATP and calmodulin are required. The present results suggest a regulation of TMEM16A 
similar to Ca
2+
-activated K
+
 (SK) channels. Also, both types of channels share 
pharmacological properties (78). Understanding the regulation of TMEM16A will allow the 
development of novel classes of pharmaceutical compounds, such as benzimidazolinones. 
Because both Ca
2+
 dependent K
+
 and Cl
-
 channels are expressed in human airways, in contrast 
to adult human colon which does not express Ca
2+
 activated Cl
-
 channels, benzimidazolinones 
are promising tools to reinstall Cl
-
 secretion in airways in cystic fibrosis (CF). 
Materials and Methods 
Cell culture, cDNAs, and transfection 
HEK293 and Calu-3 cells were grown in DMEM (Gibco, Karlsruhe, Germany) supplemented 
with 10% fetal bovine serum at 37°C in a humidified atmosphere with 5% CO2. Cells were 
plated on fibronectin- and collagen-coated cover slips and co-transfected with cDNA 
encoding either mTMEM16A, hTMEM16A, hSK4, or empty pcDNA3.1 vector (mock) along 
with P2Y2 receptor and CD8. Transfections were carried out using lipofectamine 2000 
(Invitrogen, Karlsruhe, Germany) according to the manufactures protocol.  
Patch Clamping 
At 2 or 3 days after transfection, transfected cells were identified by incubating the cells 1-2 
min with Dynabeads CD8 (Invitrogen).  Coverslips were mounted on the stage of an 
inverted microscope (IM35, Carl Zeiss, Jena, Germany) and kept at 37 °C. The bath was 
perfused continuously with Ringer at the rate of 5 ml/min. For fast whole cell patch clamping 
Calmodulin-dependent activation of the epithelial calcium-dependent chloride channel TMEM16A                   54 
pipettes were filled with intracellular like “physiological” solution containing (mM) KCl 30, 
potassium gluconate 95, NaH2PO4 1.2, Na2HPO4 4.8, EGTA 1, calcium gluconate 0.758, 
MgCl2 1.034, D-glucose 5, ATP 3 (pH 7.2), with an input resistance of 2–4 M . Experiments 
were conducted as described earlier (124). 
Ussing chamber experiments 
After isolation, mouse tracheas were put immediately into ice cold buffer solution. Tracheas 
were opened longitudinally and mounted into a perfused micro Ussing chamber with a 
circular aperture and a diameter of 0.95 mm. Luminal and basolateral sides of the epithelium 
were perfused continuously at a rate of 5 ml/min with solution containing (mM) NaCl 145, 
KH2PO4 0.4, K2HPO4 1.6, D-glucose 5, MgCl2 1, HEPES 5, and Ca gluconate 1.3, pH 7.4, 
that was heated to 37°C. Experiments were carried out under open-circuit conditions. Values 
for transepithelial voltages (Vte) were referred to the serosal side of the epithelium. 
Transepithelial resistance (Rte) was determined by applying short (1 s) current pulses (Δl = 
0.5 μA) and after subtracting the resistance of the empty chamber using Ohm’s law. 
ReAsH labeling and electron microscopy 
HEK293 or COS-7 cells were transiently transfected using DEAE dextran/chloroquine 
(Ausubel et al., 1996). Three days later cells were incubated for 1 hour at 37°C with 450 nM 
ReAsH (resorufin arsenical hairpin binding reagent; Invitrogen), 12.5 µM 1, 2-ethanedithiol 
(EDT; Fluka, Buchs, Switzerland); the cells were washed twice briefly with 500 nM 2, 
3-dimercapto-1-propanol (BAL; Fluka), incubated in 500 nM BAL for 20 minutes at 37°C, 
washed again three times with HBSS and fixed with 2% glutaraldehyde overnight.  Cells 
were blocked for 30 minutes in 50 mM glycine, 10 mM KCN, 20 mM aminotriazole, 0.001% 
H2O2 and were washed with new buffer containing 1 mg/ml of diaminobenzidine. 
Photoconversion was performed by exposing the cells at 4°C to a 585 nm light source.  
Finally the cells were washed again and embedded in Durcupan (Fluka).  Thin sections 
(50-nm) were analyzed in a Zeiss EM 902 transmission electron microscope equipped with a 
cooled CCD digital camera (TRS, Moorenweis, Germany). 
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Western blotting, immunoprecipitation 
Protein was isolated from transfected HEK293 cells in lysis buffer containing 50 mM 
Tris-HCl, 150 mM NaCl, 100 mM DTT, 0.2% Triton X-100, 5U/ml of benzonase and 1% 
protease inhibitor cocktail (Sigma-Aldrich, Taufkirchen, Germany). Prior to the addition of 
1–5 μg of the primary antibody, protein lysates were precleared with protein A agarose beads 
(Pierce, Rockford, IL, USA). Incubation with primary antibodies was performed 3 h at 4°C, 
and the protein–antibody complex was immobilized by the addition of 25 μl of protein A 
agarose beads for 1 h at 4°C. The beads were washed in PBS, and then boiled in 1X loading 
sample buffer for Western blot analysis using 10% SDS-PAGE. The protein was transferred to 
a polyvinylidene difluoride membrane (GE Healthcare, Munich, Germany) using semidry 
transfer (BioRad, Munich, Germany). Membranes were incubated with first antibodies 
(dilution from 1:500 to 1:1000) overnight at 4°C. Proteins were visualized using a horseradish 
peroxidase (HRP)-conjugated secondary antibody (dilution 1:10,000) and ECL Detection Kit 
(GE Healthcare, Munich, Germany); the protein bands were detected by FujiFilm LAS-3000 
(FujiFilm, Tokyo, Japan). 
Immunocytochemistry 
HEK293 cells were grown on glass cover slips and washed 3 times in phosphate-buffered 
saline (PBS). Cells were fixed with methanol at −20°C for 5 min and incubated with primary 
antibodies at 4°C overnight. Monoclonal rabbit anti-mouse TMEM16A antibody was used as 
first antibody. For immunofluorescence, cells were incubated with secondary AlexaFluro 488 
goat anti-rabbit IgG for 1 h at room temperature and counterstained with Hoe33342 
(Sigma-Aldrich, Taufkirchen, Germany). Immunofluorescence was detected using an 
Axiovert 200 microscope equipped with an ApoTome and Carl Zeiss AxioVision software 
(Axiovert 200M, Carl Zeiss, Jena, Germany). 
Materials and statistical analysis 
All compounds (ionomycin, 1EBIO; riluzole, cytochalasin D; BIM, dynasore, okadaic acid, 
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phalloidin, STO-609; KN93; KN62; KT5720; IBMX, forskolin, trifluoroperazine, 
Calmodulin, ATP, BAPTA-AM, U0126, apyrase, dasatinib) were from Sigma (Taufkirchen, 
Germany) or Merck (Darmstadt, Germany). Peptides were synthesized by Davids 
Biotechnologie (Regensburg Germany), the sequence of CAM-BD 1 is NH2- VRK YFG EKV 
GLY FA -COOH and CAM-BD 2 is NH2- LLS KRR KCG KYG ITS LLA –COOH. AO1 was 
generously provided by Sygnature Chemical Services Limited (Nottingham, UK). The 
anti-hTMEM16A was a generous gift from Prof. van de Rijn (Dept. of Pathology, Stanford 
University, USA). All cell culture reagents were from GIBCO/Invitrogen (Karlsruhe, 
Germany). Student’s t-test (for paired or unpaired samples as appropriate) and analysis of 
variance (ANOVA) was used for statistical analysis. P<0.05 was accepted as significant. 
Results 
TMEM16A is strictly membrane localized and is regulated by cytoskeletal components 
 
Fig. 1: TMEM16A is strictly membrane localized and is regulated by cytoskeletal 
components. (A) Immunofluorescence of TMEM16A expressed in HEK293 cells. (B) 
High-resolution electron microscopy showing tetracysteine-tagged TMEM16A in HEK293 
cells using ReAsH technology (triangles). (C) Electron microscopy of mock transfected 
HEK293 control cells. (D-F) Original recordings of whole cell currents and effects of 
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ionomycin in mock transfected cells (D) or cells overexpressing mTMEM16A before (E) and 
after (F) treatment with cytochalasin D (10 µM/2h). (G) Summary of the effects of ionomycin 
in mock and mTMEM61A-expressing cells under control conditions and after incubation with 
a specific CaCC-inhibitor (AO1, 10 µM), cytochalasin D (cyto D; 10 µM), and phalloidin (1 
µg/ml/2h). Cells were voltage clamped from -50 to +50 mV in steps of 10 mV. Means ± SE; n 
= 8- 14. Values in parentheses indicate n. Scale bars = 20µm (A); 500 nm (B). * P< 0.05 for 
activation of whole-cell conductance by ionomycin; paired t-test. # P<0.05 vs. control; 
ANOVA. 
It is believed that Ca
2+
 dependent Cl
-
 currents are activated through increase in intracellular 
Ca
2+
 and binding to TMEM16A or an associated protein. However this has not been proven 
and alternatively the current may be activated by exocytosis of TMEM16A and insertion into 
the plasma membrane. This has been proposed for the exocrine pancreas (131). We examined 
localization of TMEM16A when overexpressed in HEK293 and Cos-7 cells, using 
immunocytochemistry and electron microscopy. TMEM16A appeared clearly membrane 
localized in immunohistochemistry of HEK293 cells (Fig. 1A). This was confirmed by high 
resolution electron microscopy using REASH labeling (c.f. Methods). The images clearly 
indicate a strict membrane localization of TMEM16A in overexpressing HEK293 cells (Fig. 
1B). No REASH labeling was observed in mock transfected control cells (Fig. 1C). A similar 
staining was observed in Cos-7 cells after expression of TMEM16A (Supplemental Fig. S1). 
 
Supplemental Fig. S1: High resolution electron microscopy of mock transfected 
(-TMEM16A) and TMEM16A (+TMEM16A) expressing COS-7 cells at lower and higher 
magnification. Triangles indicate cell membrane. Bars indicate 500 and 200 nm, respectively. 
Activation of TMEM16A in HEK293 cells was examined using whole cell patch clamp 
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recordings. We expressed both human and mouse TMEM16A, which produced similar whole 
cell Cl
-
 conductances. While no currents were observed in HEK293 control cells, large whole 
cell Cl
-
 currents were activated by the Ca
2+
 ionophore ionomycin (1 µM) in TMEM16A 
expressing cells (Fig. 1D, E). Notably in TMEM16A expressing cells whole cell baseline 
currents were enhanced, even in the absence of ionomycin, and both enhanced baseline 
conductance and ionomycin-activated conductance were inhibited by 10 µM AO1, a specific 
inhibitor of Ca
2+
 activated Cl
-
 currents (31) (Fig. 1G). Interestingly activation of currents was 
suppressed by depolymerizing or stabilizing actin with cytochalasin D and phalloidin, 
respectively (Fig. 1F, G). Maneuvers that inhibit exocytosis or endocytosis (dynasore 10 µM; 
calmodulin dependent kinase kinase inhibitor STO-609, 10 µM; siRNA for synapsin 1) had no 
effects (data not shown). Thus membrane localized TMEM16A is activated by Ca
2+
 in an 
actin-dependent manner.  
Phosphorylation is not a prerequisite for activation of TMEM16A 
As reported earlier, intracellular N and C termini of TMEM6A carry a number of sites with 
consensus sequences for phosphorylation by protein kinases, such as  PKA, PKC, CAMK, 
CK2 and Erk1,2 (92). Moreover the present results and a previous study suggest that cytosolic 
ATP is required for full activation of TMEM16A (3). Activation of TMEM16A by ionomycin 
(1 µM) or stimulation of P2Y receptors with ATP (100 µM) was unaffected in the presence of 
an ATP-free pipette filling solution ( GIono = 45 ± 5.2 nS; GATP = 50 ± 5.7 nS) but was 
abolished with apyrase (2 U/ml) in the patch pipette (Fig.2A-E). This suggests that cytosolic 
ATP is required for complete activation of TMEM16A, and could be required for 
phosphorylation of the channel. We therefore applied ionomycin after inhibition of various 
kinases, for which potential phosphorylation sides have been detected in TMEM16A. Cells 
were stimulated in the presence of inhibitors of CAMKII (KN93, KN62), PKC (BIM), PKA 
(KT5720), or CK2 (TBB), or in the presence of IBMX and forskolin, which increase 
intracellular cAMP (Fig. 2B). None of these treatments changed activation of TMEM16A by 
ionomycin. In contrast the CAMKII inhibitor KN62 even augmented Ca
2+
-activated Cl
-
 
currents, similar to what has been reported for smooth muscle cells (60; 185). Moreover the 
Calmodulin-dependent activation of the epithelial calcium-dependent chloride channel TMEM16A                   59 
broad non-specific kinase inhibitor staurosporine (5 µM, 2 h) or the phosphatase 2A inhibitor 
okadaic acid (10 nM, 2 h) had no effects on channel activation (data not shown). All inhibitors 
used in the present study have been demonstrated to exert their expected actions at the 
concentrations used in the present report: i) KN63 inhibited CaCC in CFPAC cells, ii) BIM 
prevented the epithelial Na
+
 channel ENaC from inhibition by protein kinase C, iii) KT5720 
and TBB inhibited activation of CFTR, and iv) U0126 attenuated P2Y2- induced inhibition of 
ENaC. Finally neither siRNA knockdown of CAMKII  or CK2 inhibited TMEM16A (data 
not shown).  
Expression of the double mutant S967A/S970A-TMEM16A (Erk1,2-mut) that lacks of two 
consensus sequences for extracellular regulated kinase (Erk1,2) in the C-terminus, did not 
change activation of TMEM16A by ionomycin but reduced receptor-mediated activation by 
ATP (10 µM) (Fig. 2C, F).  
 
Fig. 2: Activation of mTMEM16A requires ATP but not phosphorylation by protein kinases. 
(A, D) Original recordings of whole cell currents activated by ionomycin (1 µM) or ATP (10 
µM) in mTMEM16A expressing HEK293 cells, in the presence or absence of apyrase in the 
patch pipette. (B) Summary of whole cell conductances activated by ionomycin in the 
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presence of apyrase (1 U/ml), after inhibition of CAMKII by KN93 (10 µM) or KN62 (10 
µM) or after incubation with BIM (1 µM; inhibition of PKC), KT5720 (10 µM; inhibition of 
PKA), TBB (10 µM; inhibition of CK2), and stimulation with IBMX/forskolin (I/F, 100 µM/2 
µM; activation of PKA). Dashed line indicates activation by ionomycin under control 
conditions (absence of inhibitors). (C) Summary of the effects of ionomycin (1 µM) on cells 
expressing human wtTMEM16A or a mTMEM16A mutant in which two putative Erk1,2 
phosphorylation sites have been eliminated. (E) Summary of whole cell conductances 
activated by ATP (10 µM) in the presence of apyrase in the patch pipette (1 U/ml), U0126 (10 
µM; inhibition of Mek1,2), KN62 (10 µM; inhibition of CAMKII), and BIM (1 µM; 
inhibition of PKC). Dashed line indicates activation by ionomycin under control conditions. 
(F) Summary of the effects of ATP (100 µM) on cells expressing human wtTMEM16A or a 
hTMEM16A mutant in which two putative Erk1,2 phosphorylation sites have been 
eliminated. Cells were voltage clamped from -50 to +50 mV in steps of 10 mV. Means ± SE; 
n = 6 - 14. Values in parentheses indicate n. #P< 0.05 vs. control or wt; ANOVA. 
Since the MEK-inhibitor U0126 did not inhibit receptor-dependent activation of TMEM16A, 
stimulation of P2Y2 receptors may activate Erk1,2 and TMEM16A in a MEK-independent 
manner (3; 27). Nonetheless, Erk1,2 phosphorylation is not absolutely essential for channel 
activation, as high [Ca
2+
]i levels (application of ionomycin) activates TMEM16a in an 
Erk1,2-independent fashion. Typically ion channels that are regulated by calmodulin and the 
cytoskeleton are often controlled by phosphatidylinositols such as PIP3 and PIP2 (8). However, 
we found that neither siRNA-knockdown of the phosphatase and tensin homologue (PTEN) 
which hydrolyzes PIP3 to PIP2, nor inhibition of the PI3-kinase by wortmannin (1 µM; n = 8) 
compromised activation of TMEM16A by ionomycin (data not shown). Thus it remains 
currently unclear how ATP is involved in regulation of TMEM16A.  
Calmodulin is essential for activation of TMEM16A 
A number of studies report activation of endogenous Ca
2+
-dependent Cl
-
 currents by 
calmodulin dependent kinase II (23; 63; 67; 184). However, we did not find that CAMKII is 
essential for activation of TMEM16A overexpressed in HEK293 cells (Fig. 2). In contrast, 
when calmodulin (CAM) was inhibited by trifluoperazine (TFP, 10 µM) or the highly specific 
inhibitor J-8 (50 µM), activation of TMEM16A by both ionomycin and ATP was largely 
suppressed (Fig. 3). This calmodulin- and ATP-dependence of TMEM16A is reminiscent of 
Ca
2+
 dependent KCNN4 potassium channels, which also require both factors for complete 
Calmodulin-dependent activation of the epithelial calcium-dependent chloride channel TMEM16A                   61 
activation (128; 161; 164). 
Calmodulin binds to the 
intracellular C - terminus of 
KCNN4 channel and acts as a Ca
2+
 
sensor to control channel assembly 
and surface expression of KCNN4 
(88).  
Using a Web-based prediction 
program (Calmodulin Target 
Database, Ikura Lab, Ontario, 
Cancer Institute), we identified two 
putative CAM-binding domains (CAM-BD1, CAM-BD2) located in the intracellular 
N-terminus of TMEM16A (Fig. 4A).  
In fact, calmodulin could be coimmunoprecipitated using a TMEM16A antibody, while 
TMEM16A was coimmunoprecipitated by a CAM-antibody in lysates from 
TMEM16A-expressing cells (Fig. 4B). No coimmunoprecipitation was observed with protein 
A agarose beads only. TMEM16A is expressed in different splice forms, which are 
characterized by amino acid inserts (segments a-d) in the N-terminus and the 1. intracellular 
loop (Fig. 4A) (19). The putative CAM-BD1 overlaps with segment b of the splice form 
abc-TMEM16A. We expressed the different splice forms in HEK293 cells; however, 
coimmunoprecipitation and detection by Western blot was unsuccessful with ac-TMEM16 
(data not shown), although ac-TMEM16A and abc-TMEM16A are comparably expressed at 
the plasma membrane (Supplemental Fig. S2B). To further examine the role of these putative 
Fig. 3: Calmodulin is essential for activation of mTMEM16A. (A, B) Original recordings of 
whole cell currents activated by ionomycin (Iono, 1 µM; A) or ATP (10 µM; B) in 
mTMEM16A expressing HEK293 cells in the presence of the CAM inhibitor trifluoperazine 
(TFP, 5 µM). (C-E) Summary of the whole cell conductances activated by ionomycin (C, E) 
or ATP (D) under control conditions and in the presence of TFP (C, D) or the specific 
calmodulin inhibitor J-8 (50 µM; E). Means ± SE; n = 5 - 12. Values in parentheses indicate 
n. #P< 0.05 vs. control; unpaired t test. 
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CAM-binding domains, we perfused the cytosol via the patch pipette with short peptides 
corresponding to the sequences of CAM-BD1 and CAM-BD2. In the presence of CAM-BP1 
activation by ionomycin of human and mouse TMEM16A was inhibited, while CAM-BP2 
had no effects (Fig. 4C-E). These results suggest that CAM-BP1 may bind to calmodulin 
thereby interfering with activation of TMEM16A. 
 
Fig. 4: Calmodulin physically interacts with mTMEM16A and controls channel activity. (A) 
N-terminal putative calmodulin binding domains CAM-BD1 and CAM-BD2 and location of 
the alternatively spliced sequences (a-d) are shown. (B) Coimmunoprecipitation of 
TMEM16A and calmodulin in hTMEM16A overexpressing HEK293 cells. Upper half shows 
overexpressed TMEM16A (Input 16A, 110 & 150 kDa; anti-hTMEM16A antibody) and 
coimmunoprecipitated calmodulin (IP CAM, 18 kDa; anti-hCAM antibody). Lower half 
shows endogenous calmodulin expressed in HEK293 cells (Input CAM; 18 kDa) and 
coimmunoprecipitated hTMEM16A (IP 16A; 110 & 150 kDa). (C) Activation of whole cell 
currents by ionomycin (1 µM) in hTMEM16A expressing HEK293 cells in the absence or 
presence of a peptide with the amino acid sequence of the putative calmodulin binding 
domain 1 (CAM-BP1) in the patch pipette filling solution. (D, E) Summary of the ionomycin 
activated whole cell conductances in human TMEM16A (D) or mouse TMEM16A (E) 
expressing HEK293 cells. CAM-BP1 but not CAM-BP2 inhibited activation of whole cell 
conductances by ionomycin. F) Summary of the ionomycin-activated whole cell conductances 
in cells expressing the splice forms abc-TMEM16A or ac-TMEM16A (16Aabc, 16Aac) or N- 
and C-terminal truncations of hTMEM16A (M266-16A, M350-16A, V897X-16A). G) 
Summary of ATP-activated whole cell conductances in cells expressing wtTMEM16A or 
C-terminally truncated V897X-TMEM16A. Cells were voltage clamped from -50 to +50 mV 
in steps of 10 mV. Mean ± SEM, (n = 5- 20). # significant inhibition (ANOVA). 
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Further attempts to confirm interaction of CAM with the N-terminus of TMEM16A were 
unsuccessful, since two N-terminal truncations of TMEM16A (M266-16A and M350-16A) 
annihilated membrane expression of the protein (Fig. 4F; Supplemental Fig2. A). Notably 
truncation of the C-terminus had no effect on channel activation by ionomycin, but attenuated 
receptor-mediated activation by ATP, probably due to elimination of the Erk1,2 sites (Fig. 4F, 
G). When we expressed the splice form ac-TMEM16A, we found that a Cl
-
 current was still 
activated by ionomycin, albeit the whole cell conductance was slightly attenuated when 
compared to abc-TMEM16A. Thus the putative CAM-BD1 supports Ca
2+
-dependent 
activation of the channel, but is not essential for the function of TMEM16A (Fig. 4F). 
 
Supplemental Fig. S2: (A) Immunolabeling of His-tagged full length TMEM16A (green), 
and two N-terminal truncations (M266-TMEM16A and M350-TMEM16A), which are not 
expressed in HEK293 cells. Actin staining (red) indicates plasma membrane. (B) Comparison 
of membrane expression of abc-TMEM16A and ac-TMEM16A. Bar indicates 20µm. 
TMEM16A requires Ca
2+
, ATP and calmodulin for full activation 
In cell-attached patches of TMEM16A-expressing HEK293 cells, we detected activation of a 
current noise after purinergic stimulation with ATP, which was not observed in control (mock) 
cells (Fig. 5A). However, we were unable to resolve single channel activity probably due to 
the very small single channel conductance. When membrane patches were excised inside/out 
after stimulation of TMEM16A-expressing cells, the channel noise disappeared within 
seconds, and removal of Ca
2+
 from the bath (cytosolic side) had no effects (Fig. 5B upper 
trace).  
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Fig. 5: Fast rundown of mTMEM16A currents. (A) Single channel noise was activated by 
purinergic stimulation with ATP in cell attached recordings from mTMEM16A expressing 
HEK293 cells, but not in mock transfected cells (Vc = -30 mV). (B) Lack of channel noise in 
excised inside/out membrane patches from cells expressing mTMEM16A (upper trace). 
Excised membrane patch from a SK4 expressing cell exhibits current noise that was inhibited 
by removal of Ca
2+
 from the bath solution (cytosolic side). (C, D) Current-voltage 
relationships obtained from membrane patches at different time points after excision into a 
Ca
2+
 free bath solution (C), or bath solution containing 1 mM Ca
2+
 (D). An outwardly 
rectifying current is observed immediately after excision into Ca
2+
 containing bath solution 
(D) that quickly inactivated. Cells were voltage clamped from -50 to +50 mV insteps of 10 
mV. Means ± SE; n = 6 – 9. Values in parentheses indicate n. #P< 0.05; unpaired t-test. 
In contrast to TMEM16A, Ca
2+
-dependent K
+
 channels (KCNN4, SK4) were readily 
detectable in excised inside/out patches and were inhibited by removal of cytosolic Ca
2+
 (Fig. 
5B lower trace). We measured the conductance of excised membrane patches from 
ATP-stimulated and TMEM16A-expressing cells immediately after excision, and one or two 
minutes after removal from the whole cell. When excised into Ca
2+
 free Ringer solution, the 
membrane conductance of the patch was small right after excision (Fig. 5C). In contrast, 
when excised into a Ca
2+
 containing Ringer solution, an outwardly rectifying current was 
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detected that inactivated within a minute after excision, suggesting rapid run down of 
TMEM16A currents (Fig. 5D).  
We speculated that cytosolic factors such as ATP or calmodulin might get lost during 
membrane excision and therefore added ATP (3 mM) to the bath solution (cytosolic side), 
which increased the current noise and slightly enhanced the conductance of patches from 
TMEM16A expressing cells, but not from mock transfected cells (Fig. 6).  
 
Fig. 6: Activation of mTMEM16A requires ATP and calmodulin. (A) Current recordings in 
inside /out excised membrane patches from TMEM16A and mock transfected HEK293 cells 
(Vc = +30 mV). Current noise was small after excision of the patch in a Ca
2+
 containing bath 
solution (con), but was activated in excised patches from mTMEM16A-expressing cells by 
adding ATP (3 mM) or calmodulin (1 µg/ml) together with ATP to the cytosolic side (right 
tracings). In contrast no current is activated in an excised membrane patch from a mock 
transfected cell (left tracings). (B, C) Current / voltage relationships measured in excised 
membrane patches obtained form mock transfected (B) and mTMEM16A expressing (C) 
cells, indicating current activation by ATP and calmodulin in mTMEM16A expressing cells. 
Cells were voltage clamped from -50 to +50 mV insteps of 10 mV. Means ± SE; n = 7-9. 
Values in parentheses indicate n. #P< 0.05; unpaired t-test. 
Further addition of CAM (1 µg/ml) increased the channel noise and activated a membrane 
conductance in patches from TMEM16A expressing cells but not from control cells. Thus 
ATP and CAM may be required to keep TMEM16A channels active (Fig. 6).  
TMEM16A and SK4 share pharmacological properties 
Benzimidazolinones like 1-ethyl-2-benzimidazolinone (1-EBIO) are well known activators of 
Ca
2+
 dependent K
+
 channels and enhance the affinity of K
+
 channels for Ca
2+
/calmodulin (35; 
183). Since both SK4 and TMEM16A require CAM and ATP to be activated, we examined 
whether benzimidazolinone compounds are also able to activate TMEM16A. In excised 
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mouse tracheas, 1-EBIO (50 µM) activated a small and rather steady Cl
-
 secretion and 
augmented ATP activated short circuit currents, apparently by activating both luminal 
TMEM16A and basolateral SK4 channels (Fig. 7A, B). Notably, in the presence of the CFTR 
inhibitor CFTRinh172 (5 µM) 1-EBIO still augmented ATP-induced Cl
-
 secretion (Fig. 7B). In 
whole cell patch clamp experiments with human airway epithelial (Calu-3) cells, 1-EBIO and 
the related compound S0011198 increased whole cell currents. However, in these cells SK4 
channels were activated by the benzimidazolones and hyperpolarized the membrane voltage, 
since Calu-3 cells do not express TMEM16A and do not have CaCC (92) (Fig.7C, D, 
Supplemental Fig. S3C). When expressed in HEK293 cells, TMEM16A was activated by 
1-EBIO (50 µM) and riluzole (50 µM), another known opener of SK4 channels (145). 
Moreover, the related compound DCEBIO (1 µM) also activated TMEM16A ( G = 23.1  
4.2 nS; n = 5). In summary, both luminal Ca
2+
 activated TMEM16A and basolateral SK4 K
+
 
channels are activated by the same compounds. Therefore benzimidazolinones may be ideal 
drugs for the treatment of the cystic fibrosis lung disease, which is characterized by defective 
CFTR-dependent Cl
-
 secretion and dehydration of the airways (16; 94; 133). 
 
Fig. 7: Pharmacological activation of TMEM16A and SK4 channels. (A) Transepithelial 
voltage measured in Ussing chamber recordings from mouse trachea. 1-EBIO (1 mM) 
increases transepithelial voltage and augments subsequent negative voltage deflection induced 
by application of luminal ATP (100 µM). (B) Summary of the calculated equivalent short 
circuit currents activated by ATP, 1-EBIO or simultaneous application of both. ATP activated 
transport was significantly enhanced by 1-EBIO. Even after inhibition of CFTR Cl
-
 channels 
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by the compound CFTRinh172 (CFTRinh; 5 µM), 1-EBIO still augmented ATP-induced Cl
-
 
secretion. (C) Activation of whole cell currents and hyperpolarization of the membrane 
voltage of Calu3 cells by different concentrations of the homologue of 1-EBIO, S0011198. 
(D) Comparison of the concentration-dependent hyperpolarizing effects of 1-EBIO and 
S0011198 in Calu-3 cells. E) Activation of whole cell currents by 1-EBIO (1 µM) and riluzole 
(50 µM) in mTMEM16A-expressing HEK293 cells. (F) Summary of the whole cell 
conductances activated by 1-EBIO and riluzole in mTMEM16A-expressing HEK293 cells. 
Cells were voltage clamped from -50 to +50 mV insteps of 10 mV. Means ± SE; n = 6-28. 
*P< 0.05 for augmentation of currents by 1-EBIO and riluzole; paired t-test. #P< 0.05 for 
augmentation of ATP effect by 1-EBIO; unpaired t test. 
Discussion 
Activation of membrane localized TMEM16A 
In the present study we examined the mechanisms for activation of the novel Ca
2+
 activated 
Cl
-
 channel TMEM16A and identified pharmacological properties that allow interfering with 
the activity of this highly relevant channel. The data demonstrate that TMEM16A is 
membrane localized and is activated by Ca
2+
 in an actin dependent manner. Notably, a 
contribution of the actin cytoskeleton to activation of endogenous CaCC in epithelial cells has 
been suggested earlier (76). We found no evidence for a role of exocytosis in activating 
TMEM16A, and thus confirm earlier data from pancreatic acinar cells, showing 
exocytosis-independent activation of ion channels due to spatial distribution of cytosolic Ca
2+
 
(111). Similar to other epithelial ion channels, anchoring of TMEM16A to the cytoskeleton 
and to membrane phosphatidylinositols (PIP2) may be essential to maintain channel activity 
(112; 167). A regulatory link between endogenous CaCC, actin cytoskeleton and actin-bound 
annexin IV has been detected earlier in colonic carcinoma cells (23).  
CAMKII, Calmodulin, and ATP 
Initial studies demonstrated activation of TMEM16A by increase in cytosolic Ca
2+
, but did 
not present evidence for a requirement of cytosolic ATP (149; 197). We found that the 
presence of the ATP-cleaving enzyme apyrase in the pipette solution largely reduced channel 
activity, suggesting a requirement of ATP for full activation of TMEM16A. Some properties 
of TMEM16A are clearly different to those found for endogenous CaCC in epithelial cells. 
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Firstly, TMEM16A expressed in HEK293 and FRT cells (148) is partially active at basal 
intracellular Ca
2+
 concentrations, while endogenous CaCC is closed under control conditions. 
Secondly, CAMKII inhibited TMEM16A currents expressed in HEK293 cells, but activates 
endogenous CaCC in colonic, airway and pancreatic epithelial cells (23; 63; 67; 184). Notably, 
regulation of CaCC by CAMKII is cell type dependent, and inhibition of CaCC by CAMKII 
has been described for smooth muscle cells (60; 185). Preliminary experiments also indicate 
that overexpressed TMEM16A is inhibited by CAMKII, while activation of endogenous 
CaCC in CFPAC-1 cells is CAMKII dependent (data not shown). However, CFPAC-1 cells 
express TMEM16A endogenously, and siRNA knockdown of TMEM16A inhibits CaCC, 
indicating that TMEM16A is a crucial component of the endogenous CaCC. It is therefore 
likely that the cellular environment and/or additional auxiliary proteins determine 
CAMKII-dependent regulation (92).  
The present data demonstrate calmodulin as one of the auxiliary proteins necessary for 
activation of TMEM16A. According to the present data the putative site for calmodulin 
binding overlaps with segment b of the splice form abc of TMEM16A (Fig. 4A). We found a 
reduced activity of ac-TMEM16A, when compared with abc-TMEM16A, which is actually 
different to the results of a previous study (52). This discrepancy remains currently 
unexplained. However, in preliminary experiments we found that i) intracellular Ca
2+
 itself 
triggers inactivation of the channel and ii) inactivation of ac-TMEM16A occurs at lower 
[Ca
2+
]i than for abc-TMEM16A (unpublished data). Also, it appears possible that Ca
2+
 and 
calmodulin have more than one binding site. In overexpressing cells additional accessory 
proteins may still be missing to produce a “complete” chloride channel complex. In 
preliminary experiments we performed two hybrid screening using the split ubiquitin system 
in order to identify additional interacting partners, and identified the Ca
2+
-binding protein 
S100A11. However siRNA-knocked down of S100/A11 did not change TMEM16A currents.  
Similar mechanisms for activation of SK4 and TMEM16A 
Calmodulin regulation of TMEM16A is reminiscent of Ca
2+
/CAM-dependent regulation of 
SK4 (KCNN4) potassium channels. The open probability of SK4/IK1 channels is tightly 
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regulated by cytosolic Ca
2+
 concentrations in the range between 100 and 1000 nM, although 
typical Ca
2+
 binding domains are not present in SK4. The pronounced Ca
2+
 sensitivity of SK4 
is due to its high affinity for CAM (48; 81; 87; 128; 161; 164; 190). Activation of SK4/IK1 by 
the benzimidazolinone 1-EBIO is well established and is due to enhanced Ca
2+
 sensitivity of 
the CAM/SK4 channel complex (62; 127; 183; 186). 1-EBIO has also been shown to activate 
apical Cl
-
 channels of unknown molecular identity in rabbit conjunctival epithelium and 
intestinal epithelium (5; 61). However most studies claim that activation of Cl
-
 secretion by 
1-EBIO is indirect, by increasing the driving force due to activation of basolateral SK4 
channels (34; 62). In this regard a derivative of 1-EBIO, DCEBIO 
(5,6-dichloro-1-ethyl-1,3-dihydro-2Hbenzimidazol-2-one) was very potent in activating K
+
 
channels and on top activated an unknown apical membrane Cl
-
 conductance in monolayers 
of T84 colonic carcinoma cells (154).   
We found that 1-EBIO, DCEBIO and riluzole activated TMEM16A. An exciting finding was 
that only low concentrations of these compounds were required to activate TMEM16A 
(Supplemental Fig. S3). While typically 0.1 – 1 mM of 1-EBIO is required to activate SK4, 
TMEM16A was activated at concentrations as low as 1 µM. Despite the complex Ca
2+
 
dependent regulation of TMEM16A outlined above, activation by 1-EBIO, DCEBIO and 
riluzole was robust and was observed for overexpressed TMEM16A as well as endogenous 
CaCC in CFPAC-1 cells (Supplemental Fig. S3).  
 
Supplemental Fig. S3: (A) Activation of endogenous Ca
2+
 dependent Cl
-
 currents (CaCC) in 
CFPAC cells by 1-EBIO, as detected by increase in FMP-fluorescence. Due to depolarization 
of the membrane voltage upon activation of Ca
2+
 dependent Cl
-
 channels FMP is taken up by 
the cell and fluorescence is increased. The CaCC-inhibitor AO1 (10µM) inhibited 
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1-EBIO-induced fluorescence increase. (B) Concentration-response of the effect of 1-EBIO 
on AO1-inhibitable currents. (C) No whole cell currents are activated by 1-EBIO in 
TMEM16A-expressing HEK293 cells in the presence of K
+
 channel inhibitors Ba
2+
 and 
TEA
+
. (number of experiments). 
Since benzimidazolinones activate both basolateral SK4 and luminal TMEM16A channels, 
they could be ideal compounds for the treatment of CF lung disease. As cAMP-dependent Cl
-
 
secretion is defective in CF, Ca
2+
 -dependent Cl
-
 secretion may compensate for the defect in 
CFTR-function. It will be exciting to search for more potent activators of both TMEM16A 
and SK4. Since pharmacological properties of Ca
2+
 activated Cl
-
 and K
+
 channels appear to 
overlap considerably (144), it will also be interesting to learn whether pharmacological 
properties of TMEM16A are altered by factors such as CAMKII, ATP or 
histidine-phosphorylation, as described for  SK4 channels (58; 188). As TMEM16A is 
broadly expressed in a number of tissues, it may become a highly relevant drug target in the 
future.   
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CHAPTER 5 
Control of TMEM16A by INO-4995 and other inositolphosphates 
Abstract 
Background and Purpose: Ca
2+
-dependent Cl
-
 secretion (CaCC) in airways and other tissues 
is due to activation of the Cl
-
 channel TMEM16A (anoctamin 1). Earlier studies suggested 
that Ca
2+
 activated Cl
-
 channels are regulated by membrane lipid inositol phosphates, and that 
1-O-octyl-2-O-butyryl-myo-inositol 3,4,5,6-tetrakisphosphate octakis (propionoxymethyl) 
ester (INO-4995) augments CaCC. Here we examined whether TMEM16A is the target for 
INO-4995, and if the channel is regulated by inositol phosphates. 
Experimental approach: The effects of INO-4995 on CaCC were examined in overexpressing 
HEK293, colonic and primary airway epithelial cells as well as Xenopus oocytes. We used 
patch clamping, double electrode voltage clamp and Ussing chamber techniques.  
Key results: We found that INO-4995 directly activates a TMEM16A whole cell conductance 
of 6.1 ± 0.9 nS/pF in overexpressing cells. The tetrakisphosphates Ins(3,4,5,6)P4 or 
Ins(1,3,4,5)P4 and enzymes controlling levels of InsP4 or PIP2 and PIP3 had no effects on the 
magnitude or kinetics of TMEM16A currents. In contrast in Xenopus oocytes, human airways 
and colonic cells, which all express TMEM16A endogenously, Cl
-
 currents were not acutely 
activated by INO-4995. However incubation with INO-4995 augmented 1.6 – 4 fold 
TMEM16A-dependent Cl
-
 currents activated by ionomycin or ATP, while intracellular Ca
2+
 
signals were not affected. The potentiating effect of INO-4995 on transient ATP-activated 
TMEM16A-currents in CF airways was twice of that observed in non-CF airways.  
Conclusions and implications: These data indicate that TMEM16A is the target for INO-4995, 
although the mode of action appears different for overexpressed and endogenous channels. 
INO-4995 may be useful for the treatment of CF lung disease. 
Key words: INO-4995, INO-4913, anoctamin 1, TMEM16A, inositol phosphates, 
Ins(3,4,5,6)P4, inositol 3,4,5,6-tetrakisphosphate, Ins(1,3,4,5)P4, inositol 
1,3,4,5-tetrakisphosphate, Ca
2+
 activated Cl
-
 channels, CaCC 
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Introduction 
Ca
2+
 activated Cl
-
 channels (CaCC) are highly relevant for secretion of electrolytes in 
epithelial tissues. Activation of CaCC in cystic fibrosis (CF) airways may ameliorate 
mucociliary clearance and compensate for defective cystic fibrosis transmembrane 
conductance regulator (CFTR) Cl
-
 channels (120). However, only recently the molecular 
counterpart of CaCC was identified as TMEM16A (anoctamin 1) (19; 149; 197). TMEM16A 
is the major component of Ca
2+
-dependent Cl
-
 secretion in airways and other epithelial tissues 
(124; 137). In contrast to CFTR, activation of CaCC / TMEM16A is transient and does not 
strictly follow intracellular Ca
2+
 levels. Cl
-
 currents relax faster than intracellular Ca
2+
 levels 
decline upon stimulation of phospholipase C coupled receptors. However, local 
compartmentalized Ca
2+
 in close proximity of the channel may recover quicker than global 
[Ca
2+
]i (118). Alternatively downstream products of InsP3 such as the inositol 
tetrakisphosphate Ins(3,4,5,6)P4 may inhibit CaCC, as shown for different types of epithelial 
cells (20; 32; 68; 82; 192). Thus long-term uncoupling of chloride secretion from intracellular 
calcium levels by Ins(3,4,5,6)P4 has been proposed as a mechanism for the transient Ca
2+
 
dependent Cl
-
 secretion (176). Following this, a novel therapeutic concept for treatment of CF 
lung disease had been develop, proposing cell permeant antagonists of endogenous 
Ins(3,4,5,6)P4 to allow for continuing Ca
2+
 dependent chloride secretion (140; 141). The 
membrane permeable compound 1-O-octyl-2-O-butyryl-myo-inositol 3,4,5,6-tetrakisphos- 
phate octakis (propionoxymethyl) ester (INO-4995; Inologic, Seattle,WA, USA) was 
demonstrated both to inhibit the epithelial Na
+
 channel ENaC and to activate Ca
2+
 dependent 
Cl
-
 secretion (141; 117; 173). Therefore the primary objective of the present study was to 
examine whether the novel Ca
2+
 dependent Cl
-
 channel TMEM16A is the target for INO4995. 
Studies demonstrated that intracellular Ins(3,4,5,6)P4 levels are a result of  inositol 
1,3,4-trisphosphate 5/6-kinase (ITPK1) dephosphorylation of  Ins(1,3,4,5,6)P5 and are 
regulated by Ins(1,3,4)P3 levels (114; 143). Enzymes that generate inositolphosphate 
intermediates may therefore determine the magnitude and duration of CaCC (176; 173). In 
fact Yang et al. found that expression of ITPK1 is reduced in murine airway cells lacking 
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functional CFTR, thus causing enhanced Ca
2+
 activated secretion. ITPK1 was therefore 
suggested as a novel modifier gene in CF (152; 196). How Ins(3,4,5,6)P4 inhibits Ca
2+
 
activated Cl
-
 channels is unknown. Effects of Ins(3,4,5,6)P4 on accessory proteins such as 
protein phosphatases have been proposed, although precise mechanisms remain elusive (67; 
193). In order to guide future drug development programs, a more detailed understanding of 
the regulation by phosphatidylinositols (PI(4,5)P2, PI(3,4,5)P3) and Ins(3,4,5,6)P4 is essential 
(152). The secondary objective of this study was therefore to examine whether TMEM16A is 
regulated by phosphoinositides and/or Ins(3,4,5,6)P4 (117; 173). The results indicate that 
TMEM16A is activated by INO-4995 but otherwise not affected by phosphoinositides or 
InsP4. 
Materials and Methods 
Cell culture, cDNAs, siRNAs and transfection 
HEK293, HT29 and CFPAC cells were grown in DMEM and DMEM-F12 (GIBCO), 
respectively, supplemented with 10% fetal bovine serum at 37°C in a humidified atmosphere 
with 5% CO2. Cells were plated on fibronectin- and collagen-coated 18 cm diameter cover 
slips and co-transfected with cDNA encoding either human TMEM16A (a,b,c-Ano1; 
NM_018043), or empty pcDNA3.1 vector (mock) along with P2Y2 receptor (NM_176072) 
and CD8. Expression of TMEM16A, and PTEN was suppressed by RNAi and suppression of 
mRNA was monitored by real-time RT-PCR. For each type of siRNA-knockout, real-time 
RT-PCR was performed at least in triplicates. It showed siRNA-knockdown of Ano1-mRNA 
of 82 ± 4 % (HT29), 68 ± 5 % (CFPAC), and 45 ± 6 % for PTEN (HEK293). Duplexes of 
25-nucleotide of RNAi were designed and synthesized by Invitrogen (Paisley, UK) and 
Ambion (Darmstadt, Germany). RNAi was transfected using Lipofectamin (1 µg/µl). Cells 
were examined 48h or 72h after transfection. Transfections were carried out using 
lipofectamine 2000 (Invitrogen) according to the manufactures protocol.  
Primary Human Bronchial Epithelial Cells Monolayers 
Control of TMEM16A by INO-4995 and other inositolphosphates                                             74 
Human lung tissues (non-CF and CF) were obtained from the Cardio-Thoracic Surgery 
Department (Hospital de Santa Marta; Lisbon, Portugal) after receiving patient’s written 
consent and approval by the Ethics Committee. Primary HBE cells were isolated as described 
previously (55) and expanded on collagen I - fibronectin-coated plastic dishes before passage 
to the porous membrane inserts. The primary HBE monolayers (passage 1) were grown on 
collagen IV coated porous membranes (Snapwell, Corning-Costar®) in an air liquid interface 
for three weeks. Cells were incubated repetitively for 2 hrs in 5 µM INO-4995 on 4 
subsequent days. 
Patch clamping and double electrode voltage clamp 
2-3 days after transfection, transfected HEK293, HT29 or CFPAC cells were identified by 1 - 2 
min incubation with Dynabeads CD8 (Invitrogen), which permanently bind to transfected 
cells. Cover slips were mounted on the stage of an inverted microscope (IM35, Zeiss) and 
kept at 37 °C. The bath was perfused continuously with ringer solution (mmol/l: NaCl 145, 
KH2PO4 0.4, K2HPO4 1.6, d-glucose 6, MgCl2 1, Ca-gluconate 1.3, pH 7.4) at a rate of 5 
ml/min. For fast whole cell and cell excised patch clamping pipettes were filled with 
intracellular like solution containing (mM) KCl 30, potassium gluconate 95, NaH2PO4 1.2, 
Na2HPO4 4.8, EGTA 1, calcium gluconate 0.758, MgCl2 1.034, D-glucose 5, ATP 3, pH was 
7.2 and had an input resistance of 2 – 4 M . The free Ca2+ concentration in the pipette 
solution was 0.1 µM. For measurement of excised membranes, patches were excised into a 
bath solution containing 0.1 µM [Ca
2+
]. Experiments were conducted as described earlier 
(124). Typically the cells were kept in current clamp for most of the time and the membrane 
voltage was recorded. From time to time the cells were voltage clamped (± 50 mV in steps of 
10 mV for 1 s). All data were recorded using an EPC7 and the program PULSE (HEKA, 
Lambrecht, Germany). All data were recorded continuously on a hard disc and analyzed using 
PULSE and Chart (ADInstruments GmbH, Spechbach, Germany).   
Isolation and microinjection of oocytes have been described in details elsewhere (7). Oocytes 
were pre-incubated with 5 µM INO4995 for 2h or 24h. Oocytes were impaled with two 
electrodes (Clark Instruments Ltd, Salisbury, UK), which had a resistances of < 1 M  when 
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filled with 2.7 mol/l KCI. Using two bath electrodes and a virtual-ground head stage, the 
voltage drop across Rserial was effectively zero. Membrane currents were measured by voltage 
clamping (oocyte clamp amplifier, Warner Instruments LLC, Hamden CT) in intervals from 
-60 to +40 mV, in steps of 10 mV, each 1 s. Data were collected and analyzed using Powerlab 
and Chart (AD instruments, Berlin, Germany). The bath was continuously perfused at a rate 
of 5 ml/min. All experiments were conducted at room temperature (22 °C). 
Measurement of intracellular Ca
2+
 concentration 
For single cell fluorescence measurements HEK293 cells and HT29 cells were grown on glass 
covers slips, mounted in a cell chamber and perfused with ringer solution at 5 ml/min at 37˚C. 
Cell fluorescence measurements was measured continuously on an inverted microscope 
Axiovert S100 (Zeiss, Germany) using a Fluar20x/0.75 objective (Zeiss, Germany) and a high 
speed polychromator system (VisiChrome, Visitron Systems, Germany). Cells were loaded 
(1h at 37°C) with 2 µM Fura2-AM (Molecular Probes) in ringer solution or Opti-MEM 
containing 0.2% pluronic (Molecular Probes). Fura-2 was excited at 340/380 nm, and the 
emission was recorded between 470 and 550 nm using a CCD-camera (CoolSnap HQ, 
Visitron Systems, Germany). Acquisition and data analysis were done using Meta-Fluor 
(Universal imaging, USA) and Origin (OriginLab Corporation, USA). For calibration of 
intracellular Ca
2+
 concentration cells were perfused with ringer solution and Ca
2+
 free ringer 
with 1 µM ionomycin, 10 µM monensin and 5 µM nigericin.  
Immunocytochemistry and Western blot 
HT29 cells were fixed for 10 min with 4% (w/v) paraformaldehyde at room temperature and 
permeabilized after blocking with 2% (w/v, PBS) bovine serum albumin and 0.04% (v/v, PBS) 
Triton X-100. Cells were incubated for 1h with primary anti-ß-catenin antibody (1:1000, 
Qiagen, Hilden, Germany) at 37 °C. Binding of the primary antibody was visualized by an 
Alexa 568-labeled secondary antibody (1:1.000, Molecular Probes, Invitrogen). Nuclei were 
stained with Hoe33342. Cells were examined with an ApoTome Axiovert 200 M fluorescence 
microscope (Zeiss, Göttingen, Germany). For Western blotting cells were lysed with an 
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appropriate buffer (150 mM NaCl, 50 mM Tris–HCl, 1 mM EDTA, 1% NP-40, protease 
inhibitor, 100 mM DTT; pH 7.4) and DNA was sheared by sonication. Samples were 
quantified using a Bio-rad protein assay (Biorad) and the same amount of protein (50µg) was 
separated using PAGE (7,5%). Protein were transferred to PVDF membranes (Millipore), and 
probed overnight at 4°C with a rabbit monoclonal anti-ANO1 antibody (Novus Biologicals, 
Littleton, CO, USA). Blots were visualized using a secondary HRP-conjugated anti-rabbit 
antibody (Acris, Herford, Germany) and Super Signal® West Pico Chemiluminescent 
Substrate (Pierce, Rockford, IL, USA). 
Micro-Ussing chamber recordings 
Access to human tissues used in this study received approval from the local Ethics Committee 
of the Faculty of Medical Sciences and informed consent was obtained from all patients. HBE 
monolayers (resistance ≥ 600 Ωcm2) were mounted in a modified micro-Ussing chamber. 
Apical and basolateral surfaces were perfused continuously at a rate of 5 - 10 ml/min 
(chamber volume 2 ml). The bath solution contained (mmol/l): NaCl, 145; KH2PO4, 0.4; 
K2HPO4, 1.6; D-glucose, 5; MgCl2, 1; Hepes 5; and Ca-gluconate, 1.3. pH was adjusted to 
7.4). Experiments were carried out under open circuit conditions at 37 °C. Transepithelial 
resistance (Rte) was determined by applying short (1 s) current pulses ( I = 0.5 µA) and 
recording of the corresponding voltage deflections ( Vte). Values for transepithelial voltage 
(Vte) were referred to the luminal side of the monolayers and equivalent short-circuit currents 
(Isc) were calculated according to Ohm’s law. 
Iodide Quenching 
Quenching of the intracellular fluorescence generated by the iodide-sensitive enhanced yellow 
fluorescent protein (YFP) was used to measure anion conductance. YFP fluorescence was 
excited at 490 nm using a semi-automatic Novostar plate reader (BMG-Labtech, Offenburg, 
Germany). I
-
 influx was induced by replacing 20 mM extracellular Cl
-
 by I
-
. Background 
fluorescence was subtracted and auto-fluorescence was negligible. Changes in fluorescence 
induced by I
-
 are expressed as initial rates of fluorescence decrease (arbitrary units/sec). For 
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the assays we used HT29 cells stably expressing YFP. Ca
2+
 stimulus and iodide were applied 
together because of the transient nature of the Ca
2+
 stimulation.  
Materials 
All compounds used (ionomycin, carbachol, ATP, DAG kinase inhibitor II, U73122) were of 
highest available grade of purity and were from Sigma (Taufkirchen, Germany) or Merck 
(Darmstadt, Germany). All cell culture reagents were from GIBCO/Invitrogen (Karlsruhe, 
Germany). The IPMK inhibitor chlorogenic acid (C3878) was from SIGMA (Taufkirchen, 
Germany). The inositol-1,4,5-trisphosphate 3-Kinase inhibitor N²-(m-Trifluorobenzyl), 
N
6
-(p-nitrobenzyl)purine and D-myo-Inositol 1,3,4,5-Tetrakisphosphate Octapotassium Salt 
were from Merck (Damstadt, Germany). D-myo-Inositol 3,4,5,6-tetrakisphosphate from 
Echelon (Salt Lake City, UT) was from Santa Cruz (Heidelberg, Germany). AO1 was from 
Sygnature Chemical (Nottingham, UK). INO-4995 and INO-4913 were from Inologic (Seattle, 
WA, USA).  
Statistical analysis 
Student’s t test (for paired or unpaired samples as appropriate) and ANOVA were used for 
statistical analysis. Values of p < 0.05 were accepted as significant.  
Results 
INO-4995 and INO-4913 activate human TMEM16A 
INO-4995 has been suggested to activate from the cytosolic side a non-CFTR Cl
-
 conductance 
that is Ca
2+
 dependent (CaCC) (173). Its non-esterified counterpart INO-4913 was shown to 
be less membrane permeable and thus less potent in activating CaCC. CaCC in airways and 
other epithelial and non-epithelial tissues is now known as TMEM16A (124; 137). It can be 
readily activated by increase in intracellular Ca
2+
 due to Ca
2+
 ionophores such as ionomycin 
(Fig. 1A, B). Notably, cells overexpressing TMEM16A have an increased baseline Cl
-
 
conductance, indicating a considerable leakage activity of the overexpressed channel (97). We 
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examined if esterified membrane permeable. INO-4995 and the less membrane permeable, 
non-esterified INO-4913 (176) are able to activate TMEM16A. Stable baseline currents were 
measured under control whole cell conditions (Supplemental Fig. S1A). However, when patch 
pipettes were filled with 1 µM INO-4995 and INO-4913, respectively, whole cell currents 
were activated in HEK293 cells, expressing human TMEM16A (Fig. 1C-E) upon forming a 
whole cell recording (rupture of the cell attached membrane). Similar to the activation by 
ionomycin, INO-4995 and INO-4913 activated currents showed little time dependence (Fig. 
1C, D; right panels) and were completely blocked by the TMEM16A-inhibitor CaCCinh-A01 
(AO1; 20 µM) (3; 31). Activation of TMEM16A by INO-4995 was concentration dependent 
with a maximal activation at 5 µM (Fig. 1G). While 20 µM AO1 showed complete inhibition, 
10 µM blocked 95 ± 6 % (n = 5) of the current. Moreover, INO-4995 induced conductances 
were inhibited significantly from 8  1 to 2.7  0.9 nS/pF. When measured under current 
clamp, the membrane voltages were depolarised by 11.4  2 mV (n = 6) due to replacement of 
115 mM extracellular Cl
-
 by impermeable gluconate (not shown). As HEK293 cells do not 
have endogenous Ca
2+
 activated (SK) K
+
 channels there is no contribution of K
+
 currents to 
Ca
2+
 activated whole cell currents. Thus no currents were activated in mock transfected cells. 
These experiments suggest that TMEM16A is the target for INO-4995 and INO-4913, and 
suggest that TMEM16A may be controlled by endogenous tetrakisphosphates.  
TMEM16A is not controlled by IP4 and phosphatidylinositols 
We examined whether TMEM16A is inhibited by Ins(3,4,5,6)P4, since uncoupling of CaCC 
from intracellular Ca
2+
 levels by Ins(3,4,5,6)P4 had been observed earlier, leading to transient 
Cl
-
 currents (176). The baseline (con) and ionomycin-activated Cl
-
 conductance in 
TMEM16A-expressing cells were not affected by the presence of either 10 µM Ins(3,4,5,6)P4 
or Ins(1,3,4,5)P4 in the patch pipette (Fig. 2A). Although baseline currents somewhat varied, 
ionomycin activated whole cell currents were quite similar in TMEM16A-overexpressing 
cells (Fig. 2A). We also examined whether the magnitude or time course of Ca
2+
 activated (1 
µM ionomycin) TMEM16A-currents was affected by IP4. However, we were unable to detect 
any significant effects of Ins(3,4,5,6)P4 or Ins(1,3,4,5)P4 on TMEM16A currents activate by 
Control of TMEM16A by INO-4995 and other inositolphosphates                                             79 
ionomycin (Fig. 2B). 
 
Fig. 1: INO-4995 and INO-4913 activate human TMEM16A. (A)  Original recordings of 
ionomycin (1 µM) activated whole cell currents measured in mock-transfected HEK293 cells or 
cells overexpressing TMEM16A. The cells were voltage clamped to +/- 50 mV. (B) Summary of 
the calculated whole cell conductances (related to the cell size; conductance density) before and 
after stimulation with ionomycin. (C) Whole cell currents in mock transfected and 
TMEM16A-expressing HEK293 cells. Patch pipettes were filled with 1 µM INO-4995. Upon 
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forming a whole cell configuration, TMEM16A was activated by INO-4995 in 
TMEM16A-expressing cells. The CaCC-blocker AO1 (20 µM) inhibited TMEM16A currents 
activated by INO-4995. Right panels show overlay currents. (D) Whole cell currents in mock 
transfected and TMEM16A expressing HEK293 cells. Patch pipettes were filled with 1 µM 
INO-4913. The CaCC-blocker AO1 (20 µM) inhibited TMEM16A currents activated by 
INO-4913. Right panels show overlay currents. (E, F) Summary of the effects of INO-4995, 
INO-4913 and AO1 on whole cell conductances of mock transfected and TMEM16A expressing 
cells. (G) Concentration dependence for the effect of INO-4995 on whole cell conductance in 
TMEM16A-expressing cells. Means ± SE; n = 6-10. Values in parentheses indicate n. #P< 0.05, 
unpaired t-test; *P< 0.05, paired t-test. 
 
Supplemental Fig. S1: (A) Original recordings of stable resting whole cell currents in 
mock-transfected and TMEM16A-expressing HEK293 cells. The cells were voltage clamped to 
+/- 50 mV. (B) Activation of whole cell currents by 1 µM INO-4995 in the patch pipette filling 
solution and in the absence of cytosolic Ca
2+
 (Ca
2+
 free pipette solution containing 5 mM EGTA. 
(C) Summary of the effects of INO-4995 on whole cell conductances (conductance density) in 
mock transfected and TMEM16A expressing cells, in the absence of cytosolic Ca
2+
. (D) 
Summary of the effects of 1 µM ionomycin on whole cell conductances measured in Xenopus 
oocytes 24 hrs after injection of water (control) or INO-4995 (5 µM). (E) Western blot analysis of 
TMEM16A-expression in CFBE airway epithelial cells, with and without treatment by INO-4995 
(1 µM for 2 hrs at three consecutive days). (F) Summary from YFP-fluorescence quenching by I
-
 
influx, indicating inactivation of Ca
2+
 activated Cl
-
 conductance in the continuous presence of 
100 µM ATP. I
-
 was re-added every 5 min to measure remaining halide conductance. Treatment 
with INO-4995 (2hrs for three consecutive days) prolonged activation. Means ± SE (number of 
cells). 
#
significant difference from control cells (unpaired t-test). 
*
significant effects of INO-4995 
and AO1 (paired t-test). 
§
significant difference from non-treated cells (unpaired t-test). 
Notably, ionomycin-induced TMEM16A Cl
-
 currents inactivated in the continuous presence 
of ionomycin, to even below the initial current level that was measured before stimulation 
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with ionomycin (dash line). In preliminary studies we found that this is likely due to 
Ca
2+
/CAMKII-dependent phosphorylation of Ano1 (unpublished data). Activation of 
TMEM16A through stimulation of purinergic receptors with 100 µM ATP was also not 
affected by Ins(3,4,5,6)P4 or Ins(1,3,4,5)P4 (Fig. 2C). Moreover, although INO-4913 itself 
activated TMEM16A (Fig. 1D), it did not further augment TMEM16A currents activated by 
100 µM ATP (Fig. 2D).  
 
Fig. 2: TMEM16A is not controlled by IP4 and phosphatidylinositols. (A) Individual whole 
cell baseline (no agonist) and ionomycin-activated conductances in mock transfected HEK293 
cells and cells overexpressing TMEM16A (16A). Addition of Ins(3,4,5,6)P4 or Ins(1,3,4,5)P4 
to the patch pipette filling solution did not change baseline or  ionomycin-activated Cl
-
 
conductance in TMEM16A expressing cells. (B) Time course of whole cell Cl
-
 conductances 
activated by 1 µM ionomycin in mock-transfected and TMEM16A-overexpressing HEK293 
cells. Ins(3,4,5,6)P4 or Ins(1,3,4,5)P4 in the pipette filling solution did not change the time 
course for activation and spontaneous recovery in the presence of ionomycin. (C, D) Time 
course of whole cell Cl
-
 conductances activated by 100 µM ATP in mock-transfected and 
TMEM16A-overexpressing HEK293 cells. Neither Ins(3,4,5,6)P4, Ins(1,3,4,5)P4 nor 
INO-4913 changed ATP-dependent (100 µM) activation of overexpressed TMEM16A. (E, F) 
Summary of ionomycin- and ATP-induced whole cell Cl
-
 conductances measured in 
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TMEM16A-overexpressing HEK293 cells. Cells were treated with various compounds known 
to interfere with inositolphosphates and phosphatidylinositols. Activated conductances are 
shown relative to conductances in non-treated cells. Means ± SE; n = 5-10. Values in 
parentheses indicate n. #P< 0.05, unpaired t-test; *P< 0.05, paired t-test. 
These data suggest that TMEM16A is not directly controlled by IP4. A number of enzymes are 
crucial for the production of inositol tetrakisphosphates, such as inositol-1,4,5-trisphosphate 
3-Kinase (IP3-3-K), Inositol polyphosphate multikinase (IMPK), and inositol 
1,3,4-triphosphate 5/6 kinase (ITPK-1). We incubated TMEM16A expressing cells 2 - 20 hrs 
with inhibitors of IP3-3-K
 
(20 µM N²-(m-Trifluorobenzyl),N
6
-(p-nitrobenzyl)purine), IMPK 
(2 µM chlorogenic acid) or knocked down expression of ITPK-1 by siRNA (6; 12; 24). 
However, none of these treatments inhibited activation of TMEM16A by ionomycin (data not 
shown). Taken together these data suggest that INO-4913 (and INO-4995) activate 
overexpressed TMEM16A channels directly, which does not seem to involve endogenous 
tetrakisphosphates. Moreover, intracellular Ca
2+
 does not seem to be essential for activation of 
overexpressed TMEM16A channels: When we applied INO-4995 in a Ca
2+
 free pipette filling 
solution (containing 5 mM EGTA), we found a baseline Cl
-
 conductance that was reduced by 
about 50%. However, whole cell currents were still activated by INO-4995, but were reduced 
by about 40% when compared to currents activated in the presence of 0.1 µM [Ca
2+
]i 
(Supplemental Fig. S1B, C). We performed additional experiments in excised inside out 
membrane patches of TMEM16A-expressing HEK293 cells. When we applied 1 µM 
INO-4913 to the cytosolic side, we observed an increase in channel noise and an increase in 
the conductance of cell excised membrane patches (Fig. 3A-C). In contrast no current was 
activated in membrane patches from mock transfected cells (Fig. 3D-F). These results suggest 
that INO-4913 is able to activate TMEM16A directly or by influencing regulatory proteins or 
the membrane lipid composition in close proximity of the channel. 
Cytosolic inositolphosphates are closely linked to the membrane phosphatidy- linositols 
phosphatidylinositol 4,5-bisphos- phate (PIP2) and phosphatidylinositol 3,4,5-trisphosphate 
(PIP3). Other ion channels such as Ca
2+
 activated K
+
 channels (KCNN4), epithelial Na
+
 
channels (ENaC) and renal K
+
 channel (ROMK) are controlled by these membrane lipids (58; 
71; 91; 157). We therefore examined the effects of the PI3 kinase inhibitors wortmannin (1 
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µM/4 hours) and LY294002 (100 nM/3hours), which are known to reduce PIP3 levels in the 
plasma membrane. Moreover, we tested the effects of phospholipase C inhibitor U73122 (10 
µM/5 hrs; increasing PIP2 levels), siRNA knockdown of the enzyme PTEN (decreasing PIP2 
levels), as well as the diacylglycerol inhibitor 3-[2-[4-(bis(4- Fluorophenyl)methylene)-1 
–piperi-dinyl]e- thyl]-2,3-dihydro-2-thioxo-4(1H)-quin- azolinone (25 µM/5 hrs; decreasing 
all phosphatidylinositols). However, we found no significant effects of any of these treatments 
on the activity of TMEM16A, activated directly by Ca
2+
 (1 µM ionomycin) or through 
stimulation of P2Y2 receptors (100 µM ATP) (Fig. 2E, F). It is therefore unlikely that 
INO-4913 and INO-4995 act through any of these pathways. In contrast, these treatments 
strongly interfered with the activity of the epithelial Na
+
 channel ENaC, which is known to be 
regulated by phospholipids (data not shown). 
 
Fig. 3: TMEM16A may be directly activated by INO-4913. Current recordings from excised 
inside out membrane patches of HEK293 cells overexpressing TMEM16A. (A) Current noise 
was increased by application of 1 µM INO-4913 to the cytosolic site of the excised membrane 
patch. Clamp voltage was +80 mV. (B) Continuous recording of the patch current during 
voltage clamp between ± 50 mV. INO-4913 increased the patch current. (C) Summary of the 
conductance of the excised membrane patch and effect of INO-4913. (D-F) Comparable 
experiments obtained from mock transfected cells. Means ± SE; n = 5. Values in parentheses 
indicate n. *P< 0.05, paired t-test. 
INO-4995 enhances endogenous Ca
2+
 activated chloride currents  
We examined whether INO-4913 and INO-4995 are able to activate endogenous, i.e. 
non-overexpressed TMEM16A-currents. Oocytes from Xenopus laevis are known for their 
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pronounced endogenous Ca
2+
 activated Cl
-
 current, which is now known to be due to 
expression of TMEM16A (149). We found that acute application for up to 2 hrs, of 5 µM 
INO-4995 or INO-4913 did not augment baseline Cl
-
 conductance or TMEM16A currents 
activated by 1 µM ionomycin. In contrast, incubation for 24 hours with either INO-4995 or 
INO-4913 induced an enhanced baseline Cl
-
 current and augmented ionomycin-activated 
currents (Fig. 4). 
 
Fig. 4: Endogenous TMEM16A expressed in Xenopus oocytes is activated by INO-4995 and 
INO-4913. (A) Original recordings of whole cell currents measured in Xenopus oocytes. The 
cells were voltage clamped from -60 to + 40 mV. Ionomycin (1 µM) activated a whole cell Cl
-
 
current, which was enhanced when cells were incubated for 24 hrs with 5 µM INO-4995 and 
INO-4913, respectively. (B) Summary of whole cell conductances measured under control 
conditions and after stimulation with 1 µM ionomycin. Means ± SE; n = 7-8. Values in 
parentheses indicate n. #P< 0.05, ANOVA; *P< 0.05, paired t-test. 
Very similar results were obtained when INO-4995 was directly injected into the oocytes and 
when the oocytes were measured the following day (Supplemental Fig. S1D). Obviously 
longer incubation times are necessary to activate endogenous TMEM16A, as already 
suggested from previous results, obtained for INO-4995 dependent activation of endogenous 
TMEM16A in human CF airway epithelia and CF mouse airways (173).  
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Fig. 5: INO-4995 and INO-4913 augment endogenous ATP-activated Cl
-
 currents in epithelial 
cells. (A) Summary of ATP (100 µM) induced whole cell Cl
-
 currents in HT29, CFPAC and 
M1 cells. In all three cell lines, Cl
-
 currents were largely reduced after siRNA-knockdown of 
TMEM16A. (B) Time course of the whole cell conductances relative to control. ATP induced 
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a whole cell Cl
-
 conductance that was about 3 times larger when INO-4913 was present in the 
patch pipette solution. (C) Original tracings from I
-
 quenching of fluorescent YFP in HT29 
cells after stimulation with 1 µM ATP. Cells were treated with different concentrations of 
INO-4995 (0.01 – 5 µM. (D) Concentration dependent effect of INO-4995 on I- quenching of 
fluorescent YFP in HT29 cells, upon stimulation with 1 µM ATP. ATP was applied to cells 
which had been incubated for 2 hrs at three consecutive days, with different concentrations of 
INO-4995. (E) Effect of ATP on intracellular Ca
2+
 concentrations (measured as Fura-2 
340/380 nm fluorescence ratio in HT29 cells). Ca
2+
 increase by ATP was essentially unaffected 
by 5 µM INO-4995. (F) Immunocytochemistry photo of endogenouse TMEM16A in HT29 
cells, before (upper panel) and after (lower panel) treated with INO-4995 (2 hrs at three 
consecutive days). Means ± SE; n. Values in parentheses indicate n. #P< 0.05 vs. control, 
unpaired t-test. 
We further examined whether INO-4913 controls endogenous TMEM16A expressed in 
different types of epithelial cells. To that end we first examined whether TMEM16A is respo- 
nsible for endogen- ous Ca
2+
 activated Cl
-
 currents in epithelial cells of human colon (HT29), 
human pancreas (CFPAC), and mouse collecting duct (M1). To that end we knocked down 
TMEM16A-expression using siRNA and stimulated Ca
2+
 activated Cl
-
 currents with 100 µM 
ATP (3; 92). In all three cell lines knockdown of TMEM16A largely reduced ATP-activated 
whole cell currents, suggesting that TMEM16A is the major component of endogenous CaCC 
(Fig. 5A).  
Then we went on to examine activation of whole cell Cl
-
 currents by ATP in HT29 control cells, 
and cells that had been treated with 1µM INO-4913. We found that ATP-induced whole cell 
currents were augmented by treatment with INO-4913 (Fig. 5B). When cells were incubated 
with different concentrations of INO-4995 for 2 hours at three consecutive days (173), we 
found a concentrations-dependent increase of the ATP-activated anion permeability, as 
measured in iodide quenching assays (Fig. 5C, D). Similar results were found in (n = 5) whole 
cell patch clamp experiments (data not shown). Importantly, these positive effects of 
INO-4913 and INO-4995 on Ca
2+
 activated TMEM16A currents are not due to effects on 
[Ca
2+
]i, since ATP-induced rise in [Ca
2+
]i in HT29 cells was basically unaffected by INO-4995 
up to a concentration of 5 µM (Fig. 5E). These results indicate activation of TMEM16A by 
INO-4913 and INO-4995 in mammalian epithelial cells. We could not detecte a change of 
overall expression of TMEM16A by INO-4995 (Supplemental Fig. S1E), however, 
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immunocytochemistry suggested an increase in membrane expression of TMEM16A in HT29 
cells, by treatment with INO-4995 (Fig. 5F). 
INO-4995 activates TMEM16A in primary 
cultures of airways 
The essential question is, whether INO-4995 is 
able to increase Ca
2+
 activated Cl
-
 currents in 
human airways. 
Using RT-PCR we analyzed we found 
expression of TMEM16A in all parts of the 
human respiratory polarized human bronchial 
epithelial cell monolayers mounted in 
micro-Ussing chambers. Human airway cultures 
were treated repetitively (for 2 hrs in 4 
subsequent days) with INO-4913 and INO-4995, 
respectively, similar to a previous study (173). Luminal application of 100 µM ATP activated 
Ca
2+
 dependent Cl
-
 secretion, which had a transient and a steady state component (Fig. 6B). 
ATP is known to act primarily on luminal purinergic P2Y2 receptors in human airways (124; 
137).  Both components were potently blocked by the CaCC inhibitors niflumic acid (10 µM) 
Fig. 6: INO-4995 activates endogenous TMEM16A in polarized human non-CF airway 
epithelial cells. (A) RT-PCR analysis indicates expression of TMEM16A throughout the 
native human respiratory tract. (B) Original Ussing chamber recordings (open circuit 
measurements) obtained from human primary airway epithelial cells grown on permeable 
supports with an air liquid interface. ATP (100 µM) induced transient and steady state voltage 
deflections of the transepithelial voltage, indicating activation of Cl
-
 secretion. ATP-induced 
voltage deflections were augmented after repetitive treatment (2 hrs at four consecutive days) 
with 5 µM INO-4995. (C) Summary of ATP-induced transient and steady state equivalent 
short circuit currents (calculated from voltage deflections) in control airway cells and cells 
treated with INO-4913 and INO-4995, respectively. The inhibitor AO1 (20 µM) completely 
blocked ATP-induced Isc. Means ± SE (number of cells). Values in parentheses indicate n. #P< 
0.05 vs. control; ANOVA; 
$
P< 0.05, paired t-test indicates significant inhibition by AO1 or 
significant activation by ATP.  
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(not shown) or CaCCinhAO1 (20 µM)  (31) (Fig. 6C). After treatment with INO-4995 but not 
INO-4913, ATP- induced voltage deflections were augmented and calculated equivalent short 
circuit currents (Isc-ATP) were enhanced (Fig. 6B, C). In some experiments with INO-4995 
treated cells we applied ATP for up to 20 min and found that the steady state Isc was 
substantially larger than in control cells. In additional YFP-quenching experiments we 
exposed INO-4995-treated and non-treated HT29 cells to 100 µM ATP for 15 min, and 
re-added iodide every 5 min. The results suggest a prolonged activation of Ca
2+
 dependent Cl
-
 
secretion after treatment with INO-4995 (Supplemental Fig. 1F). 
 We also performed the same treatment by INO-4995 with primary cultures from CF-airways. 
As demonstrated in Fig. 7, ATP induces a voltage deflection that was clearly enhanced after 
treatment with INO-4995. Residual CFTR Cl
-
 secretion by genistein in these CF-lung 
monolayers was not affected by INO-4995 (-INO: Isc = 0.18 ± 0.5 µA/cm
2
, n=3 vs. +INO: 
Isc = 0.20 ± 0.4 µA/cm
2
, n=3). We compared the effects of treatment with INO-4995 in 
normal and CF-airways and found a 50% enhanced effect of INO-4995 on the transient Ca
2+
 
activated Cl
-
 secretion in CF airways. Taken together, the present data indicate that INO-4995 
augments Ca
2+
 activated Cl
-
 secretion by activation of TMEM16A. The results suggest 
INO-4995 as a useful tool to augment a compensatory Ca
2+
 dependent Cl
-
 secretion in 
dehydrated CF lungs. 
 
Fig. 7: INO-4995 activates endogenous TMEM16A in polarized human CF airway epithelial 
cells: (A) Original Ussing chamber recordings (open circuit) obtained from CF primary 
airway epithelial cells grown on permeable supports with an air liquid interface. ATP (100 
µM) induced transient and steady state transepithelial voltage deflections, indicating 
activation of Ca
2+
 dependent Cl
-
 secretion. Effect of treatment by INO-4995 (5 µM; 2 hrs at 
four consecutive days). (B) Summary showing activation of transient and steady state 
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equivalent short circuit currents (calculated from voltage deflections) by ATP after treatment 
with INO-4995 relative to non-treated cells. The data demonstrate a slightly enhanced effect 
of INO-4995 on CF-primary. Effect of ATP in non-treated tissues is set to 100% (dash line). 
The inhibitor AO1 (20 µM) completely blocked ATP-induced Isc. Mean ± SEM (number of 
cells). 
#
significant difference from control cells (unpaired t-test). 
$
significant inhibition by 20 
µM AO1 (paired t-test). 
Discussion 
Activation of TMEM16A by INO-4995 
The aim of the present study was to examine whether the recently identified Ca
2+
 activated Cl
-
 
channel TMEM16A is the target for two synthetic inositol tetrakisphosphates. INO-4995 and 
INO-4913 that have been demonstrated earlier to enhance Ca
2+
 activated Cl
-
 currents and 
therefore to improve electrolyte balance in airways of CF mice (140; 173). The present results 
clearly show that both INO-4995 and INO-4913 activate TMEM16A that was overexpressed 
in HEK293 cells. Interestingly activation of TMEM16A by INO-4995 and the less membrane 
permeable but active compound INO-4913 occurred even in the absence of cytosolic Ca
2+
 
(Supplemental Fig. S1C). Moreover, the INO-compounds activated overexpressed 
TMEM16A without increasing intracellular Ca
2+
 (data not shown) and did not affect 
intracellular Ca
2+
 signalling (Fig. 5E). Notably TMEM16A channels, when overexpressed in 
HEK293 cells and other cell types, are partly active even at resting Ca
2+
 concentrations (97). 
The reasons for this is currently unclear, however, we speculate that additional proteins are 
required to regulate TMEM16A (170).  
The effects of INO-4995 and INO-4913 were remarkably different on TMEM16A, expressed 
endogenously in Xenopus oocytes or mammalian cells from colon and airways. Inhibition of 
TMEM16A by siRNA indicated that TMEM16A is a main component of endogenous CaCC 
in these cells. Here we could not detect a direct and fast activation of CaCC, i.e. endogenous 
TMEM16A by INO-4995. However, INO-4995 increased TMEM16A-currents which were 
stimulated by agonists such as ATP. To see this effect, cells needed to be incubated 
repetitively with INO-4995, or for a longer duration. The results obtained in these 
experiments are remarkably similar to those obtained previously on airways of CF mice (173). 
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We have currently no explanation why the effect of INO-4995 is different on overexpressed 
and endogenous TMEM16A channels.  
Notably, we obtained similar results with benzimidazolone compounds, which are known to 
activate Ca
2+
 activated (KCNN4) K
+
 channels: Overexpressed TMEM16A but not 
endogenous CaCC was directly activated by these compounds (169; 170). From those and the 
present results we may speculate that endogenous TMEM16A are inhibited by unknown 
auxiliary proteins. INO-4995 and INO-4913 may augment endogenous TMEM16A, once 
released from inhibitory proteins due to increase in [Ca
2+
]i. Alternatively, prolonged and 
repetitive  incubation with INO-4995 may up-regulate membrane expression of TMEM16A 
(Fig. 5F). Notwithstanding the data indicate that TMEM16A is the target of INO-4995. 
Overexpressed TMEM16A is not controlled by IP4 and phosphatidylinositols 
Although the results suggest that INO-4995 and INO-4913 activate TMEM16A by interfering 
with endogenous inositolphosphates, we found no evidence for a regulation of TMEM16A by 
IP4 or phosphatidylinositols. Ins(3,4,5,6)P4 has been proposed earlier to control the time 
course of endogenous CaCC activity (67). Evidence has been provided that the Ca
2+
 peak 
induced by activation of PLC-coupled receptors switches on CaCC, while prolonged 
activation is due to CaMKII dependent phosphorylation, which is modulated by 
inositolphosphates (63). In CFPAC cells low concentrations of ATP (2 µM) were used to elicit 
rather small endogenous Cl
-
 currents (68). It may be that at higher agonist concentrations of 
ATP, like those used in the present study, regulation by inositol phosphates is overrun. 
Alternatively, the endogenous CaCC of CFPAC cells that is inhibited by Ins(3,4,5,6)P4 is not 
TMEM16A. This, however, is unlikely since endogenous CaCC in CFPAC cells was inhibited 
by siRNA for TMEM16A in this and in a previous study (3). Moreover, IP4 protein 
phosphatases seem to have role for the inhibitory effect of IP4 on CaCC (193). Taken together, 
Ins(3,4,5,6)P4 dependent regulation of CaCC is poorly examined and could not be detected in 
any cases (20; 23; 83; 189; 192; 193). It is likely that Ca
2+
 activated Cl
-
 channels are 
composed of several, still unknown proteins and that TMEM16A is only one, however, 
essential subunit of a channel complex (19). Data have been provided suggesting that 
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different TMEM16 paralogs can heterooligomerize (92; 148), and two recent papers show that 
TMEM16A exists as a homodimer (47; 153).  
INO-4995 and INO-4913 activate endogenous TMEM16A in various cells types and in human 
airway cells  
As mentioned above, the present results demonstrate that endogenous TMEM16A in Xenopus 
oocytes, colonic HT29 and human airway epithelial cells is activated by INO-4995. It appears 
that prolonged or repetitive incubation with INO-4995 increases CaCC, as described in (173). 
This is probably not due to an upregulation of TMEM16A-expression, as we could not detect 
enhanced TMEM16A protein after repetitive incubation INO-4995 (5 µM/ 2 hrs) for up to 
four days (Supplemental Fig. S1E). However, prolonged exposure to INO-4995 appears to 
increase membrane expression of TMEM16A, as demonstrated in HT29 cells (Fig. 5F). Taken 
together the present results suggest that INO-4995 and INO-4913 may be useful tools to 
augment Ca
2+
 dependent Cl
-
 secretion in the airways of CF patients. 
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CHAPTER 6 
Discussion 
Other anoctamins can also function as CaCCs 
Anoctamins do not show any obvious homology to other ion channels. Ano2, the closest 
relative of Ano1, has been shown to function as CaCC in olfactory receptors and 
photoreceptor synaptic terminals (65; 160). Ano2, 3, and 4 are mostly expressed in neuronal 
tissues. mRNA of Ano3 and Ano4 are equally expressed in spinal cord, brain stem, 
cerebellum, and eye (115; 148). Ist2p, the anoctamin in S. cerevisiae, is translated locally at 
the peripheral endoplasmic reticulum (ER) and may be inserted into the plasma membrane by 
the fusion of peripheral ER with the plasma membrane. If these anion selective proteins in 
mammals are transported by a similar novel mechanism, they might have effects on protein 
synthesis in axons and dendrites (64). A new report on a genome-wide association study 
(GWAS) found that Ano3 is associated with Alzheimer’s disease (17). Our data proved a 
function of Ano4 as CaCC. Thus Ano3, as the closest relative of Ano4, may also function as 
CaCC, which was confirmed in an unpublished study (Oh et al, personal communication).  It 
will be exciting to examine the role of Ano3 and its related single nucleotide polymorphisms 
(SNPs) in Alzheimer’s disease. 
An unpublished doctoral thesis written by Milana Chinenkova showed that Ano6 is expressed 
in the cytoplasm of osteoblast cells, and the phenotype of knockout mice demonstrated curved 
and shorter long bones, with delayed endochondral and intramembranous ossification. That 
means Ano6 is an important factor in bone mineralization. This result is reminiscent of the 
function of Ano5. Mutations in Ano5 lead to abnormal bone mineralization and bone fragility 
called gnathodiphyseal dysplasia (GDD) (175). It is known that Ano5 is expressed in 
chondrocytes and osteoblasts (116), indicating an important role in bone formation. These two 
anoctamins are closest relatives of the same branch of phylogenetic tree of the anoctamin 
family, and their similar localization makes it likely that they are functionally related. Perhaps 
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they may even compensate for each other. In our study, we have found that Ano5 and Ano6 
require higher and maybe more sustained Ca
2+
 levels to be activated. The anion selectivity 
was similar for Ano1, 4, 6, and 10, and was I
- 
> Br
- 
> Cl
- 
> HCO3
-
, suggesting a low field 
strength anion selectivity.  
Analysis of the cation permeability showed that Ano6 is permeable for K
+
. Moreover, Ano6 is 
also permeable for Ca
2+
, as reported earlier (195). Taken together these results suggest that 
anoctamins are either poorly selective for anions or they somehow induce parallel cation 
conductances. It is currently poorly understood why Ano6 is an essential component of 
outwardly rectifying Cl
-
 channels (ORCC) and, at the same time, operates as a membrane 
localized phospholipid scramblase (110; 163). This multi-function protein attracts more and 
more attention and needs to be investigated intensively.  
Ano7, 8, 9 produce relatively small Cl
-
 currents, especially Ano8 activation was found to be 
extremely slow, with activation time far beyond that of Ano1. This property may be related to 
the predicted large extracellular loop between transmembrane domain 5 and 6. Ano7 and 
Ano9 are also related to cancer. Ano7 is expressed more specifically in the prostate and up 
regulated in prostate cancer (13), while Ano9 is expressed in human colorectal, lung and 
breast cancer (86). The relation to cancer may probably be similar to that described for Ano1, 
and could be due to the function of CaCC in cell volume regulation. Ano10 can be activated 
by both the purinergic receptor and directly by Ca
2+ 
increase through ionophores. However, 
when we replaced the extracellular Na
+
 with NMDG
+
, the activation of the channel was 
dramatically suppressed, indicating that extracellular Na
+ 
is necessary for the channel to be 
fully open, or, alternatively, the channel has a pronounced permeability for cations. The 
Ano10 gene has been suggested to be the genetic basis of autosomal recessive cerebllar 
ataxias. At the same time, we should note that the high Ano10 expression levels in brain areas 
important for cognitive performance, such as the cortex and hippocampus (182), which 
warrants future investigation of CaCC function in the brain. 
Anoctamins are the molecular identities of CaCCs and contribute to RVD 
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Ubiquitous chloride channels with permeability to Cl
-
 and other anions may be housekeeping 
proteins present in all cells. They contribute to cell volume regulation, excitability, contraction, 
and transepithelial electrolyte transport (75). These specialized functions are typically carried 
out by different Cl
-
 channels whose molecular identities became known over the past 20 years. 
Most studies have made use of the patch-clamp technique which allows characterization of 
the biophysical properties, mechanism of regulation and pharmacology of these Cl
-
 channels. 
Among the various Cl
-
 channels, CaCCs have attracted the attention of many investigators, 
because they participate in many important physiological processes, including epithelial fluid 
secretion, smooth muscle contraction and olfactory transduction (97). The molecular identities 
of CaCC have emerged through discovery of Ano1 (19; 149; 197). Amoctamins are a family 
of transmembrane proteins with 10 members, which are evolutionarily well conserved. They 
have both intracellular C- and N- termini and eight transmembrane domains (97).  
We have reported recently that all ten anoctamins are indeed a family of CaCCs (170). Among 
all other functions, we found that CaCCs also contribute to regulatory volume decrease (RVD) 
(3). When the extracellular osmolarity decreases, cells take up water and swell. Osmotic cell 
swelling increases intracellular free Ca
2+
 concentration in most cell types examined so far 
(113). Swelling-induced ATP release augments the Ca
2+
 response to a hypotonic challenge via 
stimulation of P2Y2 receptor (36). Therefore RVD is facilitated by autocrine secretion of ATP 
and subsequent release of ER-Ca
2+
. This process occurs via a G protein-coupled and 
PLC-linked P2Y2 receptor. Through the increase in intracellular Ca
2+
, CaCCs are activated 
which thereby contribute to RVD, as schematically depicted in Fig. 1 (122). 
Through description of data outlined in chapter 3, it becomes clear that Ano1 and other 
members of the anoctamin family contribute to swelling-activated whole cell currents (ICl, swell) 
in different human cell types. After siRNA knockdown of each anoctamin, we observed a 
non-additive reduction in ICl, swell. This could indicate that anoctamins hetero-oligomerize to 
form CaCCs, which are then sensitive to osmotic cell swelling. This ICl, swell is greatly 
dependent upon purinergic signaling, because when we removed ATP from our experimental 
bath solutions using ATP-hydrolyzing enzymes, or when we blocked the purinergic receptor, 
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ICl, swell was reduced dramatically. The importance of Ano1 for cell volume regulation has also 
been shown in Ano1 knock out animals. Submandibular glands express high levels of Ano1 
(124). We isolated acinar cells from submandibular glands and exposed these cells to 
hypotonic solutions. The whole cell current activated by cell swelling as detected in control 
mice was abolished in the Ano1 knockout mice.  
Further support for our study 
was provided by a recent 
report which showed that 
alpha-Hemolysin from 
Escherichia coli (HlyA) 
triggers an acute erythrocyte 
shrinkage, which depends on 
Ca
2+
 activated Cl- efflux via 
Ano1 (156). Taken together 
our data clearly indicate that 
anoctamins contribute to 
volume regulated Cl
-
 currents 
in both native mouse epithelial cells and different human cell lines. This house keeping 
function puts anoctamins in line with the true volume regulatory anion channel (VRAC), 
whose molecular identity still remains to be identified. It is important to note that the 
biophysical properties of CaCC are different from VRAC, particularly with respect to the 
typical time-dependent activation of CaCC. Despite these characteristic differences both 
currents support cellular RVD and are activated in parallel. Importantly, knockdown of Ano1 
in HEK293 cells also reduced AVD (apoptosis volume decrease) an initial cell shrinkage 
during apoptosis, suggesting that anoctamins are important for both RVD and AVD. 
Fig. 1: Schematic model of the molecular mechanism of RVD and its control mediated by G 
protein-coupled P2Y2 receptors and Ca
2+
 release in intestinal 407 cells. Gq and Gs represent G 
proteins coupled to phospholipase C (PLC) and adenylate cyclase (AC); respectively. PMCA 
represents the plasmalemmal Ca
2+
 pump (120). 
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How does Ca
2+
 regulate Ano1? 
After Ano1 had been generally accepted as CaCC, its regulation was examined most 
extensively. The research team led by Galietta showed that alternate splicing, for example 
skipping of exon-6b, which encodes 22 amino acid localized in N-terminal, increases the Ca
2+
 
sensitivity and skipping of exon-13 strongly reduces the characteristic time-dependent 
activation at positive membrane potentials (52). In contrast, the research team led by Hartzell 
reported that deleting amino acids 448EAVK in the first intracellular loop dramatically 
decreases the apparent Ca
2+
 affinity. In contrast, mutating the adjacent 444EEEE abolishes 
intrinsic voltage dependence without altering the apparent Ca
2+
 affinity (191). However, one 
year later, they revised their model of Ano1, and now suggest that the 4
th
 extracellular loop 
should be intracellular, and that this fragment contains two negative amino acids, which are 
important for Ca
2+
 sensing (198). Clearly the data provided by these groups are contradictory, 
which leaves Ca
2+ 
binding site still to be determined.  
In Chapter 4, we elucidated the mechanisms for activation of Ano1 and found that calmodulin 
(CAM) is the auxiliary Ca
2+ 
binding protein, which can bind to the putative CAM binding site 
localized in the N-terminal domain within the stretch of amino acids encoded by exon-6b. 
This putative CAM binding site is missing, after deletion of exon-6b through alternative 
splicing. It appears possible that Ca
2+
 and CAM have more than one binding site, while the 
Ano1 ac form without the CAM binding site can still be activated by Ca
2+
, maybe through 
direct binding. 
Interestingly, our data show that activation of Ano1 was suppressed by both depolymerizing 
and stabilizing actin, and thus demonstrates that Ano1 is activated by Ca
2+ 
in an 
actin-dependent manner. Further support for this finding was provided by a recent report, 
which showed that Ano1 interacts with the signaling/scaffolding proteins ezrin, radixin, 
moesin, which link the channel to the actin cytoskeleton. This team also reported that 
knockdown of moesin reduced Ano1 currents, clearly showing that Ano1 activation depends 
on actin-binding regulatory proteins (130).  
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Similar to other epithelial ion channels, anchoring of Ano1 to the cytoskeleton and to 
membrane PIP2 may be essential in maintaining channel activity (72; 138). We have also 
found in Ano1 overexpressing HEK293 cells and in the presence of 100 nM free Ca
2+ 
concentration
 
in the patch pipette that basal Cl
-
 currents are enhanced. These enhanced basal 
Cl
-
 currents were abolished after 30 min pre-incubation with the Ca
2+
 chelator BAPTA-AM. 
Surprisingly, when we coexpressed Ano1 together with Ano9, both the basal whole cell 
conductance and the currents activated by ATP were suppressed. This led us to the hypothesis 
that an inhibitory factor or additional protein might be missing in overexpressing cells that 
keeps overexpressed Ano1 closed under control conditions. It is possible that Ano9 is part of 
this inhibitory mechanism, which is under-represented in cells overexpressing Ano1 (148; 
170). 
We have also found for Ca
2+
-dependent gating of Ano1 that an increase in intracellular Ca
2+
 
initially activates the channel, but then triggers inactivation by a Ca
2+
 dependent process. This 
mechanism may be due to CAMKII, as we have shown that in the presence of the CAMKII 
inhibitor KN62, inactivation of the channel was significantly attenuated (170). This is similar 
to the inhibition of CaCC by CAMKII in smooth muscle cells (60). We tried to further 
localize the molecular site within Ano1 that is responsible for its transient activation by 
replacing the N-terminus of Ano1 with that of Ano6 (Ano1N6), since Ano6 produces more 
sustained Cl- currents. Notably, whole cell currents generated by the chimerical Ano1N6 
channel were no longer transient. This suggests that the N-terminus controls both activation 
and inactivation of anoctamins.  
The CAM-dependent regulation of Ano1 is reminiscent of Ca
2+
/CAM dependent regulation of 
SK4 (Kcnn4), a Ca
2+
-dependent potassium channel. This channel is tightly regulated by 
intracellular Ca
2+
, but also lacks of a typical Ca
2+
 binding domain (87). Surprisingly, the 
benzimidazolinone 1-EBIO, which is a well known SK4 channel activator (62), can also 
activate Ano1 with an even 1000 fold higher affinity. Since 1-EBIO activates both basolateral 
SK4 and luminal Ano1 channels in airway epithelial cells, it could be an ideal compound to 
induce Cl- secretion in airways and may therefore be useful for the treatment of the lung 
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disease in cystic fibrosis (CF). 
INO-4995 and other inositolphosphates activate Ano1 in a Ca
2+
 independent manner 
Activation of CaCC in CF airways may ameliorate mucociliary clearance and compensate for 
defective CFTR. Since intracellular Ca
2+
 is a common second messenger in all living cells, it 
activates a large number of downstream molecules, depending on the cell type or cell 
compartment. To avoid the unwanted activation of downstream molecules, a compound which 
could activate CaCC directly without increasing cytosolic Ca
2+ 
is the most preferential drug 
candidate. If CaCC could be activated without increasing cytosolic Ca
2+
, it might be an ideal 
way to treat CF. The membrane permeable compound 1-O-octyl-2-O-but-yryl-myoinositol 
3,4,5,6-tetrakis- phosphate octakis (propionoxymethyl) ester (INO-4995, Fig. 2) (172) was 
demonstrated both to inhibit the epithelial Na
+
 channel ENaC and to activate Ca
2+
 dependent 
Cl
-
 secretion (117; 141; 172). In our study we showed that it can acutely activate Ano1 in 
overexpressing HEK293 cells, without enhancing cytosolic Ca
2+
. More surprisingly, this 
activation can even happen in the absence of cytosolic Ca
2+
. 
However, we found no acute 
activation by INO-4995 of 
endogenous Ano1 expressed in 
Xenopus oocytes, human airways, 
and colonic cells. We have also 
tried prolonged and repetitive 
incubation with INO-4995. This 
treatment increases CaCC 
currents as described in (172). However, according to our Western blot analysis, there is no 
upregulation of Ano1 expression after repetitive incubation with INO-4995 for up to four days. 
The enhanced CaCC currents are probably due to increased membrane expression as 
demonstrated by immunostaining (171).  
Another report described a cell-based functional screening of ~110,000 compounds, which 
Fig. 2: Molecular structure of INO-4995. 
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identified a group of N-aroylaminothiazole “activators” (Eact) of Ano1. These compounds 
activated Ano1 in the absence of intracellular and extracellular Ca
2+
, whereas 
tetrazolylbenzamide “potentiators” (Fact) (Fig. 3) required intracellular Ca
2+
 but reduced the 
EC50 for Ca
2+
 dependent Ano1 activation (120). The team also generated an Ano1 inhibitor 
through minor structural modification of the activators. This strongly suggested direct binding 
of these small molecules to Ano1 channels. These molecules may be good candidate drugs for 
the treatment of CF patients. 
 
Fig. 3: Molecular structure of Eact and Fact. 
Ano1 and cancer 
Before Ano1 was identified as CaCC, it was actually known as cancer-associated protein in 
gastrointestinal stromal tumors (GISTs) and head and neck squamous cell carcinomas (21; 22; 
187). Ano1 is embedded within the 11q13 amplicon, which is associated with a poor 
prognosis in squamous cell carcinoma of the head and neck (74). A new report shows that 
Ano1 is very little expressed in normal human tissues, such as gastrointestinal tract, 
esophagus, liver, pancreas, testis lung and kidney (106). The team found Ano1 overexpressed 
in human prostate cancer tissues, and knockdown of Ano1 with small hairpin RNAs (shRNAs) 
resulted in a significant reduction of proliferation, metastasis and invasion of PC-3 cells. 
Another recent report claimed that Ano1 induces MAPK and contributes directly to 
tumorigenesis and cancer progression. They found that Ano1 overexpression significantly 
promoted anchorage-independent cell growth in vitro and that loss of Ano1 resulted in 
inhibition of tumor growth both in vitro and in vivo (43). Taken together, overexpression of 
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Ano1 is highly linked to cancer, probably due to the volume regulatory function of CaCC. 
However, the precise mechanism behind its anti-apoptotic role is still not clear. The ability of 
cancer cells to metastasize is linked to their ability to migrate. Migration of cells depends on 
their intracellular ion concentration and their ability to increase their volume at the leading 
edge with extension of the lamellipodium and parallel shrinkage and retraction of the rear part 
of the cell (150; 159). This cell shrinkage process needs both K
+
 and Cl
-
 channels to release 
both ions in order to maintain electro-neutrality (Fig. 4b). 
 
Fig. 4: Role of Ano1 in cancer: a Potential role of anoctamins and Gardos K
+
 channels in 
volume regulation and cell shrinkage after hypotonic cell swelling or increase in intracellular 
Ca
2+
. ATP release leads to activation of purinergic signaling along with activation of Erk1,2. b 
Anoctamin and Gardos-mediated cell shrinkage at the rear end of migrating cells. 
Accordingly, anoctamins may serve as CaCC during cellular volume regulation (Fig. 4a) (97). 
These multiple effects of Ano1 on cell physiology call for attention when used for drug 
therapy in CF. Any compound which can enhance CaCC function or increase expression of 
CaCC may be helpful for airway secretion, but, on the other hand, may have undesired effects 
on cell proliferation and could be potentially tumorigenic. 
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Summary and outlook 
To summarize, anoctamins as a newly identified family of CaCCs, play an essential role in 
embryonic development, sensation, neurobiology, epithelia secretion, muscle and bone 
formation, and gastrointestinal peristalsis (33; 77; 97; 134; 136). Overexpression of 
anoctamins is related to tumorigenesis, anoctamin mutations are related to various diseases 
(41; 97). For the most classic CaCC, Ano1, mutations in patients have not yet been reported, 
probably because loss-of-function mutations of Ano1 might be lethal in humans, just like 
Ano1 knockout mice, which can not survive after birth (124). Mutations in other anoctamins 
are extremely rare, such as those found for Ano6 and Ano5 (41). Also, defective function of 
anoctamin mutants may be compensated by other anoctamins. 
It is almost sure that in the near future, anoctamins will attract more scientists to investigate 
this highly interesting family of proteins, as demonstrated by the ever increasing number of 
publications on anoctamins. It is known that the CaCCs are ubiquitously expressed and 
evolved conservatively. Their physiological role needs to be studied comprehensively. Among 
other methods, electrophysiology is a fundamental tool to study this family of chloride 
channels, and with the help of other novel techniques and institutions such as the world wide 
association study for single nucleotide polymorphisms, we will learn to understand this family 
of proteins. 
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